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ABSTRACT
The work presented in this thesis was undertaken as part of a larger research initiative
in the field of ruminant paratuberculosis (Johne's disease). One of the group's main
research objectives was the identification and characterisation of subspecies-specific
genes and proteins of the two members of the Mycobacterium avium complex
(MAC) known to have a causal role in ruminant paratuberculosis, namely
Mycobacterium avium spp. paratuberculosis (M.a.paratuberculosis) and IS901/902-
positive strains ofMycobacterium avium (M. avium).
A protein antigen of 40kDa (p40) was identified in an IS901/902-positive strain of
M.avium, but could not be detected in M.a.paratuberculosis, IS901/902-negative
M. avium, or in any of 13 other species ofMycobacterium tested. Examination of 19
further MAC field isolates confirmed the absolute association between p40 and
IS901/902, suggesting that p40 is a novel, subspecies-specific protein which may
potentially be of value as a diagnostic antigen.
Soluble p40 antigen was precipitated from cleared cell lysates and purified to
homogeneity using a series of chromatographic separations. Chemical cleavage and
Edman degradation of the purified p40 antigen provided both amino-terminal and
internal amino acid sequence data which showed no sequence identity with any
protein sequence currently in the OWL database. Translations of IS901/902 in all six
reading frames revealed amino acid sequences which confirmed that the genomic
insertion sequence does not encode the p40 antigen. A second protein of 30kDa
(p30) was purified simultaneously, and analysis of the first 10 amino-terminal amino
acid residues revealed up to 90% sequence identity with the mature secretory
antigens of the "antigen 85 complex" of eight other species ofMycobacterium.
Experiments were designed to ascertain whether the p40 antigen was expressed in
vivo and to assess whether any immune response to the p40 could be exploited in the
development of an immune-based assay to differentiate between animals infected
with M.a.paratuberculosis, and others infected with IS901/902-positive strains of
M. avium. Two groups of sheep were infected orally with either
M.a.paratuberculosis or IS901/902-positive M.avium. In assays measuring
secondary T-lymphocyte proliferation and IFN-y production, the p40 antigen
stimulated responses only in the sheep infected with IS901/902-positive M.avium.
As such, the p40 antigen is the first protein molecule to be identified which can be
used to distinguish between the two members of the M. avium complex responsible
for causing chronic inflammatory bowel disease in ruminants. In addition, immune
responses to the p30 secretory antigen were observed in both groups of infected
sheep, but not in a third group of sheep immunised with killed M.a.paratuberculosis.
This suggests that immune responses to the p30 secretory antigen have the potential
to distinguish between vaccinated animals and those harbouring active mycobacterial
infections.
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Hyperimmune antisera against the p40 antigen were raised in rabbits. These reagents
were used to immunoscreen an amplified library prepared from randomly sheared
IS901/902-positive M. avium genomic DNA in the Xgt 11 expression vector. Five
expressing clones were identified and plaque-purified from a total of 1.6 x 106 pfu
screened. Subsequent analysis and characterisation of these clones revealed that four
contained identical insert fragments of 7.1kb and expressed a full length subunit of
bacterioferritin. The remaining clone was shown to contain an insert fragment of
2.3kb and expressed a protein which was recognised by two anti-hsp65 monoclonal
antibodies. No antigenic cross-reactivity could be demonstrated between either of
these recombinant proteins and the p40 antigen. The identification of recombinants
expressing bacterioferritin was attributed to the presence of a trace impurity in the
p40 inoculum used to immunise the rabbits, while antibodies to hsp65 proteins may
have been intrinsic to the rabbits themselves. Further immunoscreening of the
amplified library with serum absorbed exhaustively with lysates of
M.a.paratuberculosis, yielded 15 additional expressing clones. All of these were
shown to contain a 2.3kb insert fragment identical to that of the putative heat shock
recombinant. A second expression library was immunoscreened without
amplification and in its entirety (6.4 x 105 pfu) using antiserum which recognised
only p40 on Western blots of IS901/902-positive M.avium. No clones expressing
p40 were detected.
Degenerate oligonucleotides deduced from p40 amino acid sequence data were
unsuccessful in detecting homologous sequences in the amplified library. Attempts
to amplify p40 gene sequences by PCR were unsuccessful also, regardless ofwhether
template DNA was prepared from the amplified library or from cultured IS901/902-
positive M.avium cells. One 21mer oligonucleotide (M5018) hybridised with three
EcoRl fragments (5.2kb, 4.5kb and 4.0kb) common to both IS901/902-positive
M.avium and M.a.paratuberculosis on Southern blots of restricted genomic DNA,
and two additional £coRI fragments (3.7kb and 450bp) which were unique to
IS901/902-positive M.avium. All five IS901/902-positive M.avium FcoRI fragments
were cloned in plasmid vectors and sequenced across the region homologous to
oligonucleotide M5018. Analysis of the homologous genomic sequences revealed
identity and similarity values ranging between 52.4%-76.2% and 61.9%-90.5%
respectively. Translations over the five homologous 21bp regions were compared
with the sequence of seven contiguous amino acid residues from which
oligonucleotide M5018 was originally deduced. Levels of amino acid sequence
identity ranging between a single mismatch, and two mismatches plus two
conservative substitutions were revealed. However, the sequences flanking the seven
amino acid residues used to deduce oligonucleotide M5018 bore no resemblance to
those of any of the five translated genomic clones.
The gene encoding the p40 antigen remains to be cloned and characterised. The
relationship between p40 and IS901/902 is not direct and the precise nature of their
close association has yet to be established.
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1.1 The Genus Mycobacterium
The genus Mycobacterium represents the only genus in the family Mycobacteriaceae
and is placed in a taxonomic group which includes the genera Corynebacterium,
Mycobacterium and Nocardia (the CMN group) and Rhodococcus (Barksdale and
Kim, 1977). Referring to the mould-like appearance of M.tuberculosis in liquid
culture, the generic name Mycobacterium ("fungus bacterium") was proposed by
Lehmann and Neumann (1896). The group comprises straight or gently curved
bacilli, although coccobacillary, filamentous and branched forms also have been
described. The cells are gram positive although all members share a highly
impermeable and lipid-rich cell wall structure which negates the routine use of
conventional gram staining. All members are aerobic or microaerophilic, non-motile
and non-sporing. The genus includes photochromogens, scotochromogens and non-
chromogens, and the number of recognised species and subspecies names currently
exceeds seventy (Table 1.). The nutritional requirements and optimal growth
temperatures for different species vary considerably and not all members can be
cultivated on laboratory growth medium. The cultivable members of the genus have
been divided into two categories; the rapid growers and the slow growers. Although
predominantly a genus of saprophytes, living freely in the environment, the
mycobacteria include pathogens ofmany diverse hosts ranging from marine sponges
and fishes, to birds and mammals. These include the two major mammalian
pathogens M.leprae (Hansen, 1874) and M.tuberculosis (Koch, 1882), the
aetiological agents of leprosy and tuberculosis respectively. References to these
scourges in the Bible, classic literature and opera demonstrate that they have been
recognisable to the general public through the centuries, and highlight the continuity
ofman's struggle against mycobacterial disease.
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Table 1.1
Alphabetical List of Currently known Species of the
Genus Mycobacterium
Species Subspecies Pathogen Citation
M.aichiense _ Tsukamura et al., 1981
M. africanum + Castets et al., 1969
M.agri - Tsukamura, 1972a
M. alvei - Ausinaetcr/., 1992
M. asiaticum + Weiszfeiler et al., 1971
M.aurum - Tsukamura and Tsukamura, 1966
M.austroafricanum - Tsukamura et al., 1983c
M.avium:- avium + Chester, 1901
paratuberculosis + Bergey et al., 1923
silvaticum + Thorel et al., 1990
M.bovis + Karlson and Lessel, 1970
M. branderi +/- Koukila-Kahkola et al., 1995
M. celatum + Butler et al., 1993
M.chelonae:- abscessus + Kubica et al., 1972
chelonae + Bergey et al., 1923
M.chitae - Tsukamura, 1967a
M. chlorophenolicum - Haggeblom et al., 1994
M.chubuense - Tsukamura et al., 1967
M.confluentis - Kirschner et al., 1992
M.conspicuum + Springer et al., 1995
M.cookii - Kazda et al., 1990
M.diernhoferi - Tsukamura et al., 1983c
M.duvalii - Stanford and Gunthorpe, 1971
M.fallax - Levy-Frebault et al., 1983
M.farcinogenes + Chamoiseau, 1979
M.flavescens - Bojalil et al., 1962
M.fortuitum.- acetam idolyticum + Tsukamura et al., 1986b
fortuitum + da Costa Cruz, 1938
peregrinum Runyon et al., (1974)
M.gadium - Casal and Calero, 1974
M.gastri - Wayne, 1966
M.genavense + Bottger etal., 1993
M.gilvum - Stanford and Gunthorpe, 1971
M.gordonae +/- Bojalil et al., 1962
M.haemophilum + Sompolinsky et al., 1978
M. hiberniae - Kazda etal., 1993
M.hodleri - Kleespies et al., 1996
M. interjectum + Springer et al., 1993
M. intermedium + Meier etal., 1993
M. intracellulare + Runyon, 1967
M.kansasii + Hauduroy, 1955
M.komossense - Kazda and Muller, 1979
M. leprae + Lehmann and Neumann, 1896
M. lepraemurium + Marchoux and Sorel, 1912
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Table 1.1 continued
Species Subspecies Pathogen Citation
M.lentiflavum + Springer et al., 1996
M.madagascariense - Kazda et al., 1992
M.mageritense +/- Domenech et al., 1997
M.malmoense + Schroder and Juhlin, 1977
M.marinum + Aronson, 1926
M.microti + Breed et al., 1957
M.moriokaense - Tsukamura et al., 1986a
M.mucogenicum Springer et al., 1995
M. neoaurum - Tsukamura, 1972b
M. nonchromogenicum - Tsukamura, 1965
M.obuense - Tsukamura et al., 1981
M.parafortuitum - Tsukamura, 1966a
M.phlei - Lehmann and Neumann, 1899
M.porcinum + Tsukamura et al., 1983b
M.poriferae + Padgitt and Moshier, 1987
M.pulveris - Tsukamura et al., 1983a
M.rhodesiae - Tsukamura et al., 1981
M. scrofulaceum + Prissick and Masson, 1956
M.senegalense + Chamoiseau, 1979
M.shimoidei + Tsukamura, 1982
M.simiae + Karassova et al., 1965
M.smegmatis'.- smegmatis - Lehmann and Neumann, 1899
lacticolum - Tsukamura, 1967b
M.sphagni - Kazda, 1980
M.szulgai + Marks et al., 1972
M.terrae - Wayne, 1966
M. thermoresistible + Tsukamura, 1966b
M. tokaiense - Tsukamura et al., 1981
M. triplex + Floyd et al., 1996
M. triviale - Kubica et al., 1970
M.tuberculosis + Lehman and Neumann, 1896
M.ulcerans + Fenner, 1952
shinshuense + Tsukamura, et al., 1989
M.vaccae +/- Bonicke and Juhansz, 1964
M.xenopi + Schwabacher, 1959
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1.2 The Mycobacterial Cell Envelope
The mycobacterial cell envelope comprises the cytoplasmic membrane and the cell
wall complex.
1.2.1 The cytoplasmic membrane
Electron micrographs have shown that the cytoplasmic membrane is asymmetrical in
ultra-thin sections of mycobacterial cells, with the outermost of two electron-dense
layers appearing visibly thicker (Paul and Beveridge, 1992). This feature has been
attributed to the preferential association of carbohydrate, in the form of
phosphotidylinositol mannosides (PIMs), with the outer layer of the membrane
(Brennan and Nikaido, 1995). PIMs are major components of the cytoplasmic
membrane and are unique to Actinomycetes. Carotenoid compounds, which protect
the cells against photolytic damage and confer the characteristic yellow/orange
pigmentation upon photochromogenic species such as M.gordonae and M.kansasii,
are associated with the cytoplasmic membrane also.
1.2.2 The mycobacterial cell wall complex
The mycobacterial cell wall lies external to the cytoplasmic membrane. It is a
physically resilient, chemically complex structure of exceptionally low permeability
which confers characteristic acid and alcohol fastness upon the cell, as well as
resistance to many commonly used antibiotics and chemical disinfectants (Jarlier and
Nikaido, 1994). The currently favoured model of the mycobacterial cell wall
complex is that of an asymmetric lipid bilayer (Minnikin, 1982; Nikaido et al.,
1993). In this model, long-chain (C60-C90) mycolic acids in the inner leaflet are
tightly packed in a parallel array pointing in a direction perpendicular to the plane of
the cell surface. The inner leaflet is thought to be covered by a layer of solvent-
extractable lipids forming the outer leaflet of the bilayer. Evidence in support of the
lipid bilayer has been provided by X-ray diffraction studies of the M.chelonae cell
wall (Nikaido et al., 1993). The X-ray data demonstrated that the hydrocarbon
chains contained within the inner leaflet of the bilayer are packed in a near crystalline
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array, a structural arrangement suggesting very low fluidity and low permeability.
Increasingly diffuse diffraction towards the cell wall surface suggested that the
fluidity of the outer leaflet was much greater and reflected its chemical composition
and physical organisation (see below). Additional evidence was provided by electron
microscopic demonstration of a freeze-fracture plane within the cell wall complex, a
feature which is highly consistent with the lipid bilayer model (Brennan and Nikaido,
1995).
Three basic sub-structures, peptidoglycan, arabinogalactan and mycolic acids, are
covalently associated to form the mycobacterial inner cell wall complex. The
innermost layer, the peptidoglycan, is thought to function as a skeletal framework to
which arabinogalactan polysaccharides are attached via phosphodiester bonds. The
arabinogalactan polysaccharides are esterified with mycolic acids at their distal ends
via a terminal penta-arabinose unit to form a mycolyl-arabinogalactan-peptidoglycan
complex. This complex forms the major part of the bilayer inner leaflet and
connects the inner and outer leaflets of the bilayer.
The outer leaflet is thought to comprise a number of loosely associated solvent-
extractable lipid compounds such as the PIMs, including lipoarabinomannan (LAM).
Although not considered to be important for the structural integrity of the outer cell
wall, LAM has been reported to play a significant role in the immunopathogenesis of
M.tuberculosis and M.leprae (Chatterjee et al., 1992), and M.a.paratuberculosis
(McNab et al., 1991a; Sugden et al., 1987, 1989 and 1991). Several classes of free
lipids and glycolipids including phenolic glycolipids (PGLs) and glycopeptidolipids
(GPLs) are associated with the outer cell wall. The GPLs form a group of
immunogenic cell surface antigens which have been used to type isolates of
M.avium, M.intracellulare and M.scrofulaceum on the basis of serotypic identity (see
section 1.4.1). Phthiocerol dimycocerosates (PDIMs) are long-chain multimethyl-
branched waxes whose relative abundance in the outer cell wall suggests they may
act as structural components (Minnikin et al., 1985). Chemical analysis of highly
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purified M. chelonae cell wall preparations has confirmed that the outer cell wall also
contains large quantities of glycerophospholipid, a compound previously thought to
be associated exclusively with the cytoplasmic membrane (Nikaido et al., 1993).
Finally, cell wall associated proteins such as MMP II, a bacterioferritin in M. leprae
(Hunter et al., 1990; Pessolani et al., 1994) and the porin proteins of M. chelonae
(Trias et al., 1992) and M.smegmatis (Trias and Benz, 1994) lie embedded in this
lipid matrix.
The preference of any given species of Mycobacterium for a particular environment
or host is thought to reflect a process of selection during which the structure of the
cell wall has been optimised for survival by exposure to the conditions which prevail
in that environment. Thus free-living saprophytic species, which are exposed to
naturally occurring antibiotics in soil and water, are inherently less permeable to
these molecules than the obligate pathogens. For example, M.tuberculosis has been
shown to be more permeable to cephalosporins than the saprophyte M. chelonae
(Connell and Nikaido, 1994) and M. avium, another environmental species, has been
shown to be almost uniformly resistant to most commonly used antibiotics (Barrow,
1991). It has been suggested that these differences in permeability could be at least
partly attributable to the relative proportions and arrangement of the three structural
types of mycolic acids (a, keto and methoxy) in the inner leaflet of the cell wall
(Brennan and Nikaido, 1995). Interestingly, lipophilic antibiotics, such as
rifamycins, tetracyclines, macrolides, and fluoroquinolones, are more active against
mycobacteria than their hydrophilic counterparts. For example, fluoroquinolones
modified for greater lipophilicity such as sparfloxacin and alkylated-ciprofloxacin
have been shown to be more active against M.tuberculosis and M.avium than their
parent molecules (Yajko et al., 1990; Haemers et al., 1990). Such compounds are
thought to traverse the cell wall directly by virtue of their lipophilicity, while other
more hydrophilic molecules probably enter and leave the cell via water-filled porin
channels (Trias et al., 1992; Trias and Benz, 1994).
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Much work has been done to unravel the chemical and structural complexities of the
mycobacterial cell wall and current knowledge of its composition and architecture is
at an advanced stage. However, a deeper understanding of the biological functions of
the cell wall and the genes that govern its biosynthesis will help resolve aspects of
mycobacterial pathogenesis, such as intraphagocytic survival, and assist in the
identification of new drug targets and antigens of immunoprophylactic potential.
1.3 Pathogenic Species ofMycobacterium and Related Diseases
The genus Mycobacterium comprises a number of obligate pathogens, opportunistic
pathogens and many saprophytic species which can be found living freely in the
environment.
Of those species which are regarded as obligate pathogens, the aetiological agents of
tuberculosis (M tuberculosis) and leprosy (M. leprae) are certainly the best known.
However, other species also can be regarded as obligate pathogens, such as M.bovis,
M. africanum and M.microti, the other three members of the M. tuberculosis complex,
M.lepraemurium, the agent of murine leprosy, M.a.paratuberculosis, the agent of
paratuberculosis or Johne's disease of ruminants and possibly M.farcinogenes, the
agent of bovine farcy. Characteristically, the obligate pathogens have been isolated
only from infected host species and never traced to any environmental reservoir,
although M.a.paratuberculosis has been known to survive for prolonged periods in
infected faeces. The organisms are transmitted by direct contact with an infected
host or contaminated body fluids and the resulting diseases are normally highly
contagious.
A number of free-living environmental species of Mycobacterium, collectively
termed "atypical", "opportunistic", "tuberculoid", "MOTT" (Mycobacteria Other
Than Tuberculosis) and "PPEM" (Potentially Pathogenic Environmental
Mycobacteria), also have been shown to be responsible for diseases in mammals.
Unlike the obligate pathogens, the diseases caused by PPEM are not highly
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contagious and host to host transmission generally does not occur. These species are
ubiquitous in the environment and their pathogenic potential for mammalian hosts
varies from harmless colonisation to invasive disease. The opportunistic nature of
such infections usually requires certain pre-disposing factors before tissue invasion
and disease can occur. For example, chronic lung disease due to an environmental
species of Mycobacterium is often secondary to existing parenchymal damage
(Contreras et al., 1988). Similarly, the risk of contracting a wide range of
mycobacterial infections and clinical manifestations is greatly increased in
individuals with malignancies (Feld et al., 1976), recipients of organ or tissue
transplants (Patel et al., 1994) and patients receiving immunosuppressive drug
therapy (Skogberg et al., 1995). However, such opportunistic infections are
generally less severe in these groups than in patients with the acquired
immunodeficiency syndrome (AIDS), even when CD4/CD8 ratios are seen to be in
the range expected for AIDS (Peters et al., 1989). AIDS patients are particularly at
risk of disseminated infection by certain strains of M.avium (Horsburgh and Selik,
1989) (see below).
Wayne and Sramek (1992) divided the commonly encountered PPEM into three
categories: "Well-documented species of slowly-growing PPEM" (M.kansasii,
M.marinum, M.scrofulaceum, M.simiae, M.szulgai, M.ulcerans, M.xenopi and some
members of the M.avium complex), "Well documented species of rapidly-growing
PPEM'' (members of the Mfortuitum/M.cheloni complex) and "Newly characterised
mycobacteria" (M.asiaticum, M.haemophilum, M.malmoense and M.shimoidei).
Although these organisms have been isolated from patients with different clinical
manifestations, most give rise to tuberculous pulmonary disease. Exceptions include
M.marinum, originally isolated from marine fish (Aronson, 1926), and M.ulcerans,
both of which can cause necrotic skin lesions in humans. More recently, the list of
PPEM has been extended to include a number of new species of Mycobacterium:
M.intermedium (Meier et al., 1993), M.genavense (Bottger et al., 1993),
M.interjectum (Springer et al., 1993; Emler et al., 1994), M.celatum (Bull et al.,
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1995a; Dahl et al., 1995), M.branderi (Koukila-Kahkola et al., 1995), M.conspicuum
(Springer et al., 1995b), M.mucogenicum (Springer et al., 1995a) M.lentiflavum
(Springer et al., 1996) and M. triplex (Floyd et al., 1996). These organisms have been
associated with a variety of clinical conditions including pulmonary disease,
lymphadenopathy, lymphadenitis, spondylodiscitis, skin disorders such as
granulomatous lesions and subcutaneous abscesses, and disseminated infections in
immunocompromised individuals. The list of PPEM continues to expand and some
newly identified species such as M.poriferae (Tortoli et al., 1996), M.hassiacum
(Schroder et al., 1997) and M.mageritense (Domenech et al., 1997) have been
isolated from tuberculous lesions in snakehead fish and the human urinary and
respiratory tracts respectively. There is no evidence to suggest that any of these
species is pathogenic in mammals.
An unusually high susceptibility to infection with PPEM is a striking feature of
patients with AIDS (Wayne and Sramek, 1992). However, even though many of the
PPEM mentioned above have been associated with disseminated infections in AIDS
patients, approximately 90% of AIDS-related mycobacterioses are attributable to
infection with either M.tuberculosis or M.avium (Peters et al., 1989). It has been
suggested that AIDS-related tuberculosis could be the result of reactivation rather
than that of primary exposure, but M.avium infections are thought to arise from
unavoidable continuous environmental exposure. Because of the ubiquitous nature
of M. avium, it is possible that primary colonisation of the gastrointestinal tract may
follow normal ingestion of organisms (Jacobson et al., 1991). It has been proposed
that the HIV-related immunosuppression in AIDS patients may provide the
opportunity for some strains of M. avium to disseminate from the primary
colonisation site and cause invasive disease (Peters et al., 1989). Potential
environmental sources of acquired M. avium infection include soil, water, vegetation,
animal products and processed organic materials (Horsburgh, 1994), but the precise
reservoirs of infection are not known. In cases of cervical lymphadenitis, it is
presumed that organisms from soil or water are ingested and enter the lymphatics via
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mucosal associated lymphoid tissue (von Reyn et al., 1996). The isolation of MAC
from cigarette tobacco (Eaton et al., 1995) and of other PPEM from bronchoscopes
(Spach et al., 1993) point to potential sources of pulmonary infection. In addition,
the recovery of MAC from hospital tap water (von Reyn et al., 1994; Peters et al.,
1995) highlights the potential for nosocomial infection of immunocompromised
patients.
The prevalence of MAC-related diseases, especially in AIDS, emphasises the need
for further research into the pathogenesis of this important group of organisms, and
for a deeper understanding of the molecular basis of virulence. The following
sections provide a description of the members of the MAC and a brief overview of
their molecular characteristics.
1.4 The Complex (MAC)
The MAC comprises a group of closely related species including M. avium,
M.intracellulare, M.a.paratuberculosis, the wood pigeon bacillus (see section 1.4.3)
and M.lepraemurium.
1.4.1 M.avium and M.intracellulare
Infection by an organism similar to, but distinct from, the then recently discovered
"Tuberkelbacillus" was shown to be the cause of tuberculosis in chickens (Maffucci,
1890). The causative organism was shown to differ from those associated with
tuberculosis in humans and other animals and was later named Mycobacterium avium
(Chester, 1901). M.avium was considered indistinguishable from M.intracellulare in
terms of cultural and biochemical characteristics and the two species were separated
only on the basis of their pathogenicity in chickens. Isolates which killed
experimentally infected birds were regarded as M.avium and those which did not as
M.intracellulare (Schaefer, 1980). Early serological studies on M.avium and
M.intracellulare revealed the presence of two agglutinating M.avium serotypes, (1
and 2), with the latter predominating in the USA (Schaefer, 1965). A third M.avium
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serotype (3) was isolated in Europe a few years later (Marks et al., 1969) and
M.intracellulare isolates comprised an additional 17 serotypes designated by Roman
numerals or author's surnames (Schaefer, 1980). In adopting the convention used for
M.avium, all M.intracellulare serotypes are currently designated by Arabic numerals
and the two species are now represented by serotypes 1-28.
For many years, a set of clearly defined criteria on which M. avium and
M.intracellulare could be distinguished was not available and the two species were
grouped together in the MAC on the grounds of close phenotypic similarity and
serotypic identity (Meissner et al., 1974). It had been observed during earlier studies
that M.intracellulare serotypes 4, 5, 6, 8 and 9 were lethal for experimentally
infected chickens (Anz and Meissner, 1972), and therefore were considered to be
more like M.avium than M.intracellulare. Subsequent DNA hybridisation studies
(see section 1.5.1) confirmed that a number of these M.intracellulare serotypes were
genetically indistinguishable from M.avium (Baess, 1983; Saito et al., 1990). These
revelations led to a redistribution of agglutinating serotypes, but disagreement over
precisely which serotypes belong to M.avium or M.intracellulare continues to fuel
debate between independent authors (Baess, 1983; Roberts et al., 1987; Peterson et
al., 1989; Yakrus and Good, 1990; Saito et al., 1990). The current serotypic
groupings, as detailed by Wayne and Sramek (1992), acknowledge and take into
consideration the results of DNA homology studies. Serotypes 1-6 and 8-11 have
been assigned to M.avium and serotypes 7, 12-17, 19, 20 and 25 to M.intracellulare.
The remaining serotypes do not fit satisfactorily into either category. Some isolates
of serotype 18 type as either M.intracellulare or M.simiae, while others cannot be
assigned to any species. Other serotypes (22, 23, 26 and 28) which are
phenotypically compatible with the MAC are not recognised by DNA probes which
are specific for either M.avium or M.intracellulare.
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1.4.2 M.scrofulaceum
The grouping of the 3 currently known serotypes of M.scrofulaceum (serotypes 41,
42 and 43) (Schaefer, 1968) together with the members of the MAC has exacerbated
confusion which continues to surround classification within the complex.
In 1977, Hawkins referred to strains of mycobacteria which exhibited pigment,
urease and catalase patterns that were inconsistent with M.scrofulaceum, M.avium or
M. intracellulare, but which appeared to belong to one or other of these species on the
basis of other characteristics. In the absence of criteria to enable a more precise
classification, it was proposed that these unusual isolates be regarded as unspeciated
M.avium/intracellulare/scrofulaceum (MAIS) intermediates. However, the original
proposal has been misconstrued by some authors and references to a "MAIS
complex" are common in the literature. The "MAIS" acronym includes well-defined
strains of all three species, but is misleading when used in combination with
"complex" because a close taxonomic relationship is implied. Definitive evidence
based on numerical taxonomy (Meissner et al., 1974), reciprocal intradermal skin
testing (Magnusson, 1980), immunodiffusion (Stanford and Grange, 1974),
immunological distance of catalases (Wayne and Diaz, 1979 and 1982) and DNA
homology (Baess and Weis-Bentzon, 1978; Baess, 1979, 1983 and 1984; Hurley et
al., 1988) has demonstrated that M.scrofulaceum is a distinct species and that its
inclusion with M.avium and M.intracellulare in a "MAIS complex" is inappropriate.
1.4.3 M.a.paratuberculosis and the "wood pigeon bacillus"
While M.avium serotypes 1, 2 and 3 are those most commonly associated with
infections in birds and animals (Meissner and Anz, 1977), the closely related
M.a.paratuberculosis has been identified as the aetiological agent of Johne's disease
(see section 1.8) or paratuberculosis of ruminants (Chiodini et al., 1984a).
M.a.paratuberculosis also has been isolated from humans suffering from Crohn's
disease (see section 1.11) (Chiodini et al., 1984b; McFadden et al., 1987b) although
the aetiological significance of its presence in diseased gut tissue is still the subject of
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ongoing research. Although indistinguishable from M.avium on biochemical and
serological criteria, characteristic features of M.a.paratuberculosis include slow
growth rate in vitro and fastidious nutritional requirements. The organism may take
up to 4 months to form visible colonies on primary isolation and then only when
provided with an exogenous supply of the iron-chelating growth factor mycobactin
(Merkal and Curran, 1974). Unlike most other species of Mycobacterium,
M.a.paratuberculosis is a mycobactin auxotroph unable to synthesise its own
mycobactin. However, M.a.paratuberculosis can be propagated on mycobactin-free
medium supplemented with iron at concentrations of <100pM at pH5.0, or >100pM
at pH6.8 (Lambrecht and Collins, 1992). The identification of M.a.paratuberculosis
on the basis of growth requirements and pathogenicity in ruminants is no longer
considered reliable, since certain strains of M. avium such as the "wood pigeon
bacillus" (Matthews and McDiarmid, 1979) have been shown to require mycobactin
also, particularly on primary isolation. In addition, experimental infection of bovine
calves with the "wood pigeon bacillus" resulted in a disease resembling clinical
paratuberculosis (Matthews and McDiarmid, 1979; Thorel et al., 1984; Collins et al.,
1985). Subsequent analysis at the genomic level (see section 1.5) has demonstrated a
close genetic relationship between M.avium, M.a.paratuberculosis and "the wood
pigeon bacillus".
1.4.4 M.lepraemurium
Unlike most other members of the MAC, the aetiological agent of "rat leprosy",
M.lepraemurium, has proved extremely difficult to cultivate in vitro and only sparse
growth has been achieved on solid inspissated egg yolk medium (Ogawa and
Motomura, 1970). However, analyses of M.lepraemurium propagated in mice
provided evidence that the chemical composition and ultrastructure of the cell wall
(Kanetsuna et al., 1968; Draper, 1971), biochemical patterns (Saito et al., 1976) and
serological cross reactivity with other mycobacteria (Kronvall et al., 1977) were
characteristic of the genus Mycobacterium. Molecular characterisation of the
M.lepraemurium genome (see section 1.5) showed that the M.wt and G+C content
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were in the range predicted for mycobacteria and revealed a close genetic
relationship with M.avium and M.a.paratuberculosis (Imaeda et al., 1982).
1.5 Molecular Characterisation of the MAC
1.5.1 DNA-DNA hybridisation
DNA homology determinations have made a major contribution to mycobacterial
phylogeny, particularly where studies have focused on clusters of closely related
species such as the members of the M. tuberculosis and M. avium complexes (Baess,
1979). The technique functions on the principal that, under appropriate conditions of
temperature and salt concentration, two different species of genomic DNA will
hybridise at a rate and to an extent that is proportional to the concentration of
homologous nucleotide sequences.
Determinations on DNA homology between the members of the MAC have shown
that the genomes ofM.avium, M.a.paratuberculosis, the "wood pigeon bacillus" and
some strains of M.intracellulare are 72-100% similar (Hurley et al., 1988). When
M. intracellular was excluded from the comparisons, levels of DNA homology
between M.a.paratuberculosis, M.avium and the "wood pigeon bacillus" were much
higher at 95-100% (McFadden et al., 1987a; Hurley et al., 1988; Saxegaard and
Baess, 1988; Yoshimura and Graham, 1988). Comparisons of DNA species which
differ by less than ~5% are beyond the resolving capabilities of the technique
however, and these species are considered indistinguishable by this method
(McFadden et al., 1990). In a separate study, McFadden et al (1987c) reported <2%
base substitution between strains of M.avium and M.a.paratuberculosis, but >15%
base substitution between strains of M.intracellulare. The observed heterogeneity
amongst M.intracellulare strains prompted the authors to question whether these
strains should remain as a single species and to suggest that the "M.intracellulare
complex" might be a more appropriate term for this particular group ofmycobacteria.
M.lepraemurium has been shown to be more closely related to M.avium strains than
to any other mycobacterial species. DNA homology levels of 74-93% (Imaeda et al.,
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1982) and 85-87% (Athwal et al., 1984) have been measured between the genomes
ofM.lepraemurium and M.avium. An even closer relationship between these species
was reported by McFadden et al (1987c) who calculated DNA base substitutions of
only 2% between M.lepraemurium and M.a.paratuberculosis (ATCC 19689) and 3%
between M.lepraemurium and M.avium (serotype 2 strain).
Despite some clear phenotypic similarities, it has been shown that M.scrofulaceum
shares only 34-41% genomic DNA homology with M.avium (serotype 2 strain)
(Baess, 1979 and 1983), 11-24% homology with M.a.paratuberculosis (Hurley et al.,
1988) and 33-36% homology with M.intracellulare (serotype 16) (Baess, 1983). The
difference in DNA homology observed between M.scrofulaceum and M.avium
(serotype 2), and M.scrofulaceum and M.a.paratuberculosis is surprising since
M.avium (serotype 2) strains and M.a.paratuberculosis are considered
indistinguishable on the basis of genomic hybridisation (McFadden et al., 1990). In
any case, most authors now regard M.scrofulaceum as a species which is separate and
distinct from the members of the MAC (see section 1.4.2).
Within the limitations of the technique, DNA hybridisation studies have proved
invaluable in determining levels of genetic similarity between the members of the
MAC. However, the results of these studies must be interpreted with caution as high
levels of genomic DNA homology may not necessarily reflect true taxonomic status.
For example, Brenner (1972) showed that under stringent conditions, genomic DNA
homology between E.coli K12 and Shigella spp. (71-85%) could, in some cases, be
higher than that observed between different strains of E.coli (72-100%). Therefore,
if the degree of nucleotide sequence divergence tolerable within a species is accepted
at <40% (Wayne, 1978), it could be argued that the Shigellae be included as one or
more species within the genus Escherichia. Consequently, in assigning an organism
to a genus or a species on the basis of genomic homology measurements, it is
important that phenotypic expression is taken into consideration also.
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1.5.2 Restriction Endonuclease (RE) profiling and Restriction Fragment Length
Polymorphism (RFLP) analysis
Small differences (i.e. single base pair changes) between single genes or entire
genomes can be exploited to differentiate between closely related species which are
indistinguishable by DNA-DNA hybridisation. Provided that these differences occur
within the specific recognition sequence of a given restriction endonuclease,
enzymatic cleavage of the DNA followed by electrophoretic separation of the
resulting fragments should reveal discernible differences in banding pattern. These
differences are known as restriction fragment length polymorphisms (RFLP).
Direct comparison of RE-digested genomic DNA on agarose gels has been used to
demonstrate polymorphisms between the members of the MAC (Patel et al., 1986,
Collins and deLisle, 1986, Whipple et al., 1987). Overall, distinctions based on
differences observed between the individual members of the MAC were seen to
concord with the results of genomic DNA homology studies. Easily distinguishable
RE profiles supported the status ofM. avium, M. intracellulare and M.scrofulaceum as
separate and distinct species (Patel et al., 1986). In addition, the banding patterns
observed for strains ofM.avium and M.intracellulare were largely in agreement with
current serotypic groupings (Whipple et al., 1987). With the notable exception of
"strain 18", all M.a.paratuberculosis isolates examined were shown to share an
identical RE profile (Collins and deLisle, 1986; Whipple et al., 1987; Wards et al.,
1987) which was distinct from those of serotype 2 strains of M. avium and the wood
pigeon bacillus (Whipple et al., 1987). M.a.paratuberculosis strain 18 has since
been reclassified (see section 1.6).
The value of direct comparison of two or more genomic RE profiles, as visualised in
stained agarose gels, often can be limited by the complexity of the banding pattern
and the resolving capabilities of the gel system in use. Simpler and more
interpretable banding patterns are obtained when a labelled DNA probe is hybridised
to a few homologous fragments on Southern blots of RE-digested genomic DNA.
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McFadden et al (1987b and c) applied this technology to the identification of RFLP
types which could be used to distinguish between isolates of M. avium and
M.a.paratuberculosis. Ten random genomic DNA clones, derived from a Crohn's
disease isolate (strain Ben), were used as probes and one of these (clone pMB22) was
shown to produce RFLPs which resolved the two species. In concordance with the
results of RE analysis, all isolates of M.a.paratuberculosis, including strain Ben,
were shown to share an identical RFLP type, except "strain 18" which was identical
to M.avium serotype 2 strains. RFLP types within M. avium isolates were noted to be
more heterogeneous.
Subsequent characterisation of clone pMB22 revealed the presence of the genomic
insertion sequence IS900, of which there are an estimated 15-20 copies per
M.a.paratuberculosis genome (Green et al., 1989). Identification of a short species-
specific region at the 5' end of the insertion element provided a probe which did not
hybridise to genomic DNA from any other species of Mycobacterium tested,
including the members of the MAC. In combination with multiple homologous
target sequences, the IS900-derived probe yielded simple yet informative banding
patterns on Southern blots of RE-digested M.a.paratuberculosis DNA. On the basis
of these RFLP types, M.a.paratuberculosis isolates have been reported to fall into
three groups. The first of these comprised mainly New Zealand cattle strains, but
also included some sheep and goat isolates (Collins et al., 1990); the second group
comprised predominantly sheep isolates from New Zealand and the Faeroe Islands
(deLisle et al., 1993), while the third group included sheep isolates from South
Africa (deLisle et al., 1992), Iceland and Canada (Collins et al., 1990). In addition,
of 20 M.a.paratuberculosis isolates recovered from farmed deer, 17 were shown to
be identical to the cattle isolates while the remaining 3 were the same as the New
Zealand and Faeroe Island sheep isolates (deLisle et al., 1993). In a further study
which examined genomic DNA from 90 M.a.paratuberculosis isolates of bovine,
ovine, caprine and human origin, Pstl digestion and hybridisation with an IS900-
derived probe revealed three RFLP types, but could not correlate RFLP type with
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host preference (Pavlik et al., 1995). More recently, Bauerfeind et al (1996)
demonstrated five distinct Pvull RFLP types amongst 42 M.a.paratuberculosis
isolates collected from sheep, goats and cattle in Morocco, South Africa, the USA
and Germany. Although individually distinct, the RFLP types could be divided into
two major clusters on the basis of similarity of profile. Moreover, complete
concordance was observed between RFLP cluster and in vitro growth rate, with all
sheep isolates falling into cluster I (extremely slow growth) and all goat and cattle
isolates falling into cluster II (moderately slow growth). In support of the earlier
studies, the authors concluded that in spite of the obvious similarity between isolates
ofM.a.paratuberculosis, there is evidence to support the existence of limited genetic
heterogeneity within the subspecies. However, the relationship between RFLP type
and host preference remains unclear (Thoresen and Olsaker 1994; Pavlik et al., 1995;
Bauerfeind et al., 1996).
Chiodini (1990) used a probe consisting of the entire E.coli 5S rRNA gene and
~200bp of the adjacent 23S rRNA gene to identify RFLPs within the rRNA gene
region of the members of the MAC. The presence of just one copy of the 5S rRNA
gene in the slow growing mycobacteria yielded banding patterns of either a single
fragment, or two fragments if the polymorphism was present within the probe target
sequence. None of the 8 REs used, including Ava I, Bam HI, Bgl II, EcoBA, EcoRII,
IHindlll, Pvull and Xhol, revealed polymorphisms among the 19
M.a.paratuberculosis isolates tested. Differences between M.a.paratuberculosis and
M.avium serotypes 2, 4 and 9 were revealed by digestion with Ava I, Bam HI,
Hindlll, Pvull and Sstl, while differences between the 3 M.avium serotypes were
apparent on digestion with Aval, Pvull and Sstl. M.intracellulare and
M. lepraemurium were not included in this study.
1.5.3 Pulsed-field and field-inversion gel electrophoresis
Pulsed-field gel electrophoresis (PFGE) and field-inversion gel electrophoresis
(FIGE) represent alternative methods of simplifying the banding patterns obtained by
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electrophoretic separation of fragments resulting from restriction endonuclease
digestion of genomic DNA. The basic technique, which was developed originally to
separate yeast chromosomes (Schwartz et al., 1983), entails digesting DNA with
restriction endonucleases that cleave only at rarely occurring scission sites. The
resulting large restriction fragments (LRFs) are then resolved in agarose gels in a
specially devised electrophoresis cell which delivers forward and reverse electric
pulses of varying duration.
FIGE analysis of Dral-digested genomic DNA from isolates of
M.a.paratuberculosis, the wood pigeon bacillus, M.avium and M.intracellulare
demonstrated a high level of homogeneity between the LRF patterns obtained for
M.a.paratuberculosis isolates (Levy-Frebault et al., 1989). LRF patterns obtained
for isolates of the wood pigeon bacillus were observed to share a high degree of
similarity also, but were distinct from those of M.a.paratuberculosis and the more
heterogeneous patterns obtained for M.avium and M.intracellulare. These results
corroborated the findings of earlier observations, based on restriction endonuclease
analysis, which demonstrated genetic homogeneity among isolates of
M.a.paratuberculosis, and heterogeneity among isolates of M.avium (Collins and
deLisle 1986; Wards et al., 1987; Whipple et al., 1987).
In a later study, Coffin et al. (1992) used PFGE to analyse Ssp I-digested genomic
DNA from a number ofMAC type strains and field isolates. These authors divided
strains between four groups on the basis of their LRF patterns: group 1 contained 2
bovine isolates of M.a.paratuberculosis, 1 human isolate from Crohn's disease and
the M.a.paratuberculosis neotype strain ATCC 19698; group 2 contained 1 isolate
from a case of bovine paratuberculosis, M. avium strain ATCC 35712 (serotype 2)
and "Strain 18"; group 3 contained M.intracellulare type strain ATCC 13950
(serotype 16); and group 4 contained M.intracellulare ATCC 35771 (serotype 8) and
an isolate from a case of bovine paratuberculosis. The results of this study seem
somewhat spurious in light of previous data and would have benefited from proper
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and thorough identification of the isolates under analysis. Firstly, because all group
1 isolates share an LRF with the M.a.paratuberculosis neotype strain ATCC 19698,
all are probably correctly identified as M.a.paratuberculosis, although screening for
the presence of the genomic insertion sequence IS900 would have confirmed this
(see sections 1.5.2 and 1.5.5.1). Secondly, because all the isolates in group 2 share
an LRF with "Strain 18" (an IS901/902 positive strain ofM.avium), it is likely that
all are strains ofM.avium containing the insertion sequence. Once again, this could
have been confirmed by screening for the presence of the IS901/902 by PCR.
Thirdly, group 4 contains an isolate designated M.intracellulare (serotype 8) and a
field strain designated M.a.paratuberculosis. Given that serotype 8 isolates are now
considered to be strains ofM.avium (see section 1.4.1) and that both isolates in this
group share an identical LRF pattern, it is likely that both organisms in this group are
strains ofM.avium which lack IS901/902. Yet again, this could have been confirmed
by screening for the presence/absence of the insertion sequence.
PFGE has since been used to demonstrate LRF polymorphism among MAC isolates
of identical serotype (Mazurek et al., 1993), to highlight genetic diversity among
strains isolated from AIDS patients harbouring monoclonal and polyclonal M.avium
infections (Arbeit et al., 1993; Slutsky et al., 1994; Burki et al., 1995) and to draw
genotypic comparisons between strains of M.avium isolated from humans and
animals (Bono et al., 1995; Feizabadi et al., 1996). In addition, the technique has
been applied usefully to studying genetic heterogeneity among other species of
Mycobacterium, including M.tuberculosis, M.terrae complex, M.gordonae, M.avium-
M. intracellular complex and M.fortuitum (Kim et al., 1996).
1.5.4 Ribosomal RNA gene sequences
Comparative analysis of ribosomal RNA (rRNA) subunits or their encoding genes
has been useful for the phylogenetic classification of bacteria (Woese, 1977).
Studies based on mycobacterial rRNA sequences have correlated the classical
division of the genus into slow- and fast-growing species, with the presence of either
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one or two copies respectively of the rRNA operon (rrn) (Bercovier et al., 1986,
Stahl and Urbance, 1990). The order of genes along the mycobacterial rrn has been
demonstrated as -5'-16S-23S-5S-3'- with intergenic spacer regions 1 and 2 separating
16S and 23S, and 23S and 5S rRNA subunit genes respectively (Bercovier et al.,
1986). It has been suggested that the low rrn copy number in mycobacteria might be
at least partly responsible for their slow rate of growth relative to other bacteria
which possess higher copy numbers (Bercovier et al., 1986).
Examination of variable regions within mycobacterial 16S rRNA genes has revealed
species-specific nucleotide sequences which can be used for genotypic identification
of mycobacterial species (Bottger, 1989, Edwards et al., 1989). Direct sequence
determination of 16S rRNA gene fragments amplified by the polymerase chain
reaction (PCR) has been used to identify mycobacteria in clinical specimens (Rogall
et al., 1990a, Kirschner et al., 1993). These studies have shown that while the
member species of the tuberculosis complex are indistinguishable by this
methodology, many other species, including M.avium and M. intracellulare possess
unique signature sequences. However, while it is generally accepted that a particular
16S rRNA signature sequence is associated with a single species, it should be noted
that microheterogeneity between 16S rRNA gene sequences of different isolates of
M.gordonae has been reported (Kirschner and Bottger, 1992). In addition, a slow-
growing Mycobacterium "Strain X" was shown to contain two 16S rRNA genes
which differed in 18 positions (Ninet et al., 1996). Phylogenetically, one gene
sequence shared a common root with M.terrae, while the second was placed entirely
separately. The presence of two such markedly different 16S rRNA gene sequences
on the same bacterial chromosome has obvious implications for the reliability of
methodologies based on species-specific signature sequences. However, because the
members of the M.tuberculosis complex, M.leprae and the members of the MAC
possess only a single copy of the rrn, their identification on the basis of 16S rRNA
signature sequences should remain unaffected.
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The identification of specific 16S rRNA sequences led to the development of a
diagnostic test kit which is marketed commercially by Gen-Probe Inc., San Diego,
®
California, USA. The Gen-Probe AccuProbe system has been shown to be useful
for the identification of the tuberculosis complex, the MAC, M.gordonae and
M.kansasii (Reissner et al., 1994). The Gen-Probe® Rapid Diagnostic System for the
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MAC contains two I-labelled oligonucleotide probes, each specific for either
M. avium or M.intracellulare 16S rRNA signature sequences. This system has been
used successfully to discriminate between the two species in both medical (Saito et
al., 1990) and veterinary (Thoresen and Saxegaard, 1993) laboratories. Both of these
studies reported results which were in concordance with currently accepted serotypic
divisions.
The use of DNA probes based on 16S rRNA gene sequences has been unsuccessful
in distinguishing M.a.paratuberculosis from other subspecies or serotypes of
M.avium (Thoresen and Saxegaard, 1991, van der Giessen et al., 1992a). This can be
attributed to the high degree of relatedness (99.9%) between the 16S rRNA genes of
this group of organisms (Rogall et al., 1990b, Kirschner, et al., 1993). Although a
single base pair substitution has been shown to exist at position 135 in the variable
region of the 16S rRNA gene, demonstration of the substitution can be achieved only
by direct nucleotide sequencing ofPCR-amplified 16S rRNA gene fragments (Rogall
et al., 1990a).
An assay based on the amplification of 16S rRNA gene sequences and which was
originally designed to detect M.a.paratuberculosis infection in cattle, has been
shown to detect M.avium specifically and is in full agreement with current serotypic
groupings (van der Giessen et al., 1993). Applied directly to diagnostic specimens,
the assay enabled the rapid detection of M.avium, wood pigeon mycobacteria and
M.a.paratuberculosis with no cross-reactivity with any of the other mycobacterial
species tested, including M.intracellulare.
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For the purpose of sequence-based species differentiation, the intergenic spacer 1
regions and 23 S rRNA genes have been shown to exhibit greater variability than 16S
rRNA genes (Frothingham and Wilson, 1993, van der Giessen et al., 1994). The
complete nucleotide sequence of the intergenic spacer 1 region (~280bp) was
determined for each of 35 MAC isolates, revealing 12 distinct sequence variants
(Frothingham and Wilson, 1993). Of these, 4 variants were noted to correspond to
M.avium, 1 to M.intracellulare and a further 7 variants were observed to vary
markedly, both with each other and with those deemed to correspond to M. avium and
M.intracellulare. Although consistent with Gen-Probe MAC typing (see above),
the results of intergenic spacer 1 region sequencing correlated poorly with serotypic
groupings. Identical sequence variants were shown to belong to different serotypes
and some isolates of the same serotype were shown to belong to different sequence
variants (Frothingham and Wilson, 1993). van der Giessen et al (1994) reported only
9 mismatches (99.7% sequence identity) between the complete 23S rRNA genes
(~3.1kb) ofM.avium and M.a.paratuberculosis, and only 2 mismatches between their
respective intergenic spacer 1 regions (278bp). Consequently, such high levels of
sequence homology over the 16S, 23S and intergenic spacer 1 regions effectively
preclude their use as target sites for DNA probe-based differentiation ofM. avium and
M. a.paratuberculosis.
1.5.5 Genomic insertion elements
The isolation and characterisation of IS900 in M.a.paratuberculosis was the first
report of a genomic insertion element in the genus Mycobacterium (Green et al.,
1989). IS900 is considered atypical in that, unlike classical insertion sequences, it
lacks inverted terminal repeats and flanking direct repeats. Consequently, IS900 is
classed in a family of insertion elements which includes IS 110 of Streptomyces
coelicolor A3(2) (Brunton and Chater, 1987), IS 116 of Streptomyces clavuligerus
(Leskiw et al., 1990), IS901/902 ofM.avium (Kunze et al., 1991; Moss et al., 1992a)
and IS 1110 of M.avium (Hernandez Perez et al., 1994). Two further mycobacterial
insertion sequences, designated IS 1245 (Guerrero et al., 1995) and IS 1311 (Guerrero
23
et al., 1994, unpublished database submission) have been found in M.avium also, but
are unrelated and will be considered separately (see section 1.5.5.4). Lastly, some
strains of M.intracellulare have been reported to contain an insertion element
designated IS1141 (Via and Falkinham, 1993).
1.5.5.1 IS900 ofM.a.paratuberculosis
IS900 is 1451 bp in length with a nucleotide composition consisting of 66% G+C
(Green et al., 1989). Comparisons of IS900 and IS 110 at the nucleotide level
revealed an overall homology of 52%, although this was observed to be significantly
higher at the 3' ends. Typically, between 15 and 20 copies of IS900 are found per
M.a.paratuberculosis genome and chromosomal insertion has been shown to be site-
specific, conforming to the consensus sequence 5'-CATG(N)(4.6)*CNCCTT-3' where
the asterisk denotes the site of insertion (Green et al., 1989). Originally, IS900 was
reported to contain a single open reading frame (ORF) of 1197bp encoding a putative
transposase of 399 amino acids (M.wt 43kDa). More recently however, a second
ORF has been identified on the complementary strand (Doran et al., 1994a, 1994b
and 1997). This gene, designated "bed" (host expression dependent), utilises a
promoter, ribosome-binding site (RBS) and termination codon acquired upon
insertion into the M.a.paratuberculosis genome. This is achieved by insertion
between the RBS and start codon of a putative host gene. Insertion aligns the bed
initiation codon adjacent to a host RBS and possibly downstream of an active
promoter sequence (e.g. "PAN"). PAN has been located proximal to the 3' end of a
copy of IS900 (Murray et al., 1992). Expression of both ORF1 and ORF2 in IS900
has been reported (Tizard et al., 1992; Doran et al., 1997), although the effects of
their expression on M.a.paratuberculosis virulence remain unknown. The use of
IS900 to mediate stable integration of a kanamycin resistance gene into the
M.smegmatis genome highlights the potential of such mobile genetic elements for
use in transposon-mutagenesis experiments (England et al., 1991).
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1.5.5.2 IS901/902 ofM.avium
15901 in M.avium RFLP type A/I (Kunze et al., 1991) and IS902 in M.avium subsp.
silvaticum (Moss et al., 1992a) are actually the same insertion sequence isolated and
characterised independently by two different research groups. However, descriptions
of the two insertion sequences are not absolutely identical and they are reported to
share 98% homology at the nucleotide level. IS901 has a nucleotide sequence of
1472bp, is composed of 62% G+C and contains a single ORF of 1203bp which
encodes a protein of 401 amino acid residues (M.wt 44kDa) (Kunze et al., 1991).
15902 is reported to be 1470bp in length, 62% G+C and to contain an ORF of
1200bp encoding a protein of 400 amino acid residues (M.wt 43.9kDa) (Moss et al.,
1992a). The translation products of IS901/902 share a high level of sequence
identity with that of IS900, although overall sequence homology between IS901/902
and IS900 at the nucleotide level is reported at only 60% (Kunze et al., 1991).
However, higher levels of nucleotide homology at the 3' ends of the insertion
elements allowed probes derived from IS900 to detect multiple copies of IS901/902
in Southern blots of M.avium (wood pigeon bacillus) genomic DNA (McFadden et
al., 1987c). Multiple copies (10-12 per genome) of IS901/902 have been reported to
occur in the M.avium genome (Moss et al., 1992a) and like IS900 of
M.a.paratuberculosis, chromosomal insertion appears to be site-specific conforming
to the consensus sequence 5'-CAT(N)(7)*TTCCNTTC-3' (Kunze et al., 1991) or 5'-
CAT(N)(7_g)*CCTTC-3' (Moss et al., 1992a) where the asterisk denotes the site of
insertion. A second ORF on the complementary strand of IS901/902 encodes a
homologue to the IS900 Hed protein. However, unlike the IS900 hed gene, ORF2 of
IS901/902 encodes a termination codon resulting in a hypothetical peptide of 477
amino acid residues (Doran et al., 1997). To date, no evidence for expression of
either ORF in IS901/902 has been reported.
Examination ofM.avium strains from human, animal and environmental sources has
demonstrated that IS901/902 is associated almost exclusively with pathogenic animal
isolates. Conversely, most human and all AIDS-related M.avium isolates have been
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observed to lack IS901/902 (Kunze et al., 1992). Interestingly, strains ofM.avium in
possession of IS901/902 (RFLP type A/I) were observed to be more virulent in
experimentally infected BALB/c mice than strains lacking the insertion sequence
(RFLP type A) (Kunze et al., 1991).
1.5.5.3 IS1110 ofM.avium
IS 1110 is a highly mobile insertion element which was first detected in M.avium
strain LR541 following an observed increase in the size of a plasmid pLR20
(Hernandez Perez et al., 1994). Subsequent analysis of the enlarged plasmid
(pLR20') revealed the acquisition of a 1457bp insertion sequence which shared
approximately 60% nucleotide homology with IS900 of M.a.paratuberculosis,
IS901/902 ofM.avium and IS116 ofStreptomyces clavuligerus. Nucleotide sequence
analysis of the insertion element revealed the presence of an ORF, although unlike
ORF1 of the related insertion elements, a termination codon was absent from the
reading frame. From flanking-sequence data, the authors hypothesised that if the
nearest downstream termination codon was utilised, the putative transposase encoded
by ORF1 would have a C-terminus extended by 46 amino acid residues, yielding a
translation product of 50.2kDa. Unlike IS900 and IS901/902, an in-frame stop codon
in ORF2 on the complementary strand of IS 1110 resulted in early termination of
translation and a hypothetical peptide of only 12 amino acid residues. Sites of
IS 1110 insertion were similar to the consensus sequences observed for related
insertion elements, although genomic copy numbers were observed to be lower. In
addition, IS 1110 was not found in any other species of Mycobacterium other than
M.avium and the presence of IS 1110 in only 2 of the 24 isolates examined would
suggest that it occurs relatively infrequently.
1.5.5.4 IS1245 and IS1311 ofM.avium
Some isolates ofM.avium from human, animal and avian sources have been shown to
harbour the insertion element IS 1245 (Guerrero et al., 1995). IS 1245 shows no
significant sequence homology with any of the insertion elements described above
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and differs again in its possession of two imperfect inverted repeats at its extremities.
IS 1245 is 1313bp in length and contains an ORF of 1233bp encoding a putative
transposase which shares 64% amino acid sequence identity with that of IS 1081 of
M.bovis. Both IS 1245 and IS 1081 have been classed among the Staphylococcus
aureus IS256 family of insertion elements. IS 1245 has been shown to be present in
multiple copies in strains ofM.avium isolated from various species. RFLP analysis
using an IS1245-specific DNA probe revealed high copy numbers (>8 and up to 27)
and highly polymorphic banding patterns among human and porcine isolates. Some
avian isolates contained characteristically low copy numbers (2-3), while isolates
from other non-human sources were observed to differ widely in IS 1245 copy
number and banding pattern.
IS 1245 has been shown to share 83% sequence identity with another M.avium
genomic insertion sequence, IS 1311 (Guerrero et al., unpublished database
submission). IS 1311 is 1317bp in length, contains an ORF of 1233bp and encodes a
putative transposase similar to that of IS 1245. Probes based on IS 1311 internal
nucleotide sequences have been used to identify up to 19 different RFLPs among 75
clinical isolates of M.avium (Roiz et al., 1995). In addition, PCR amplification of
sequences located between copies of IS 1245 and IS 1311 on the same genome yielded
reproducible banding patterns and provided the basis for an alternative method to
RFLP analysis for typing M. avium strains (Picardeau and Vincent, 1996).
1.5.5.5 IS1141 ofM.intracellulare
IS1141 was identified in the 68kb plasmid ofM.intracellulare strain Val4 and is the
only insertion element known in this species (Via and Falkinham, 1993). This
element is 1595bp in length and lacks terminal inverted repeats and short direct
repeats in common with several other mycobacterial insertion elements (see above).
An ORF of 1002bp encodes a putative transposase which has been observed to share
29% amino acid sequence identity with that of IS916 of the E.coli IS3 family of
insertion elements. IS 1141 is present in 3-6 copies in colonial variants of some
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strains of M. intracellular. Colonial variation, as defined by opaque or transparent
morphology, has been observed to concord with different RFLP types using IS 1141 -
derived DNA probes. To date, IS 1141 has not been detected in any other species of
Mycobacterium including M.avium ssp. and M.scrofulaceum.
1.5.6 Plasmids
Since the first mycobacterial plasmids were described by Crawford and Bates (1979),
research on their distribution and characterisation has focused largely on those
identified in M.avium, M.intracellulare, M.scrofulaceum and the M.fortuitum
complex. Plasmids are common in these species, with some strains harbouring
multiple plasmids.
The plasmids found in the MAC fall predominantly into one of two categories.
Small (<30kb) or large (>150kb) plasmids are the most frequently isolated, although
a range of intermediate sized plasmids spanning 60-90kb also have been isolated
from some strains (Crawford and Falkinham, 1990). The small plasmids have been
divided into two groups which are not related at the nucleotide level (Jucker and
Falkinham, 1990). Group 1 is represented by pVT2, a 12.9kb plasmid carried by
some strains ofM.avium (Jucker and Falkinham, 1990), while group 2 is represented
by pLR7, a 15.3kb plasmid carried by M.avium strain LR113 (serotype 4) (Crawford
and Bates, 1984).
The M.avium plasmid pLR7 is the most extensively studied of the small MAC
plasmids. Hybridisation studies have shown that pLR7 exhibits significant
nucleotide sequence homology with another MAC plasmid pLRl (17.2kb), but
restriction maps of the two plasmids show that there is considerable divergence of
restriction sites despite their similarity (Crawford and Bates, 1984; Crawford and
Falkinham, 1990). More recently, the replication region of pLR7 was located to a
1.8kb Pvu II to Sma I restriction fragment and an ORF of 1068bp, encoding a
putative Rep protein of 39.4kDa, was identified. The putative Rep protein was
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shown to contain a potential helix-turn-helix motif consistent with other DNA-
binding proteins and 43% amino acid sequence similarity with the Rep protein of the
M.scrofulaceum plasmid pMSC262. The pLR7 origin of replication was used to
construct a shuttle vector (pMB351) which was used subsequently to transform
M.avium, M.tuberculosis and M.bovis at an effiency of 105 cfu/qg DNA (Beggs et
al., 1995).
Plasmids pVT2 and pLR20 are closely related and both of these have been shown to
hybridise to a region of the 28kb plasmid pLR2 (Crawford and Falkinham, 1990).
DNA probes derived from pVT2 and pLR7 have been used in a number of studies to
establish relationships between different plasmids and to assess the distribution of
plasmids in MAC strains recovered from human (both AIDS and non-AIDS
patients), veterinary and environmental sources. Maskai et al (1989) showed that the
small plasmids recovered from porcine MAC isolates were homologous to those
recovered from human strains. Jucker and Falkinham (1990) showed that a pVT2-
derived DNA probe hybridised with every plasmid of <13.5kb from MAC isolates of
environmental, AIDS and non-AIDS origin. The authors suggested that the observed
relatedness between plasmids from environmental and clinical MAC isolates
supports the hypothesis that the environment is the most likely source of human
infection. In the same study, a second DNA probe derived from pLR7 was observed
to hybridise with larger plasmids (15.3-25kb) from environmental, AIDS-associated
and non-AIDS related MAC isolates. Another study compared rates of plasmid
carriage in both AIDS-associated and non-AIDS related MAC strains from the UK
and the USA (Hellyer et al., 1991). Higher rates of plasmid carriage were observed
in American AIDS-associated isolates than in non-AIDS strains, whereas no
significant difference was observed among UK isolates. However, regardless of
geographic origin, pLR7-related plasmids were noted to occur more frequently in
MAC serotypes 4 and 8 which are closely associated with AIDS-related infections
(Hellyer et al., 1991). The higher frequency of plasmids among these strains
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corroborated previous observations (Crawford and Bates, 1986; Meissner and
Falkinham, 1986; Jucker and Falkinham, 1990) and suggested that their presence
may be associated with virulence. However, curing MAC strains of plasmids has
proved difficult and many failed attempts have delayed further investigation of this
hypothesis (Falkinham and Crawford, 1994).
Bacterial plasmids often contain genes whose expression products confer new
phenotypic characteristics and enhanced chances of survival upon the host organism.
In order to determine the phenotype conferred upon an organism by any given
plasmid, it is necessary to compare strains which are isogeneic apart from the
plasmid DNA. This type of comparison allows different phenotypic traits, e.g.
antibiotic resistance, to be identified and attributed to the presence of the plasmid.
Unfortunately, because of the difficulties encountered in attempting to cure strains of
plasmids, and also because the genetic manipulation of mycobacteria was achieved
only relatively recently, the functions ofmany mycobacterial plasmids have yet to be
elucidated. However, some plasmid-encoded characteristics have been identified and
examples include a 173kb plasmid (pVTl) in M.scrofulaceum strain W262 which
confers resistance to mercury and copper (Meissner and Falkinham, 1984; Erardi et
al., 1987).
1.6 Taxonomy of the MAC
Attempts to establish clear taxonomic divisions within the MAC have been hampered
by the close genetic and phenotypic relationships shared between the members of the
group. Serotyping schemes have allowed only a crude differentiation between
M.avium and M.intracellulare, but this is partly because standardised antisera are not
generally available for seroagglutination typing. Laboratories utilising this assay
must generate their own antisera by immunising rabbits with strains which are
considered to be representative of known serovars (Wayne et al., 1993). Not
surprisingly, this lack of uniformity has resulted in disagreement between
laboratories participating in the characterisation of strains and has exacerbated the
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confusion surrounding classification within the complex. Although comparison of
different serotypes at the genomic level has helped to assign most strains to either
M. avium or M.intracellulare, species assignments for some serotypes remain
unresolved (see section 1.4.1).
Further difficulties in defining clear taxonomic boundaries within the MAC stem
from the remarkably close genetic and phenotypic similarities shared between
M.avium, M.a.paratuberculosis and the "wood pigeon bacillus" (see section 1.5). It
has not been possible to differentiate between these organisms on biochemical or
serological criteria, and unlike M.avium and M.intracellulare, they cannot be
resolved by genomic DNA homology determinations (Hurley et al., 1988) or DNA
probes targeting 16S rRNA genes (Thoresen and Saxegaard, 1991, van der Giessen et
al., 1992a). However, they can be separated by RFLP analysis (McFadden et al.,
1987c) and this has been facilitated by the identification of the genomic insertion
elements IS900 in M.a.paratuberculosis (Green et al., 1989) and IS901/902 in the
wood pigeon bacillus and some other strains ofM.avium (Kunze et al., 1991; Moss et
al., 1992a). Short species-specific regions situated at the 5' end of each insertion
element have provided DNA probes and oligonucleotides which allow the three
species to be resolved by Southern blotting or PCR respectively (Kunze et al., 1992).
Currently, there are two schools of thought regarding taxonomy within the MAC.
The first of these is based on a numerical taxonomic study conducted by Thorel et al
(1990). This study assigned each of 38 MAC strains to one of four clearly defined
clusters on the basis of their reactions in 22 out of 51 separate cultural and
biochemical tests. Cluster 1 contained M.a.paratuberculosis strains; cluster 2
contained M.avium and M.intracellulare reference strains; cluster 3 contained wood
pigeon isolates; and cluster 4 contained only M.a.paratuberculosis strain 316F, a
vaccine strain used for antigen production. The results of this study were observed to
concord with those of other studies based on FIGE banding patterns (Levy-Frebault
et al., 1989) and pathogenicity for bovine calves and chickens (Matthews and
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McDiarmid 1979; Thorel et al., 1984; Collins et al., 1985). From the collective
results of genotypic and phenotypic studies, Thorel et al suggested that M. avium,
M.a.paratuberculosis and the wood pigeon bacillus be reduced to subspecies of
M.avium, and proposed the following designations: M.avium subsp. avium, M.avium
subsp. paratuberculosis and M. avium subsp. silvaticum, respectively.
Further comment on the taxonomic divisions within the MAC stems from the results
of a study on the distribution of genomic insertion elements among clinical and
environmental MAC isolates (Kunze et al., 1992). Strains containing IS900 were
identified as M.a.paratuberculosis, while M.avium strains were divided into two
subgroups depending on whether IS901/902 was absent or present. Strains lacking
the insertion sequence were designated "M avium RFLP type A" (environmental
organisms rarely associated with animal disease but frequently associated with
opportunistic infections in AIDS patients), while those which contained IS901/902
were designated "M. avium RFLP type A/I" (rarely associated with human infections
but frequently associated with Johne's disease of ruminants and tuberculosis of birds
and mammals). This division was further supported by differences in plasmid
content and serotype antigens. The final conclusions of this study differed from
those based on numerical analysis in a number of respects. Firstly,
M.a.paratuberculosis is described as a slow-growing, mycobactin dependent
organism which is isolated from animals with clinical Johne's disease. This
description fits both M.a.paratuberculosis and M.avium RFLP type A/I, which can
be considered distinct on the basis of their different insertion elements, their ability to
cause tuberculosis in birds and mammals and on the stability of their dependence on
mycobactin. Secondly, whereas Thorel et al placed M.a.paratuberculosis strain
316F separately in cluster 4, Kunze et al demonstrated the presence of IS900 and
confirmed its identity as typical M.a.paratuberculosis. Thirdly, all wood pigeon-
derived isolates examined by Kunze et al were shown to possess IS901/902 and were
typed therefore as M. avium RFLP type AH. However, M.avium RFLP type A/I did
not agree fully with M. avium subsp. silvaticum, because the former includes strain 18
32
and M.a.paratuberculosis 2103, both of which were placed in cluster 2 by Thorel et
al and therefore were considered to be M.avium subsp. avium. Finally, although
there was broad agreement between M. avium RFLP type A and M. avium subsp.
avium (cluster 2 of Thorel et al), the exclusion of strain 18 (IS901/902 positive) from
M.avium RFLP type A highlighted a major discrepancy between the results of the
two studies. It should be noted that the former working strain of
M.a.paratuberculosis "strain 18" has been observed to be more closely related to
M. avium on the basis of cultural characteristics (Merkal, 1979), FIGE banding
pattern (Levy-Frebault et al., 1989) and RFLP analysis (McFadden et al., 1987a).
Strain 18 has since been identified as a serotype 2 strain ofM. avium and its abolition
as a strain ofM.a.paratuberculosis was recently proposed by Chiodini (1993).
For the purposes of this thesis, Mycobacterium paratuberculosis will be referred to
as "M.a.paratuberculosis" in accordance with the taxonomic divisions proposed by
Thorel et al (1990), and as accepted in the International Journal of Systematic
Bacteriology. However, because the divisions separating different strains of
Mycobacterium avium remain unclear, IS901/902-positive M. avium will be referred
to as M. avium type A/I in accordance with the nomenclature used by Kunze et al
(1992).
1.7 Previously Characterised Genes and Proteins of
M.a.paratuberculosis and M.avium
Pioneering work on the identification and characterisation of mycobacterial genes
and their expression products was presented to the scientific community when Young
et al. (1985a and 1985b) prepared libraries ofM.tuberculosis and M.leprae genomic
DNA in the Igtll expression vector and screened for expression of particular
antigens using a range of monoclonal antibodies. Since then, libraries have been
prepared from genomic DNA of many other species of Mycobacterium, including
M.avium and M.a.paratuberculosis, and a continually expanding catalogue of genes
and gene products is now readily accessible. Some of these, such as bacterioferritins
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(Brooks et al., 1991; Pessolani et al., 1994; Inglis et al., 1994b), and the alpha
secretory proteins of the antigen 85 complex (Matsuo et al., 1988; Wiker et al., 1990;
de Mendonica Lima et al., 1991; Matsuo et al., 1990a; Ohara et al., 1993; Kitaura et
al., 1993; Takano et al., 1994) are common to more than one species of
Mycobacterium, while others, such as heat shock proteins, are conserved across the
phylogenic spectrum.
Catalogues of previously characterised genes and proteins of M. avium and
M.a.paratuberculosis are presented in tables 1.2 and 1.3 respectively.
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♦Adapted from Stevenson and Sharp, 1997 with permission*
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Table 1.3
Previously characterised genes and proteins of
Mycobacterium avium ssp. paratuberculosis
Gene or EMBL
Antigen clone accession Function Features References
number

























































31 kDa A44892* Unknown Antigen A Sugden
etal., 1991
20 kDa A44893 Bacterioferritin Antigen D Sugden
etal,. 1991









X74495 50S subunit Van der
Giessen
etal,. 1994

















As early as 1826, an enteric disease of cattle with chronic diarrhoea was reported by
d'Aroval. The cattle dying from this condition were observed to be emaciated,
passing blood in the faeces and at post-mortem examination, the intestinal mucosa
was noted to be thickened and highly corrugated. It was not until 1895 however, that
Johne and Frothingham demonstrated the presence of acid-fast bacilli in sections of
diseased intestine and described the disease as "a peculiar case of tuberculosis". Ten
years later, Bang (1906) recognised that the disease was not tuberculosis and named
it "pseudo-tuberculosis enteritis" or "Johne's disease". Shortly afterwards the name
of "paratuberculosis" was coined and the causative agent was isolated and used to
reproduce the disease in laboratory animals (Marek, 1910; Twort and Ingram, 1912;
Twort, 1914). The organism was renamed "Mycobacterium enteritidis chronicae
pseudotuberculosae bovis johne" (Twort, 1914), but later became known as
Mycobacterium johnei, Mycobacterium paratuberculosis and more recently,
Mycobacterium avium subsp. paratuberculosis (Thorel et al., 1990) (see section
1.6).
Although M.a.paratuberculosis is the predominant pathogen in Johne's disease,
wood pigeon strains of M. avium (RFLP type A/I) are also known to cause
paratuberculosis in ruminants (see section 1.6).
1.8.2 Infection
The primary route of paratuberculosis infection appears to be faecal/oral. Infected
animals may excrete the organism in the faeces for up to 18 months prior to
developing visible signs of infection and clinical cases may shed as many as 5 x 1012
organisms/day (Chiodini et al., 1984a). Young animals may contract the infection
via sucking on teats contaminated with faeces, ingesting infected colostrum or milk
or grazing on contaminated pasture. Following oral ingestion, the organism is
thought to become localised in the mucosa of the small intestine, its associated
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lymph nodes and to a lesser extent, in the tonsils and suprapharyngeal lymph nodes.
The organism traverses the intestinal mucosa via M cells in the dome epithelium of
ileal Peyer's patches and subsequently is phagocytosed by subepithelial macrophages
(Momotani et al., 1988). Evidence supporting the role of ileal Peyer's patches in the
uptake of the organism is provided by histopathological observations in
experimentally infected calves (Payne and Rankin, 1961; Gilmour et al., 1965;
Momotani et al., 1988) and sheep (Kluge et al., 1968; Gilmour et al., 1978; Perez et
al., 1996; Perez et al., 1997).
The isolation of organisms from bovine placental tissue, uterus and foetal tissues
(Seitz et al., 1989; Sweeney et al., 1992) provides evidence of intrauterine infection
of the foetus. However, to date, lesions associated with paratuberculosis have not
been demonstrated in the foetus. Contamination of the male reproductive tract and
seminal fluid also has been reported (Larsen and Kopecky, 1970), but sexual
transmission of the infection has not been demonstrated.
Paratuberculosis has been reproduced experimentally by oral inoculation of calves
(Payne and Rankin, 1961; Gilmour et al., 1965), lambs (Nisbet et al., 1962; Kluge et
al., 1968; Allen et al., 1974; Gilmour et al., 1978; Garcia Marin., et al., 1992) and
deer (Nyange, 1990). Experimental infection, resulting in lesions in the intestine and
other organs, also has been transmitted successfully in sheep via intratracheal and
intravenous routes (Kluge et al., 1968). Attempts to transmit the disease by
experimental intramammary and intrauterine inoculation were unsuccessful (Larsen
and Miller, 1978; Merkal et al., 1982).
1.8.3 Prevalence and economic impact
Paratuberculosis is a global disease problem whose prevalence has been reported to
be increasing in some countries. Results of studies on bovine paratuberculosis have
provided evidence of infection in 15% and 18% of cattle in the UK and USA
respectively (Chiodini et al., 1984a; Chiodini and Van Kruiningen, 1986; Braun et
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al., 1990). Prevalence rates as high as 30% have been reported among beef cattle
herds in Louisiana (Turnquist et al., 1991), while in other areas of the USA and
Canada, rates may be as low as 1.6%-5% (Merkal et al., 1987; McNab et al., 1991).
Rates of mortality are normally <1%, but have been reported to be as high as 10%
(Radostits et al., 1994). Recently, the UK Veterinary Investigation Centres reported
that the annual incidence of ruminant paratuberculosis in the UK has been rising
since 1985. The number of ovine cases is only around 10% of the number seen in
cattle, but the geographical distribution is disproportionate with 40% of bovine cases,
75% of ovine cases and 42% of caprine cases being recorded in Scotland. In the
Tayside region alone, the incidence of ruminant paratuberculosis has increased over
the last three years to constitute 42% of the Scottish total (Grieg, pers.comm.).
It has been estimated that paratuberculosis costs the US agricultural industry in
excess of $1.5 billion annually (Chiodini et al., 1984a; Jones, 1989). Losses totalling
approximately $US 15.4 million have been reported in the cattle industry alone in
New England, Australia (Chiodini and Van Kruiningen, 1986; Gill, 1989). Although
paratuberculosis is widespread in New Zealand, in common with many other
countries throughout the world, there are no reliable estimates on the national
prevalence of the disease (deLisle and Milestone, 1989). The absence of reliable
data has made the global economic impact of paratuberculosis difficult to calculate
and it is likely that the true cost of the disease is considerably higher than currently
accepted estimates. In an Australian study, losses attributed to paratuberculosis were
arbitrarily classified as being due to direct, indirect and inapparent costs (Gill, 1989).
Direct costs include 1. reduced productivity due to clinical and subclinical disease; 2.
increased susceptibility of infected cattle to disease and infertility; and 3. the costs of
implementing control measures. Indirect costs include; 1. export testing of live
animals; 2. testing of animals moving interstate; and 3. funding for paratuberculosis
research. Inapparent costs are less specific and are difficult to calculate. An example
would be the protection of the export market afforded by government and
agricultural industry efforts in implementing paratuberculosis control measures, and
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maintaining an effective and credible animal health infrastructure. The costs of
running these programmes in respect of paratuberculosis alone are unquantifiable
since the service provides other important functions also.
In bovine calves, the risk of infection with M.a.paratuberculosis appears to be higher
in young animals under four weeks of age, but adult animals exposed to the organism
for the first time may develop the disease (Larsen et al., 1975). Results of
experimental transmission studies have shown that infection is achieved most
successfully by inoculating young calves orally with large numbers of organisms
(Larsen et al., 1975). Factors regarded as predisposing animals to infection include
intensive farming systems, acid soils, low dietary intake, stress and
immunosuppression due to infection with bovine virus diarrhoea virus (Clarke,
1997). Exposure to infected faeces is probably the single most important factor in
disease transmission, and may explain why paratuberculosis has been observed to be
more prevalent in dairy cattle than beef cattle (Braun et al., 1990). Natural
transmission of the disease between different species remains an unresolved issue,
and the significance of experimental inter-species infections in relation to naturally
occurring paratuberculosis has yet to be established. However, the potential for
transmission of the disease from wild rabbits to domestic ruminants is the subject of
ongoing research (Greig et al., 1997).
1.9 Immunological Aspects of Johne's Disease
Immunological parallels have been drawn between Johne's disease and leprosy in
humans (Cocito et al., 1994). Both mycobacterioses are characterised by an early
stage, where a strong cell mediated immune (CMI) response limits proliferation of
the organism, and a terminal anergic stage, where CMI is no longer detectable and
serum antibody levels are elevated. As in other mycobacterioses, CMI is considered
to be the most important immune mechanism for clearing M.a.paratuberculosis
infection. Although high titres of circulating antibody are characteristic of advanced
clinical Johne's disease, the humoral arm of the immune response to infection is
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ineffective against mycobacteria which occupy, and replicate in, an intracellular
environment (Chiodini et al., 1984a; Clarke, 1994).
1.9.1 Cell mediated immunity
Detectable CMI responses to M. a.paratuberculosis appear early in the infection and
in some cases are sufficient to clear the invading organism and render the host animal
resistant to reinfection (Gilmour et al., 1978). However, CMI may weaken
progressively over the protracted period of a persistent infection resulting in bacterial
proliferation and disease associated with multibacillary (lepromatous) lesions.
Alternatively, persistent and chronic inflammatory disease associated with a
paucibacillary (tuberculoid) state may result from prolonged CMI mounted in
response to organisms which resist killing (Chiodini et al., 1984a; Clarke, 1997).
T-lymphocytes are responsible for activating macrophages and play a central role in
orchestrating the CMI response to mycobacterial infections. The importance of T-
lymphocytes in clearing infection with M. a.paratuberculosis has been demonstrated
in a study where experimentally infected athymic mice were observed to be incapable
of impeding mycobacterial proliferation and preventing the development of intestinal
lesions (Hamilton et al., 1989). Class I and II major histocompatibility complex
(MHC) molecules on the surface of macrophages and other antigen presenting cells,
play a central role in delivering mycobacterial protein antigens to T-lymphocytes and
triggering their activation and clonal proliferation (Kaufmann, 1993; Rock, 1996). In
addition, CD 1-restricted T-lymphocyte recognition of mycobacterial lipid antigens,
including those ofM.avium, has been demonstrated in humans (Sieling et al., 1995).
T-lymphocytes carrying ap T-cell receptors, including CD4+, CD8+ and CD4", CD8"
subsets, and y8 T-cell receptors are known to be active in mycobacterial infections.
Experiments where CD4+ T-cell deficient "knockout mice" were observed to
succumb to challenge with M. tuberculosis have shown that this particular subset is of
paramount importance in arresting the progression of mycobacterial disease (Boom
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et al., 1991). Thl and Th2 subsets of murine CD4+ T-lymphocytes can be
distinguished on the basis of their characteristic cytokine production patterns. Thl
cells secrete interferon gamma (IFN-y), interleukin-2 (IL-2) and IL-12, and promote
activation of macrophages and delayed type hypersensitivity (DTH) responses. Th2
cells produce IL-4, IL-5, IL-6 and IL-10, and promote B-cell differentiation and
antibody production (Mosman et al., 1986; Mosmann and Moore, 1991). A balance
between the effects of Thl and Th2 activity is achieved through reciprocal
antagonism with IL-4 and IL-10 exerting a suppressive effect on Thl responses, and
IFN-y having a similar suppressive effect on Th2 responses (Mosmann and Moore,
1991). These mechanisms have been observed in mycobacterial diseases such as
tuberculosis and leprosy where IFN-y production, strong DTH reactions and low
numbers of mycobacteria are associated with Thl responses, and depressed IFN-y
production, high antibody concentrations and large numbers of mycobacteria are
associated with Th2 responses (Orme et al., 1992; Barnes et al., 1993). A similar
immunological picture has emerged from studies on paratuberculosis in sheep and
cattle. During the course of the disease, high CMI, which is characteristic of the
early phase of infection, begins to fall and is replaced by an increase in circulating
immunoglobulin (see below). This suggests that a Thl-Th2 balance operates in
paratuberculosis also. Evidence supporting early CMI responses is provided by
measurement of in vitro secondary T-lymphocyte proliferation (Lepper et al., 1989;
Perez et al., 1994; Burrells et al., 1995) and intradermal skin testing, where positive
DTH reactions seen early in infection were observed to weaken progressively in
animals with chronic disease (Gilmour et al., 1965; Davies et al., 1974). In addition,
stimulation with mycobacterial antigens evoked only weak in vitro secondary
proliferative responses in T-lymphocytes taken from cattle with advanced
paratuberculosis (Kreeger and Snider, 1992). Electron microscopic examination of
intestinal macrophages of sheep with paratuberculosis revealed a correlation between
strong DTH skin reactions and small numbers of morphologically damaged
intracellular mycobacteria (Gilmour et al., 1978). In the same study, intestinal
46
macrophages of other animals with depressed DTH responses were observed to
harbour large numbers of apparently intact intracellular organisms.
To date, descriptions of the immunological course of paratuberculosis have focused
primarily on peripheral responses rather than those occurring locally at the intestinal
mucosa. Observations following intravenous inoculation of cattle with killed
M.a.paratuberculosis showed that early CD4+ T-lymphocyte and DTH responses
preceded an anergic phase and subsequent increases in antigen specific-reactivity of
y8+ and CD8+ T-lymphocytes (Chiodini and Davis, 1992 and 1993). These
observations prompted the authors to suggest that these cells may have a modulatory
effect on the CD4+ response. Shortly afterwards, experimental infections in
susceptible (strain C57BL/6) and resistant (strain C3H/He) mice demonstrated both
CD4+ T-lymphocyte depletion and reduced CD25 expression in the intestines of
susceptible animals, whereas no such changes were observed to have occurred in the
resistant strain (Veazey et al., 1994). In addition, the susceptible mice were noted to
possess increased numbers of antigen-reactive CD8+ and y8+ T-lymphocytes,
although this was not seen to confer any obvious immunological advantage as the
development of characteristic granulomatous multibacillary lesions progressed
unhindered. These observations contrast with the situation in the murine lung where
CD8+ cells have been shown to afford protection against infection with
M. tuberculosis. The specific role of CD8+ lymphocytes in the lung and the reasons
why they appear to be less important in protecting other organs against mycobacterial
infection are unknown. However, the results of a recent study suggest that the
protective mechanism of CD8+ lymphocytes in the murine lung is one of cytokine
production rather than lysis of infected macrophages (Cooper et al., 1997). Further
studies conducted in sheep showed that animals with multibacillary lesions and weak
CMI responses were depleted in numbers of both CD4+ and CD8+ intestinal T-
lymphocytes, while those with paucibacillary lesions and strong CMI responses were
noted to possess increased numbers of both CD4+ and y8+ intestinal T-lymphocytes
(Little et al., 1996). Support for these findings comes from the results of recent
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studies which correlated strong peripheral and local antigen-specific lymphocyte
reactivity in paucibacillary paratuberculosis with increased Thl cytokine (IFN-y and
IL-2) production. Conversely, conditions likely to favour mycobacterial persistence,
such as depressed lymphocyte reactivity and Thl cytokine production, were observed
to be characteristic ofmultibacillary paratuberculosis (Burrells, pers. comm.).
Finally, the role of natural killer (NK) cells in the ruminant immune response to
paratuberculosis has yet to be described fully. IFN-y production in response to
mycobacterial infection has been observed in NK cells (Moreno and Rees, 1993).
More recently, experimental infection ofNK cell-depleted beige (highly susceptible)
and C57BL/6 (control) mice showed that growth of virulent strains of M.avium was
not affected in either group (Florido et al., 1997). The authors concluded that lack of
NK cell activity is not responsible for the increased susceptibility of beige mice to
pulmonary M.avium infection.
1.9.2 Humoral immunity
Antibody production in animals with paratuberculosis appears later during the course
of infection than corresponding CMI responses, and has been noted to coincide with
depressed antigen-specific T-lymphocyte reactivity or even anergy (Chiodini et al.,
1984a; Burrells et al., 1995). It has been suggested that intracellular mycobacteria
proliferate in the face of decreasing CMI, and that the release of organisms by the
lysis of infected cells serves as the stimulus for antibody production (Clarke, 1997).
Thus, higher circulating antibody levels are characteristic of animals with
multibacillary lesions, whereas lower antibody levels are associated with
paucibacillary cases (Sockett et al., 1992a; Clarke et al., 1996). However, circulating
antibody is ineffective against remaining intracellular organisms and of no value in
arresting the progression of clinical disease.
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1.10 Diagnosis of Johne's Disease
Historically, the absence of accurate and reliable methods for the diagnosis of
paratuberculosis has been a major limitation to effective control of the disease.
Unlike most other bacterial diseases, a long and protracted disease course and late
humoral immune response (see section 1.9) preclude early serological detection of
animals infected with M.a.paratuberculosis. In addition, unavoidable exposure to
antigenically related environmental mycobacteria generates a background of non¬
specific host immunity, against which specific immune-based diagnosis of
paratuberculosis may become discretionary and based on quantitative rather than
qualitative measurements. More direct methods of detection such as faecal smearing
do not discriminate between different species of Mycobacterium, and cultural
isolation of the organism from clinical specimens requires laboratory confirmation of
species identity. However, DNA technology has provided new approaches to the
identification of M.a.paratuberculosis and, in conjunction with more traditional
techniques, can be used to circumvent the problems of specificity and sensitivity
associated with many of the currently used diagnostic procedures.
1.10.1 Microscopic detection ofM.a.paratuberculosis in faeces
Successful detection ofmycobacteria in faeces by direct microscopic examination of
stained smears depends on the number of organisms present in the specimen at the
time of sampling and on the extent to which they may be clustered together. Overall
sensitivity is poor on an individual basis because faecal shedding of the organism at
levels detectable by smearing can be irregular and may not occur during the early
stages of infection (Chiodini et al., 1984a; Merkal, 1984). Therefore, animals in the
early or asymptomatic stages of the disease are often missed at a time when a
positive diagnosis would be of greatest value for the purpose of disease management.
Conversely, animals with more advanced paratuberculosis are scored positive using
this technique, but as animals in the later stages of the disease can usually be
identified on clinical criteria alone, laboratory confirmation is unnecessary. The
sensitivity of faecal smearing can be improved by centrifugal concentration of
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specimens and/or replacing acid-fast staining with immunofluorescent staining of
organisms (Abbas et al., 1983a). However, problems with specificity due to
antigenic cross-reactivity between M.a.paratuberculosis and ubiquitous
environmental mycobacteria negates the routine use of this procedure.
1.10.2 Cultural isolation ofM.a.paratuberculosis from clinical specimens
Faecal culture is considered to be more sensitive than microscopic examination of
smears, but is very slow and often difficult due to the fastidious nature and long
generation time of M.a.paratuberculosis. In addition, false negatives due to reduced
mycobacterial viability may result from chemical decontamination of the sample
prior to culture (Ridge, 1993). Also, some strains of M.a.paratuberculosis,
especially those of ovine origin, appear to be non-cultivable (Chiodini et al., 1984a).
Cultural isolation ofM.a.paratuberculosis from biopsy and necropsy tissues such as
mesenteric and ileocecal lymph nodes has been used as an alternative, or in addition
to faecal culture (Smith, 1954; Rac, 1955; Benedictus and Bosma, 1985; Benedictus
and Haagsma, 1986). The rate of isolation of M.a.paratuberculosis from tissues is
generally higher than from faeces, especially in animals shedding low numbers of
organisms (Merkal et al., 1987). However, identification ofM.a.paratuberculosis on
cultural characteristics such as slow rate of growth and mycobactin dependence on
primary isolation cannot be assumed, as these characteristics are shared by some
strains of M.avium which also can cause paratuberculosis in ruminants (Matthews
and McDiarmid, 1979). The actual identity of any such isolate should be confirmed
by PCR-amplification of the subspecies-specific nucleotide sequences within IS900
fox M.a.paratuberculosis and IS901/902 for M.avium spp. (see section 1.10.6).
1.10.3 Histopathological detection ofmycobacteria in tissue biopsies
Histopathological examination of biopsy and necropsy tissues has provided a rapid
and accurate means of detecting mycobacteria in the mesenteric lymph node and
terminal ileum of infected cattle (Buergelt et al., 1978b; Pemberton, 1979;
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Benedictus and Haagsma, 1986). Again however, differentiation between
M.a.paratuberculosis and other species of Mycobacterium is not possible using this
technique alone.
1.10.4 Serological detection ofM.a.paratuberculosis infection
Many different assays for the serological diagnosis of paratuberculosis have been
described. Examples include complement fixation (CF), agarose gel
immunodiffusion (AGID) and enzyme-linked immunosorbent assay (ELISA). All
are affected by a lack of specificity and none afford the ability to detect animals in
the early stages of the disease when circulating antibody levels are either below
detectable levels or absent altogether (Chiodini et al., 1984a; Cocito et al., 1994).
Of these, ELISA is the most sensitive, but like other serological assays, it suffers
from a lack of specificity when crude or even partially purified protein extracts are
used as capture antigens (Abbas et al., 1983b; Yokomizo et al., 1985; Collins et al.,
1991; Molina et al., 1991). Although background noise may be reduced by pre-
absorption of test sera with M.phlei cell lysates prior to analysis (Yokomizo et al.,
1985; Molina et al., 1991; Bech-Nielsen et al., 1992), this step has not circumvented
the problem of cross-reactivity between M.a.paratuberculosis and strains of
M.avium. Earlier confusion surrounding the actual identity of "M.paratuberculosis
strain 18" (see section 1.6) served only to exacerbate the problem of distinguishing
between these two closely related organisms. Ironically, this problem was
emphasised by the introduction of a commercially available ELISA (Allied ELISA,
Allied Monitor Inc., Fayette, Mo.) which was based on partly purified antigens
prepared from "M.paratuberculosis" strain 18, an isolate now known to be a serotype
2 strain ofM. avium (see section 1.6). Another ELISA, this time based on glycolipid
(LAM) rather than protein antigens, also was shown to lack specificity due to
extensive cross-reactivity between different mycobacterial and corynebacterial LAM
preparations (Sugden et al., 1989; McNab et al., 1991a & 1991b). More recently, a
clone isolated from a A,gtl 1 expression library was shown to encode a peptide (a362)
which carried subspecies-specific B-cell epitopes corresponding to a 34kDa protein
antigen ofM.a.paratuberculosis (De Kesel et al., 1993). A peptide derived from the
carboxyl terminus of a362 was used to develop an ELISA which the authors claimed
was capable of detecting cattle harbouring M.a.paratuberculosis infection
specifically, and against a background of antibody known to cross-react with strains
ofM. avium (Vannuffel et al., 1994a).
1.10.5 CMI-based detection ofM.a.paratuberculosis infection
The major advantage of techniques which measure cell mediated rather than humoral
immunity is the ability to detect animals in the early or asymptomatic stages of the
disease. Cell mediated immune responses to infection with M.a.paratuberculosis
have been measured in vivo using the intradermal skin test (Kormendy, 1988), and in
vitro using the secondary T-lymphocyte proliferation assay (Buergelt et al., 1977 &
1978a) and the migration inhibition test (Bendixen, 1977). Cutaneous testing entails
intradermal inoculation of tuberculin-like preparations of partially purified
M.a.paratuberculosis or M.avium antigens, and measuring the diameter of any
subsequent DTH response at the site of inoculation. These antigen preparations elicit
cross-reactive as well as specific inflammatory responses and comparative testing of
positive animals with both avian and bovine tuberculin is necessary in EEC countries
where tuberculosis testing of cattle is compulsory. Animals which react strongly to
bovine tuberculin but weakly to avian tuberculin are considered tuberculous and
removed from the herd for slaughter. However, the intradermal skin test for
paratuberculosis lacks specificity and false positives can result from antigenic cross-
reactivity with other species of Mycobacterium, and also with Actinomyces spp.,
Dermatophilus spp., Nocardia spp., Streptomyces spp., Corynebacterium spp. and
certain species of fungi (Chiodini et al., 1984a). In addition, the intradermal skin test
cannot distinguish between diseased animals, vaccinates, or others which have
successfully cleared the infection and are immune to re-infection. More recently, the
correlation between lymphocyte blastogenesis and the production of IFN-y was used
to develop an ELISA designed to detect IFN-y released by short term whole blood
cultures in response to an antigenic stimulus (Rothel et al., 1990; Wood et al., 1991).
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This assay was shown to be more sensitive than any of those mentioned above for the
diagnosis of tuberculosis in cattle.
1.10.6 Nucleic acid-based detection ofM.a.paratuberculosis
PCR amplification of specific genomic DNA sequences has been used in the
diagnosis of a number of mycobacterial infections, and several target sequences have
been exploited for this purpose (Hawkey, 1994). The identification and
characterisation of IS900 in M.a.paratuberculosis and IS901/902 in certain strains of
M.avium (see sections 1.5.5.1 and 1.5.5.2), has enabled not only definitive strain
differentiation, but a highly specific and sensitive means of detecting the presence of
these organisms in pathological specimens by PCR (Vary et al., 1990; Collins et al.,
1993a; Challans et al., 1994; Ahrens et al., 1995). A number of studies evaluating
the performance of PCR-based diagnosis ofM.paratuberculosis in clinical specimens
have been conducted (van der Giessen et al., 1992b; Sockett et al., 1992b; Whipple
et al., 1992; Collins et al., 1993a & 1993b), but a lack of uniformity in sampling and
template-DNA extraction techniques precludes any direct comparison. However,
PCR-based diagnosis ofM.paratuberculosis in bovine faeces was found generally to
be less sensitive than culture, requiring at least 104 organisms/g faeces for positive
detection. Conversely, PCR-based detection of M.a.paratuberculosis in ovine faeces
was found to be more sensitive than culture (Collins et al., 1993b) and could be due
to the extremely fastidious nature of some ovine strains which so far have proved
impossible to culture in the laboratory. Higher levels of sensitivity and greater
reliability have been achieved using tissues obtained from necropsies as opposed to
faeces (Stevenson and Sharp, 1997).
In addition to IS900, a second genomic sequence (F57) with M.a.paratuberculosis
specificity has been cloned and sequenced (Poupart et al., 1993). F57 is 620bp in
length, composed of 59% G +C and although an ORF appears to run through the
entire fragment, it does not share significant homology with any other sequence
currently held in the EMBL database. Labelled RNA transcripts from the F57
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fragment were shown to hybridise to genomic DNA from all strains of
M.a.paratuberculosis tested, but not to the genomes of any other mycobacteria
included in the study. Although F57 appears to have diagnostic potential, it's use is
not widespread and current DNA-based techniques for the detection and
identification of M.a.paratuberculosis rely on IS900. Very recently however, a
multiplex PCR, utilising simultaneous amplification of both IS900 and F57 genomic
markers, was applied to the detection of M.a.paratuberculosis DNA in Crohn's
disease tissue biopsies (Al-Shamali et al., 1997).
1.11 The Association of M.a.paratuberculosis With Crohn's Disease
in Humans
Crohn's disease is a chronic inflammatory bowel disease, typically of the terminal
ileum, but which often affects the entire alimentary canal and extends to involve
other tissues such as muscle, bone and skin. The similarities between Crohn's
disease and ruminant paratuberculosis were noted by Dalziel (1913) and Crohn et al.
(1932). Both conditions are diseases of young adults which share similar
pathological features and are characterised clinically by intractable diarrhoea and loss
of body weight. Crohn's disease lesions are characteristically associated with
thickening of the intestinal wall, primarily due to oedema and inflammation of the
submucosa, but the lesions are often seen to affect the local lymphatics also. The
inflammatory changes often result in fibrosis of the bowel wall leading to intestinal
stenosis, and ulceration which often develops to form fistulae (Clarke, 1997).
The precise aetiology of Crohn's disease has yet to be elucidated and a number of
potential contributory factors have been suggested (Thompson, 1994). These include
host genetic predisposition, environmental factors, immunological influences and
microbial factors of which M.a.paratuberculosis has been the most commonly
implicated.
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Occasionally, it has been difficult to detect acid-fast organisms in paratuberculosis
lesions, a feature which also is characteristic of Crohn's disease. However, in a
proportion of Crohn's cases both electron microscopic examination and prolonged
tissue culture of gut biopsies have revealed the presence of cell wall-deficient, non-
acid fast spheroplasts (Chiodini et al., 1986; Graham et al., 1987; Gitnick et al.,
1989). By way of a corollary, electron microscopic examination of paucibacillary
gut lesions in cattle with subclinical paratuberculosis has revealed the presence of
similar spheroplastic organisms (Condron et al., 1994). Also, tuberculoid lesions
consistent with paratuberculosis and corresponding anti-mycobacterial immune
responses have been observed in sheep in the absence of detectable acid fast bacilli
(Clarke and Little, 1996; Perez et al., 1996). PCR amplification of DNA extracted
from diseased gut tissue revealed the presence of M.a.paratuberculosis DNA
sequences and suggested that cell wall-deficient organisms may be involved in the
paucibacillary form of paratuberculosis (Clarke and Little, 1996).
The identification ofmycobacteria recovered from Crohn's disease patients has been
difficult. In combination with the rather imprecise taxonomic divisions within the
MAC, M.a.paratuberculosis has been incorrectly diagnosed and implicated on a
number of occasions (Chiodini, 1989). Early attempts to establish a microbial
aetiology for Crohn's disease by experimental inoculation of laboratory animals with
material derived from Crohn's disease gut tissue were inconclusive. However,
experimental infection of goats with a M.a.paratuberculosis strain isolated from a
case of Crohn's disease resulted in a disease with pathology consistent with that of
ruminant paratuberculosis (Van Kruiningen et al., 1986). Significantly, pathology
characteristic of Crohn's disease was reported in a colony of stumptail macaque
monkeys infected with M.a.paratuberculosis (McClure et al., 1987). These findings
confirm that the organism is capable of causing a chronic inflammatory enteritis in
primates and lend support to the possibility that M.a.paratuberculosis may play a
role in the aetiology ofCrohn's disease in humans.
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Immunological evidence for an aetiological association ofM.a.paratuberculosis with
Crohn's disease has been inconclusive. Serum antibodies which react with
M.a.paratuberculosis PPD have been demonstrated in Crohn's disease patients
(Thayer, 1984), but the specificity and significance of these remain uncertain given
the undefined antigenic composition of PPD and the close relationship between
M.a.paratuberculosis and ubiquitous environmental mycobacteria. The results of
other studies have failed to demonstrate any association between Crohn's disease and
antibodies to M.a.paratuberculosis (Cho et al., 1986; Tanaka et al., 1991; Brunello et
al., 1991). More recently however, antibodies to M.a.paratuberculosis-specific
epitopes on the carboxyl terminus of a 34kDa protein were reported in 36% of
Crohn's disease patients (Vannuffel et al., 1994b).
The identification of species-specific sequences on the genomic insertion sequences
IS900 and IS901/902, and the application of PCR has enabled rapid and specific
detection of M.a.paratuberculosis and Mycobacterium avium (wood pigeon strains)
genomic DNA in Crohn's disease gut biopsies (Moss et al., 1992b; McFadden et al.,
1992). Using this methodology, up to 72% of Crohn's disease patients tested have
been shown to harbour M.a.paratuberculosis (Moss et al., 1992b; Sanderson et al.,
1992; Wall et al., 1993; Dell'Isola et al., 1994; Fidler et al., 1994; Erasmus et al.,
1994). However, these findings do not provide unequivocal proof of a causal role for
M.a.paratuberculosis in Crohn's disease. The results of other studies, which failed
to detect M.a.paratuberculosis DNA in any of the patients tested, have cast doubt
over the association ofM.a.paratuberculosis with Crohn's disease (Rosenberg et al.,
1991; Wu et al., 1991; Dumonceau et al., 1995; Rowbotham et al., 1995; Al-Shamali
et al., 1997)). In any case, it remains to be established whether M.a.paratuberculosis
is of primary aetiological significance in Crohn's disease, or present in lesions
merely as a secondary opportunistic invader.
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1.12 Identification of Subspecies-Specific Protein Antigens of
M.avium and M.a.paratuberculosis
The search for proteins carrying subspecies-specific epitopes has been driven
primarily by the paucity of currently available antigens affording specific and
unambiguous immune-based diagnosis of mycobacterial enteritis. Antigenic
similarity, even between phylogenetically distant species, is a characteristic feature
of the genus Mycobacterium, but is exemplified by the members of the MAC which
can be up to 98% homologous at the genomic level (McFadden et al., 1987a, 1987c
and 1990; Yoshimura and Graham, 1988). That such close genetic relatedness is
reflected at the antigenic level is not surprising, and that the host immune response to
MAC infection lacks species or subspecies specificity is a natural consequence of
phenotypic similarity within the group.
In terms of relative abundance, any potential subspecies-specific antigen may exist as
a minor antigenic component and its presence could be masked by an overwhelming
number of chemically diverse and possibly more immunogenic cellular antigens.
However, monoclonal antibody (mab) technology has provided a means through
which the specificity of individual antigens and epitopes can be assessed and
compared between species. Efforts to produce mabs against M. avium cell wall
components have been successful in identifying epitopes on the glycopeptidolipid
antigens which confer serotypic identity upon different MAC isolates (Kolk et al.,
1989; Rivoire et al., 1989). In addition, a number of mabs raised against
mycobacterial cell lysates have highlighted MAC-specific epitopes on two protein
antigens of 20kDa and 34kDa, and putative M.avium-specific epitopes on a further
four proteins of 30, 33, 35 and 36kDa (Rouse et al., 1991). However, as the mabs
produced in this study were not screened against M.a.paratuberculosis, the claimed
specificity of these reagents remains unconfirmed. To date, the only mab with
confirmed subspecies-specificity is Avi-3 which recognises an epitope on a 27kDa
protein antigen (alkyl hydroperoxidase) ofM.avium (Abe et al., 1989). Identification
of M.a.paratuberculosis-specific protein antigens using mab technology has been
57
attempted as part of a CEC-funded collaboration conducted between the Moredun
Research Institute, Edinburgh and the Danish Veterinary Laboratory, Copenhagen.
Unfortunately, none of the reagents generated were shown to exhibit specificity for
M.a.paratuberculosis (Stevenson and Sharp, 1997).
Techniques such as high resolution sodium dodecyl sulphate polyacrylamide gel
electrophoresis (SDS-PAGE), two-dimensional gel electrophoresis and Western
immunoblotting have been used to identify a number of MAC protein antigens with
potential subspecies-specificity (Bech-Nielsen et al., 1985; Valentin-Weigand et al.,
1991; Valentin-Weigand and Moriarty, 1992; Deshpande et al., 1992; Elsaghier et
al., 1992; Gilot et al., 1992; White et al., 1994). The 34kDa protein of
M.a.paratuberculosis described by De Kesel et al. (1993) represents an example of
an antigen carrying subspecies-specific carboxyl-terminal epitopes. The latter has
been incorporated into a diagnostic ELISA for the detection of antibodies in
M.a.paratuberculosis infected cattle (Vannuffel et al., 1994a) and in patients with
Crohn's disease (Vannuffel et al., 1994b) (see sections 1.10.4 and 1.11). Additional
examples include two M.avium proteins of 38.3kDa and 48.8kDa (Gilot and Cocito,
1993), although the subspecies-specificity of these antigens remains to be confirmed.
Similarly, the expression products of ORF 1 (p43) (Tizard et al., 1992) and ORF 2
(Hed protein) (Doran et al., 1997) of the M.a.paratuberculosis-specific insertion
element IS900 have yet to be evaluated for subspecies-specificity and their potential
as diagnostic antigens.
More recently, a clone encoding a potentially subspecies-specific protein antigen of
35kDa (p35) was isolated from a M.a.paratuberculosis genomic expression library
(El-Zaatari et al., 1997). While the DNA fragment containing the p35 gene was
observed to hybridise to all members of the MAC tested, sero-reactivity to the
protein was confined to animals infected with M.a.paratuberculosis. The authors
claimed that overall sensitivity and specificity of an immunoblotting assay based on
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the p35 was superior to those of commercially available diagnostic tests for
paratuberculosis.
1.13 Aim and Topic of This Thesis
The main topic of this thesis is a 40kDa protein antigen (p40), present in IS901/902-
positive strains ofM. avium, which cannot be detected in either M.a.paratuberculosis
or in strains of M.avium which lack IS901/902. The p40 potentially represents the
first example of an entire protein molecule carrying subspecies-specificity for a
pathogenic member of the MAC. As such, the p40 is a unique protein and merits
characterisation and evaluation of its role in the life cycle and pathogenesis of
IS901/902 positive M.avium. The following chapters describe the chromatographic
purification of p40, its evaluation as a subspecies-specific diagnostic antigen and
experiments aimed at its molecular characterisation.
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CHAPTER 2
GENERAL MATERIALS AND METHODS
2.1 Culture ofMycobacteria
2.1.1 M.avium type A/I and M.a.paratuberculosis
M.avium type A/I (strain JD88/118) and M.a.paratuberculosis (strain JD88/107)
(Appendix 3) were isolated from commercially farmed red deer (Cervus elaphus)
(Nyange, 1990) and propagated on solid Stuart's medium (Stuart, 1965) or modified
7H11+ medium (Appendix 4). Cultures were incubated at 37°C for 4-6 weeks for
M.avium type A/I and 8-10 weeks fox M.a.paratuberculosis.
2.1.2 M.avium type A
M.avium type A (strain T133) (Appendix 3) was provided by Dr. J.J. McFadden,
Molecular Biology Group, Dept. of Microbiology, University of Surrey. On receipt
the organism was sub-cultured and maintained subsequently on solid normal 7H11
medium (McClatchy (1976) (Appendix 4). Cultures were incubated at 37°C for 6-8
weeks.
2.1.3 MOTT strains
MOTT including M.fortuitum, M.gordonae, M.kansasii, M.malmoense and
M.marinum (Appendix 3) were supplied on slopes of IUT medium (Appendix 4) by
the Scottish Mycobacteria Reference Laboratory (SMRL), City Hospital, Edinburgh.
Others including M.avium (chicken isolate), M.intracellulare, M.scrofulaceum and
M.smegmatis (Appendix 3) were purchased from the National Collection of Type
Cultures, Central Public Health Laboratory, Colindale, London. M.phlei (Appendix
3) was isolated on modified 7H11+ medium (Appendix 4) at the Moredun Research
Institute (MRI), Edinburgh. All of the above organisms were propagated and
maintained on solid modified 7H11+ medium at 37°C.
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2.1.4 TB-complex
Organisms of the TB-complex were provided by the SMRL. M.africanum and
M.tuberculosis (Appendix 3) were supplied on slopes of IUT medium (Appendix 4),
while M.bovis (Appendix 3) was supplied on a slope of L-JP medium (Appendix 4).
Cultures were propagated and maintained on their respective media at 37°C for 4-6
weeks.
2.2 Disruption of Mycobacterial Cells
2.2.1 By Eaton press
Cells were scraped from the surface of solid growth medium and transferred to a
universal bottle. The cells were washed three times in fresh PBS (Appendix 2) by
vortexing and centrifugation at 4,800 x g for lOmin. Approximately lg of washed
mycobacterial cells was resuspended in 10ml of PBS containing PMSF at ImM final
concentration. The cell suspension was transferred to the top chamber of an Eaton
press (Eaton, 1962) pre-chilled to -70°C and allowed 3-4min to freeze. The Eaton
press assembly was placed in a floor-standing hydraulic press (Neil Inglis
Engineering) and the frozen cells disrupted at 10,000psi. The frozen lysate was
thawed and transferred to a universal bottle on ice. The viscous nature of cell lysates
prepared by Eaton press was attributable to the presence of high M.wt genomic
DNA. The viscosity of the lysate was reduced by 2 x 15sec rounds of sonication at
50% amplitude in a Vibra-cell model VCX 600 sonicator (Sonics & Materials),
allowing lmin cooling on ice between each sonication.
2.2.2 By French pressure cell
Approximately 250-300mg of washed mycobacterial cells were resuspended in 3ml
of PBS containing PMSF at ImM final concentration. The cells were transferred to
the pressure chamber of a Mini French Pressure-Cell (SLM-Aminco) and disrupted at
1500psi in a floor-standing hydraulic press. The lysate was collected and passed
through the pressure cell for a second and third time.
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2.2.3 By zirconium bead-beating
Approximately lOOmg of washed mycobacterial cells were resuspended in 0.4ml of
PBS containing PMSF at ImM final concentration. The cells were transferred to a
screw-cap Eppendorf tube containing 1ml of washed zirconium beads (0.1mm
diameter). Cells were disrupted by bead-beating in a Mini Bead-Beater (BioSpec
Products) (Hurley et al., 1987). Five beating cycles of lmin each were separated by
lmin cooling on ice to avoid overheating and possible denaturation of the antigen
preparation.
2.3 Determination of Soluble Protein Concentrations
Soluble protein concentrations were determined using the Micro BCA* Protein
Assay Reagent (Pierce-Warriner) in accordance with the manufacturer's
recommendations. A set of protein concentrations ranging from 0-20pg/ml BSA was
prepared in the same diluent used for the unknown samples. Equal volumes (0.5ml)
of protein standard and protein assay reagent were mixed in borosilicate glass tubes
and incubated at 60°C for lhr. The spectrophotometer was zeroed against equal
volumes of sample diluent and protein assay reagent and the optical densities of
standard and unknown protein samples was measured at 562nm. A standard curve
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prepared by plotting OD" against protein concentration (pg/ml) was used to read
off the protein concentrations of each unknown sample. Samples whose values fell
outside the linear working range of the assay (0.5-20pg/ml) were re-tested after
adjusting the sample dilution accordingly.
2.4 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Polyacrylamide gel electrophoresis of proteins was carried out using the
discontinuous buffer system of Laemmli, (1970). Stacking gels of 3% (wt/v)
acrylamide, 0.08% (wt/v) bis-acrylamide in 1 x LSGB (Appendix 2) were layered over
resolving gels of 10% (wt/v) acrylamide, 0.26% (wt/v) bis-acrylamide in 1 x LRGB
(Appendix 2). Mini gels (80 x 70 x 0.7mm) were prepared in a Mini Protean™ II
Dual Slab Cell (Bio-Rad Laboratories) and run at 200V (constant voltage) for 45-
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50min in LEB. Large gels (160 x 140 x 0.75mm) were prepared in a Vertical Slab
Gel Unit SE600 (Eloefer Scientific Instruments) and run at 20mA (constant current)
for 2-3hr in LEB (Appendix 2). For Commassie blue-stained gels (see section 2.5.1),
loadings ranged between 1 pg/lane, for a highly purified protein and 20pg/lane for a
complex mixture of proteins. However, loadings were reduced -10-50 fold where
silver staining (see section 2.5.2) was used. Protein molecular weight markers
spanning size ranges of 12.3-78kDa (cytochrome c 12.3kDa, myoglobin 17.2kDa,
carbonic anhydrase 30kDa, ovalbumin 42.7kDa, BSA 66.25kDa and ovotransferrin
76-78kDa) and 42.7-200kDa (ovalbumin 42.7kDa, glutamate dehydrogenase
55.5kDa, ovotransferrin 76-78kDa, phosphorylase b 97.4kDa, p.galactosidase
116.3kDa and myosin 200kDa) (Merck) were used.
2.5 Post-Electrophoresis Staining of Proteins Resolved in SDS-
PAGE Gels
2.5.1 By Coomassie brilliant blue staining
Gels were incubated in Coomassie Blue stain (Appendix 2) for 30min with gentle
agitation on an orbital shaker. Background staining was eliminated by incubating the
stained gel in Coomassie destaining solution (Appendix 2) until the desired level of
destaining was attained. The destaining process was assisted by placing a small wick
of tissue paper at one end of the destaining dish to absorb excess stain.
2.5.2 By silver staining
Gels were silver-stained using the method described by Morrisey (1981) with minor
modifications. Polyacrylamide gels were incubated for 20min in each of the three
following solutions sequentially: 1. 50% (v/v) methanol, 10% (v/v) glacial acetic acid;
2. 5% (v/v) methanol, 7% (v/v) glacial acetic acid; 3. 10% (v/v) glutaraldehyde. Gels
were then washed in 8-10 x 500ml changes of DW over a period of 3-4hr or soaked
overnight in a large volume (2-3L of DW). Washed gels were then incubated
sequentially for 20min in each of the following two freshly made solutions: 1.
5(j.g/ml DTT; 2. 6mM silver nitrate. Silver-equilibrated gels were rinsed briefly in
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DW and then twice in freshly made developer solution (0.28M sodium carbonate
containing 0.05% (v/v) formaldehyde 37-42% solution). Gels were then incubated in
developer solution until the desired level of staining was attained. The colour
development reaction was stopped by the addition of 2.3M citric acid (5ml/100ml of
developer solution) and continuing agitation for a further 20min. Typically, 200ml
(large gels) or 50ml (mini-gels) of each solution was used at each stage of the
staining procedure. All stages of the procedure were carried out with gentle agitation
on an orbital shaker.
2.6 Preservation of Stained SDS-PAGE Gels
Stained gels were soaked in 4% (v/v) glycerol for 30-40min prior to drying on to
3MM filter paper (Whatman Scientific) in a slab gel dryer (Hoefer Scientific
Instruments).
2.7 Western Transfer and "Immunoblotting"
2.7.1 Western transfer
Electrophoretic transfer of proteins from SDS-PAGE gels to nitrocellulose
membranes was carried out in accordance with the method of Herring and Sharp
(1984). The procedure was based on the method previously described by Burnette
(1981) using TGBB (Appendix 2). Proteins resolved in mini gels were transferred in
a Mini Trans-Blot Electrophoretic Transfer Cell (Bio-Rad Laboratories) at
100V/250mA (constant voltage) for lhr. Proteins resolved in large gels were
transferred in a Trans-Blot Electrophoretic Transfer Cell (Bio-Rad Laboratories) at
100V/1.0A (constant voltage) for lhr, or 15V/100mA (constant voltage) for 16hr.
2.7.2 Immunoblotting
Immunoblotting was carried using a modification of the method of Herring and
Sharp (1984). Membranes were blocked by washing in WFB (Appendix 2) in the
absence of any extraneous protein e.g. BSA or horse serum. The blotted proteins
were probed in appropriate dilutions of primary antibody in WFB for lhr at RT.
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Excess primary antibody was removed by 3 x 5min washes in WFB. Membranes
were then incubated in secondary antibody (HRP-conjugated anti species IgG)
(Dako) diluted V^oq in WFB for lhr at RT. Excess secondary antibody was removed
by a further 3 x 5min washes in WFB. Proteins recognised by the primary antibody
were visualised by incubating the filters in a substrate solution containing lOOmM
Tris/HCl pH 7.5, ImM DAB and 60mM H202. The colour reaction was stopped by
washing the membrane thoroughly in running tap water.
2.8 Visualisation of Nitrocellulose-Bound Proteins
2.8.1 By Ponceau S staining
Freshly transferred proteins were stained reversibly by incubating the membrane in
Ponceau S solution (Sigma-Aldrich) for 5min. Excess stain was removed by rinsing
briefly in DW. The positions of M.wt marker proteins were marked with a black
ball-point pen and the membrane was processed as described in section 2.7.2.
2.8.2 By Coomassie brilliant blue staining
Freshly transferred proteins were stained irreversibly by incubating the membrane in
Coomassie Brilliant Blue stain (Appendix 2) diluted '/25 in blot destain solution (30%
(v/v) methanol, 5% (v/v) glacial acetic acid) for l-2hr. Background staining was
reduced by soaking the membrane in Coomassie destain solution as described in
section 2.5.1.
2.9 Immuno-Dot Blotting
Protein dot-blots were prepared in a Bio-Dot 96 well Microfiltration Apparatus (Bio-
Rad Faboratories). A sheet of nitrocellulose membrane (Schleicher and Schuell) was
cut to the size of the microfiltration unit and wetted in 1 x PBS (Appendix 2) prior to
assembling the apparatus. Approximately 0.5-1.0pg of highly purified protein, or up
lOpg of a complex mixture of proteins, was applied to the membrane in lOOpl of 1 x
PBS. Samples were drawn on to the membrane under gentle vacuum and washed
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with a further 200pl of 1 x PBS. The membrane was removed from the apparatus
and processed as described in section 2.7.2.
2.10 Confirmation of Strain Identity by Polymerase Chain Reaction
2.10.1 Detection of IS900 in M.a.paratuberculosis
Cultured mycobacterial cells were mechanically disrupted by bead beating (see
section 2.2.3). Lysates were centrifuged at 13,000 x g for 5min and the supernatants
transferred to fresh tubes. 5pi of lysate was added to pre-prepared reactions mixtures
of 50pl (final volume) containing 67mM Tris/HCl pH8.8, 3mM MgCl2, 200pg/ml
gelatin, 25mM each of dATP, dCTP, dGTP and dTTP, 20pmol of primers (forward
primer 5'-GTT CGG GGC CGT CGC TTA GG-3') (positions 22-41), (reverse primer
5'-CCC ACG TGA CCT CGC CTC CA-3') (position 410-391), and 1 unit of Taq
polymerase (Boehringer Mannheim). The reactions were covered with lOOpl of
mineral oil (Sigma) to prevent evaporation. PCR conditions consisted of an initial
denaturation step of 5min at 94°C and 30 cycles of annealing at 55°C for 30sec,
extension at 72°C for 60sec and denaturation at 94°C for 30sec. The final cycle
included an extension at 72°C for 120sec. Amplification products were analysed by
agarose gel electrophoresis, and a single band of 389bp confirmed species identity as
M. a.paratuberculosis.
2.10.2 Detection of IS901/902 in M.avium type A/I
Template DNA was prepared from cultured cells as described in section 2.10.1. 5pi
of lysate was added to pre-prepared reactions mixtures of 50pl (final volume)
containing 67mM Tris/HCl pH8.8, 3.7mM MgCl2, 200pg/ml gelatin, 25mM each of
dATP, dCTP, dGTP and dTTP, 20pmol of primers (forward primer 5'-CTG ATT
GAG ATC TGA CGC-3') (positions 132-149), (reverse primer 5'-TTA GCA ATC
CGG CGC CCT-3') (position 383-365), and 1 unit of Taq polymerase (Boehringer
Mannheim). PCR conditions were as described for amplification of IS900 (see




IDENTIFICATION AND PURIFICATION OF A 40kDa PROTEIN
OF Mycobacterium avium
3.1 Introduction
During a study on the prevalence and pathogenesis of M.a.paratuberculosis in red
deer, it was observed that some of the strains isolated from clinical cases differed at
the polypeptide level by the presence of a prominent band of ~40kDa as visualised in
polyacrylamide gels (Fig. 3.1) (Nyange, 1990). Like M.a.paratuberculosis, the
organisms isolated from these animals were characteristically slow growing and
exhibited mycobactin dependence on primary isolation. However, unlike
M.a.paratuberculosis they could be adapted to propagate on mycobactin-free growth
medium and required only 4-6 weeks to reach confluence, as opposed to the 8-12
weeks required by M.a.paratuberculosis. Experimental infection of deer calves with
these organisms produced a disease clinically and pathologically similar to
paratuberculosis (Nyange, 1990). However, the disease was observed to be one of
greater severity, following a more rapid progression with the infection disseminating
to involve organs other than the intestine. In spite of obvious similarities between
the two organisms, genomic DNA extracted from these mycobacteria was not
recognised in a PCR based assay designed to amplify a 389bp (see section 2.10.1)
M.a.paratuberculosis-specific region of the genomic insertion element IS900. The
isolates were identified subsequently as strains of M. avium type A/I (Stevenson,
unpublished observation).
The presence of the p40 antigen in strains ofM. avium type A/I represented a distinct
difference between two pathogenic mycobacteria, which share a high degree of
genotypic and phenotypic similarity (Inglis et al., 1994a). At the outset of this study,
immune based differentiation of M.a.paratuberculosis and M.avium had not been
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Fig. 3.1 Coomassie blue stained polyacrylamide slab gel showing the polypeptide
profiles of nineteen isolates of M.a.paratuberculosis and M.avium. Lanes
1,2,6,8,10,13,15,17 and 19 contain isolates ofM.a.paratuberculosis as confirmed by
mycobactin dependence and the presence of IS900. Lanes 3,4,5,7,9,11,12,14,16 and
18 contain isolates of IS901/902-positive M.avium as confirmed by PCR. The lane
marked M contains M.wt markers. Note the presence of a prominent band of
~40kDa in the M.avium isolates which is absent in M.a.paratuberculosis. The author
is indebted to Dr. John F.C. Nyange for providing all the material shown in this
illustration.
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achieved and the p40 antigen was identified as one which might potentially form the
basis of an assay to distinguish between the two.
As an initial objective, the extraction and purification of p40 from M.avium type A/I
cell lysates was of fundamental importance to the work presented in subsequent
chapters. The work presented in this chapter describes the optimisation of a serial
chromatographic procedure to enable the production of milligram quantities of high
purity p40.
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3.2 Materials and Methods
Methods and protocols used for in vitro culture of mycobacterial strains, mechanical
disruption of mycobacterial cells, determination of soluble protein concentration,
SDS-PAGE, western transfer and "immunoblotting" are described fully in sections
2.1-2.4, 2.7.1 and 2.7.2 respectively ofChapter 2.
3.2.1 Ammonium sulphate precipitation of soluble proteins
Intact cells and insoluble material were removed from M. avium type A/I cell lysates
by centrifugation at 100,000 x g for 60 min at 4°C. Soluble proteins in the resulting
supernatant were precipitated in a stepwise manner using ammonium sulphate
[(NH4)2 S04] in accordance with the method of Scopes (1984). Precipitated proteins
in fractions selected for further study were redissolved in 1ml of PBS and passed
through a 0.22|am membrane filter to remove insoluble material and particulate
matter.
3.2.2 Purification of p40 by high performance liquid chromatography (HPLC)
All chromatographic separation steps were performed on a System Gold HPLC
Apparatus (Beckman Instruments).
3.2.2.1 Size exclusion HPLC
Size exclusion HPLC was performed using a TSK-G3000-SW (8 x 300mm) silica gel
column pre-equilibrated with PBS (Appendix 2). Five individual injections of 200|_tl
were applied to the column and proteins were resolved over a period of 40 min at a
flow rate of 0.5ml/min. The proteins, which eluted from the column, were monitored
spectrophotometrically at a wavelength of 280nm. Fractions of 0.5ml were collected
and examined for the presence of p40 by SDS-PAGE and silver-staining. Fractions
containing p40 were pooled (2ml x 5 runs = 10ml total) and dialysed against 1000ml
ofBTN buffer (Appendix 2) for 16hr at 4°C.
70
3.2.2.2 Anion exchange HPLC
Anion exchange HPLC was performed using a TSK-DEAE-5PW (8 x 75mm)
column pre-equilibrated with BTN buffer. Following dialysis the entire sample was
applied to the column in a series of 1ml injections. Sufficient time was allowed after
the final injection for non-absorbed material to pass through the column and for the
baseline to stabilise. Absorbed proteins were eluted from the anion exchange matrix
over a period of 60 min by the application of a stepped NaCl gradient at a flow rate
of 0.5ml/min. NaCl concentration was increased linearly from 0.15M to 0.3M
between 4 min and 14min, 0.3M to 0.5M between 19 min and 49 min and 0.5M to
1.5M between 49 min and 54 min. Fractions of 0.5ml were collected and examined
for the presence of p40 by SDS-PAGE and silver-staining.
3.2.2.3 Hydrophobic interaction HPLC
Hydrophobic interaction HPLC was performed using a TSK-phenyl-5PW (8 x
75mm) hydrophobic interaction column, pre-equilibrated with BTA buffer
(Appendix 2). Anion exchange fractions containing p40 were diluted ten fold in
BTA buffer and applied to the column in a series of 1ml injections. Sufficient time
was allowed after the final injection for non-absorbed material to pass through the
column and for the baseline to stabilise. Absorbed proteins were eluted from the
column matrix over a period of 30 min by the application of a linear (NH4)2 S04
gradient, decreasing in concentration from 1.5M to 0.0M, at a flow rate of 0.5ml/min.
The quality of fractions containing p40 was assessed visually by SDS-PAGE and
silver-staining.
3.2.3 Chromatographic purification of a 30kDa (p30) antigen
Size exclusion HPLC was performed as described for p40 and the resulting fractions
were examined for the presence of p30 by SDS-PAGE and silver staining. Fractions
containing p30 (-24-25 min) were collected and pooled. Following overnight
dialysis against BT buffer (Appendix 2), p30 was purified further by anion exchange
HPLC. The column was equilibrated with BT buffer and the sample applied in a
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series of 1ml injections. Bound proteins were eluted over a period of 30 min by the
application of a linear NaCl gradient increasing in concentration from 0.0M to 0.5M.
Resulting fractions were examined for the presence of pure p30 by SDS-PAGE and
silver-staining.
3.2.4 Production of immune reagents
Both polyclonal and monoclonal immune reagents were raised against HPLC
purified p40 antigen:-
(i) Generation of anti p40 polyclonal antibodies in rabbits
Each of two 10 week old NZ/Lop cross female rabbits were inoculated
intramuscularly with 50pg of purified p40 emulsified in incomplete Freund's
adjuvant (IFA). Primary inoculations were followed by two further boosting doses
of 20pg, 2 and 6 weeks later. Seroconversion in response to the p40 antigen was
demonstrated by reacting a /80 dilution of pre- and post-immunisation rabbit serum
against western blotted M. avium type A/I cell lysate.
(ii) Generation of anti p40 monoclonal antibodies
As part of a Commission of the European Communities (CEC) funded collaboration,
highly purified p40 was sent to the Danish Veterinary Laboratory, Copenhagen,
Denmark, where the protein was used to produce eleven Mabs (Ahrens et ai, 1995;
Klausen et al., 1997). Briefly, eight to ten week old BALB/c mice were inoculated
intraperitoneally on three occasions, at two week intervals, with p40 purified from
M. avium type A/I (strain JD88/118). The mice were boosted three days before fusion
of their spleen cells with the myeloma cell line P3 X63 Ag.8.6.5.3 using standard
procedures (Goding, 1983). Hybridoma culture supernates were screened by ELISA
in microtitre plates coated with p40.
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3.3 Results
The various techniques and procedures used during the serial chromatographic
purification of p40 and p30 are summarised schematically in Fig. 3.2.
3.3.1 Salt Precipitation of Proteins in Mycobacterial Cell Lysates
Although most of the proteins resulting from stepwise ammonium sulphate
precipitation could be re-solubilised in aqueous buffer, some material remained
insoluble, presumably resulting from irreversible denaturation of protein tertiary
structure. However, SDS-PAGE analysis of the soluble and insoluble fractions of the
precipitates revealed a major band of 40kDa in the soluble 60% ammonium sulphate
fraction (Fig. 3.3). Some p40 was present in the soluble 40% and 80% ammonium
sulphate fractions also, but insufficient quantities of pure protein were recovered
from these to justify the lengthy purification procedure. Therefore, efforts towards
obtaining usable quantities of p40 focused upon the soluble 60% fraction which
contained the majority of the protein. The p40 in the soluble 60% ammonium
sulphate fraction redissolved readily in PBS facilitating subsequent chromatographic
procedures. No p40 was detected in any of the insoluble fractions.
3.3.2 Size Exclusion HPLC of Salt-Precipitated p40
Size exclusion chromatography of proteins recovered from the soluble 60%
ammonium sulphate fraction (see Fig. 3.3) revealed a series of eight peaks between
10.13 and 24.3 min, with a major peak at 17.67 min (Fig. 3.4). Subsequent analysis
of the resulting fractions by SDS-PAGE and silver staining (Fig. 3.5) revealed that
the major peak contained the p40, most of which eluted from the silica gel column
between 17 and 18 min. Smaller quantities of p40 could be seen in the fractions
corresponding to elution times of 19-21 min, but these were not used for further
purification. The p40 which eluted between 17 and 18 min was collected, pooled and
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Fig. 3.3 Silver stained SDS-PAGE gel showing proteins which were precipitated out
of the soluble phase of M. avium type A/I cell lysates at 20%, 40%, 60% and 80%
saturation with ammonium sulphate. Lanes are in pairs showing the material which
was re-solublilised in buffer after salt precipitation (S) and that which was rendered
insoluble and lost (I). Lanes marked M contain M.wt markers. Note that the
majority of the p40 is contained in the soluble 60% ammonium sulphate fraction.
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Fig. 3.4 Chromatogram resulting from size exclusion HPLC of proteins contained in
the soluble 60% ammonium sulphate fraction (see Fig. 3.3). The peak of U.V
absorbing material at 17.67 min was shown to contain p40 (see Fig. 3.5). The
smaller peak at 24.3 min, which coincides with the column Vt (see Fig. 3.6),
contained a protein which was shown subsequently to be a member of the "antigen
85 complex" ofmycobacterial secretory antigens (see main text).
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Fig. 3.5 Silver stained SDS-PAGE gel showing proteins contained in the soluble
60% ammonium sulphate fraction as resolved by size exclusion HPLC. Lanes
marked 14-25 correspond to retention times (min). The lane marked M contains
M.wt markers. Note that the majority of the p40 eluted from the size exclusion
column between 17 and 18 min and that a protein of ~30kDa eluted at a time
coinciding with the column Vt (see Fig. 3.6).
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3.3.3 Anion Exchange HPLC of Size Exclusion Fractions
Anion exchange chromatography of the proteins that eluted from the size exclusion
column at 17-18 min (see Fig. 3.5) revealed approximately 20 peaks corresponding
to NaCl concentrations ranging between ~0.3M-1.5M NaCl (Fig. 3.7). Analysis of
the resulting fractions by SDS-PAGE and silver staining revealed that a dominant
peak between 0.35M-0.39M NaCl (Fig. 3.7) and which corresponded to an elution
time of 28-31 min, consisted largely of p40 (Fig. 3.8). The p40 collected between 30
and 31 min was in a higher state of purity than the majority of the protein which
eluted between 28 and 29 min. Separate pools of p40, corresponding to 28-29 min
and 30-31 min, were prepared and stored individually for the purpose of further
purification by hydrophobic interaction chromatography.
3.3.4 Hydrophobic Interaction HPLC of Anion Exchange Fractions
Hydrophobic interaction chromatography (HIC) of pools of anion exchange-purified
p40 revealed a single peak (Fig. 3.9), regardless of whether the 28-29 min, or 30-31
min anion exchange pool (see above) was applied to the column. Subsequent SDS-
PAGE analysis of fractions resulting from HIC purification of the 28-29 min anion
exchange pool, revealed that p40 eluted from the column between 26 and 29 min at a
salt concentration of ~0.37-0.32M ammonium sulphate (Fig. 3.10). The 26 and 27
min HIC fractions contained the majority of the p40, but were observed to contain
some additional protein components ranging between ~12-38kDa. The p40 which
eluted at 28-29 min appeared to be more highly purified. The p40 fractions which
contained extraneous proteins were re-dialysed against BTA to remove ammonium
sulphate and both anion exchange and HIC separations were repeated as described
above. Repeating the separations in this way increased the total yield of highly
purified p40 (Fig. 3.11), which was collected and stored as HIC fractions at 4°C. Up
to lmg of p40 could be purified from lg (wet weight) of M. avium type A/I cells.
Ammonium sulphate was removed by dialysis immediately prior to use. This pure
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Fig. 3.6 Chromatogram illustrating the Vt of the size exclusion column used for the
serial chromatographic purification of p40. A 200pl sample of a 0.9% sodium azide
solution was injected onto the column and run under the same conditions used to
resolve mycobacterial proteins. The peak of U.V absorbing material at 25.14 min
marks the point at which sodium azide eluted from the column. At a flow rate of








Fig. 3.7 Chromatogram resulting from anion exchange HPLC of proteins which had
retention times of between 17 and 18 min on the size exclusion column (see Fig. 3.5).
A large peak at 29.63 min, which represents material which eluted from the column
between 0.35M and 0.39M NaCl (marked by X-X), was shown subsequently to
contain p40 (see Fig. 3.8).
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Fig. 3.8 Silver stained SDS-PAGE gel showing fractions resulting from anion
exchange HPLC of proteins which had retention times of between 17 and 18 min on
the size exclusion column (see Fig. 3.5). The lane marked S contains a sample of the
pooled starting material. Lanes marked 20-31 correspond to elution times (min) and
the lane marked M contains M.wt markers. The p40 component eluted between
0.35M and 0.39M NaCl (see Fig. 3.7) with the majority of the protein being collected
between 28 and 29 min. A smaller quantity of high purity p40 was collected between
30 and 31 min.
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Fig. 3.9 Chromatogram resulting from hydrophobic interaction HPLC of proteins
which eluted from the anion exchange column between 0.35M and 0.39M NaCl (see
Figs. 3.7 and 3.8). The p40, which was the most abundant component, eluted from
the column between 0.37M and 0.32M ammonium sulphate (marked by X-X) and is
represented by a single peak ofU.V absorbing material at 26.98 min.
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Fig. 3.10 Silver stained SDS-PAGE gel showing fractions resulting from
hydrophobic interaction HPLC of proteins which eluted from the anion exchange
column between 0.35M and 0.39M NaCl (see Figs. 3.7 and 3.8). Lanes marked 24-
29 correspond to elution times (min). The lane marked M contains molecular weight
markers. p40 eluted from the column between 0.37M and 0.32M ammonium
sulphate (see Fig. 3.9). The majority of the p40 was collected between 26 and 27
min whilst a smaller quantity of highly purified material was collected between 28
and 29 min. Further anion exchange and hydrophobic interaction separations
increased the total yield of pure p40 (see Fig. 3.11).
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Fig. 3.11 Silver stained SDS-PAGE gel showing highly purified p40. Material
collected from hydrophobic interaction HPLC between 26 and 27 min (see Fig. 3.10)
was further purified by additional anion exchange and hydrophobic interaction HPLC
separations. Lanes marked 26-29 correspond to elution times (min) from the
hydrophobic interaction column. The lane marked M contains M.wt markers. This
highly purified p40 was used for subsequent experiments and analyses. NB The
bands visible in lanes 26-29 at ~55-67kDa are artefactual and originate from the 2-(3-
mercaptothenol used in the sample denaturing buffer (Tasheva and Dessev, 1983).
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3.3.5 Simultaneous purification of p30
During the serial chromatographic purification of p40, it was observed that a peak of
UV absorbing material eluted from the size exclusion column at a time which
coincided with the column Vt (24-25 min) (Figs. 3.4 and 3.6). Analysis of these
fractions by SDS-PAGE and silver staining revealed the presence of p30 in a
relatively pure form (Fig. 3.5, 23-25 min). The delayed elution of a 30kDa molecule
was unexpected and contrasted with the migration rates of standard proteins
ovalbumen (42.7kDa) and chymotrypsinogen (25kDa), whose respective elution
times were recorded at 19.22 min and 22.09 min (Fig. 3.16). The p30 was collected
for further purification and analysis. Retrospective analysis of the other ammonium
sulphate fractions showed that larger quantities of the protein could be obtained from
the soluble 40% fraction than the 60% fraction. Further purification of p30 therefore
utilised this soluble 40% fraction as starting material. Anion exchange HPLC
yielded a peak of material at 0.15M NaCl (22-23 min) which contained pure p30
(data not shown). Up to 150pg of p30 could be purified from lg (wet weight) of
either M.avium type A/I or M.a.paratuberculosis cells. P30 was stored at -20°C for
future use (see Chapter 4). Analysis of the first ten amino-terminal amino acid
residues by Edman degradation yielded the following sequence:-
FSP/RPGL PVEY
Phe Ser Pro/Arg Pro Gly Leu Pro Val Glu Tyr
3.3.6 Production of Polyclonal Antibodies in Rabbits
Pre-bleeds taken from the rabbits immunised with HPLC purified p40 demonstrated
that neither animal had had any previous immunological experience of M. avium.
Post-immunisation bleeds taken after a second boosting dose reacted strongly with
the p40 antigen and weakly with a number of other protein bands on western blots of
M.avium cell lysates (Fig. 3.12).
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Fig. 3.12 Strips of Western blotted M.avium type A/I cell lysate probed with
polyclonal and monoclonal antibodies raised against HPLC purified p40. Lane 1.,
rabbit R692 pre-bleed; lane 2., rabbit R696 pre-bleed; lane 3., rabbit R692 6wk post-
immunisation bleed; lane 4., rabbit R696 6wk post-immunisation bleed; lane 5., Mab
6.66; lane 6., donkey anti rabbit-HRP conjugate control; lane 7., sheep anti mouse-
HRP conjugate control. The lane marked M contains M.wt markers. Note that the
hyperimmune rabbit sera recognised mycobacterial proteins in addition to p40.
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3.3.7 Production ofMonoclonal Antibodies
Eleven Mabs were raised against p40 and all were classified as IgGj. In ELISA, all
11 Mabs were shown to react with every strain of IS901/902-positive M.avium
tested, but not with IS901/902-negative strains of M. avium or M.a.paratuberculosis.
Only five of the 11 Mabs were shown to react strongly with p40 in western blots of
M.avium cell lysates (Fig. 3.13).
3.3.8 Expression of p40 in Mycobacteria Other Than M.avium Type A/I
Western blotted cell lysates of 15 different species of Mycobacterium (Table 3.1)
were immunoscreened with rabbit anti-p40 polyclonal antibody. Only strains of
M.avium which tested positively for IS901/902 by PCR were observed to express the
p40 antigen (Fig. 3.14a,b and c). Interestingly, M.avium strain T133 tested negatively












Fig. 3.13 Strips of Western blotted HPLC purified p40 each probed with one of
eleven Mabs raised against the antigen. Lanes are marked with Mab identification
numbers with the exception of the lane marked "control" which was probed with the
sheep anti mouse-HRP conjugate. The lane marked M contains M.wt standards.






















Table 3.1 Mycobacterial species tested for the presence of
IS901/902 by PCR and expression of p40 by immunoscreening
Western blots of cell lysates. aM avium NTCC chicken isolate;
bM.avium strain JD88/118; cM.avium strain T133 (a gift from Dr. J.

















Fig. 3.14a Coomassie blue stained SDS-PAGE gel and Western blot of cell lysates
of:- lane 1., M.gordonae; lane 2., M.marinum; lane 3., M.kansasiv, lane 4.,
M.malmoense; lane 5., M.fortuitum; lane 6., M.africanum; lane 7., M.bovis and lane
8., M.tuberculosis. The lane marked M contains M.wt markers. The blot was probed
with anti p40 hyperimmune rabbit serum. None of the above species could be shown



















Fig. 3.14b Coomassie blue stained SDS-PAGE gel and Western blot of cell lysates
of:- lane 1., M.avium type A/I (chicken isolate, NTCC); lane 2., M.intracellulare;
lane 3., M.scrofulaceum; lane 4., M.a.paratuberculosis (strain JD 88/107); lane 5.,
M.avium type A/I (strain JD 88/118); lane 6., M.leprae (cell sonicate); lane 7.,
M.smegmatis and lane 8., M.phlei. The lane marked M contains M.wt markers. The
blot was probed with anti p40 hyperimmune rabbit serum. Only IS901/902-positive









Fig. 3.14c Western blot of cell lysates of:- lane 1., M.avium type A/I (strain
JD88/118) and lane 2., M.avium type A (strain T133). The lane marked M contains
M.wt markers. Only strain JD88/118, which was positive for IS901/902, could be
shown to express p40. Strain T133 tested negatively for IS901/902 and could not be
shown to contain p40 or any cross-reacting protein.
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3.4 Discussion
The MAC comprises a group of closely related organisms (Meissner et al., 1974)
which show not only phenotypic similarity, but share up to 98% homology at the
genomic level (McFadden et al., 1987a and 1987c). Among the many attempts to
distinguish between the members of the MAC, seroagglutination (see section 1.4.1)
and genetic analysis (see section 1.5) have allowed differentiation between M. avium
and M.intracellulare. However, it was not until the identification of the genomic
insertion elements IS900 in M.a.paratuberculosis (Green et al., 1989) and IS901/902
in some strains of M.avium (Kunze et al., 1991; Moss et al., 1992) that PCR-based
techniques were developed to differentiate between these two organisms and strains
of M.avium type A. While the search for species- or subspecies-specific proteins
with diagnostic potential has enjoyed limited success (see section 1.12), to date only
the carboxy terminus of a 34kDa protein of M.a.paratuberculosis appears to contain
specific epitopes that may be applied usefully to the detection of humoral immune
responses in cattle with paratuberculosis (DeKesel et al., 1993; Vannuffel et al.,
1994a). The results presented in this chapter describe the identification and
purification of a novel 40kDa protein which appears to concur with the presence of
IS901/902 in some strains of M.avium. The p40 provides a marker which allows
both visual and immunological discrimination between M.a.paratuberculosis and
strains ofM.avium type A/I (Inglis et al., 1994a).
The p40 protein was shown to partition to the soluble phase ofM.avium type A/I cell
lysates. Following ammonium sulphate precipitation at 60% saturation, the p40
component of the precipitated material was readily resolubilised in buffer without
incurring any measurable losses (Fig. 3.3). Frozen storage of the solublised proteins
was observed to result in the irreversible denaturation and consequent precipitation of
some protein components. However, analysis of the precipitated material by SDS-
PAGE revealed that p40 was absent. Indeed a single freeze/thaw cycle was
considered advantageous in that some non-p40 proteins were selectively removed
from the preparation whilst leaving the p40 molecule intact. There can be no doubt
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that the inherently soluble nature of p40 simplified its chromatographic purification
by allowing non-denaturing conditions to be applied throughout.
The term "p40" seemed appropriate for a protein whose M.wt was estimated at
~40kDa from its migration through SDS-PAGE gels. However, a retention time of
-17 min during size exclusion chromatography (Fig. 3.15) suggested the protein may
in fact be considerably larger than 40kDa. Calibration of the size exclusion column
showed that BSA (67kDa), ovalbumin (42.7kDa), chymotrypsinogen (25kDa),
lysozyme (14.6kDa) and uridine (~300Da) had retention times of 18.5, 19, 22, 24 and
25.5 min respectively (Fig. 3.16). The largest of these standard molecules (BSA,
67kDa) was observed to elute from the column 1 min later than p40 (Fig. 3.17) and
suggested that the latter could possibly exist naturally as a dimer of ~80kDa.
Alternatively, it is conceivable that p40 dimer formation may occur artefactually and
as a consequence of purification. It is possible also, that p40 may complex with
another protein or proteins to form a multimer of ~80kDa. This possibility is
supported by the observation that, even after rigorous serial chromatographic
purification, extraneous proteins can be seen contaminating the majority of the HIC-
purified p40 (see Fig. 3.10, 26-27 min). These two apparently conflicting results can
be reconciled however. Amino-terminal amino acid sequence determinations carried
out on purified p40 (see Chapter 5) provided a clean and unambiguous sequence with
no contaminating peaks. Protein for Edman degradation was obtained by western
transfer of SDS-PAGE-resolved p40 onto PVDF membrane, and precise excision of
the Coomassie blue-stained p40 band. Other than molecules of equal M.wt, which
would co-migrate with p40, all contaminating proteins are removed at this stage. It is
unlikely therefore that there is covalent association between p40 and any other
protein, although covalent bonding between two p40 molecules, or the existence of
weaker interactions between p40 and other protein molecules cannot be ruled out.
Inter-molecular interactions such as electrostatic attraction, van der Waals forces,
disulphide bridging or hydrogen-bonding would remain intact under the non-
denaturing conditions applied throughout the purification of p40, but would be
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Fig. 3.15 Chromatogram illustrating the retention time of partially purified p40 on
the size exclusion column. The peak of U.V absorbing material at 17.53 min
represents the p40 component in a sample of first run HIC-purified protein (see Fig.
3.10, 26 min). The observed retention time of-17.5 min was not consistent with that
predicted for a molecule of 40kDa (compare with Figs. 3.16 and 3.17).
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Fig. 3.16 Chromatogram showing the results of a calibration run on the size
exclusion column. A mixture containing five molecules of known concentration and
M.wt was injected onto the column and run under the same conditions used to
resolve mycobacterial proteins. Peaks ofU.V absorbing material at 18.45 min, 19.22
min, 22.09 min, 23.93 min and 25.45 min represent 40pg BSA (67kDa), 40pg
ovalbumin (42.7kDa), 40pg chymotrypsinogen (25kDa), 20pg lysozyme (14.6kDa)





Fig. 3.17 Superimposed chromatograms (Figs. 3.15 and 3.16) to illustrate the
retention time of p40 relative to those of five standard molecules. The p40 was
observed to elute from the size exclusion column ~1 min earlier than the largest
standard molecule (BSA at 67kDa) suggesting that the former may exist as a dimer
of ~80kDa.
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disrupted by heating in the presence of SDS and 2-p-mercaptoethanol prior to SDS-
PAGE analysis. A fourth possibility is that the migration of p40 through the size
exclusion column may have been retarded by reversible non-specific interaction of
surface groups with the column matrix. An example of this type of retarded
migration is provided by a protein of ~30kDa which eluted from the silica gel size
exclusion column at a time coinciding with the Vt (Figs. 3.4 and 3.5).
A number of common pathogenic and non-pathogenic species of Mycobacterium,
including three different isolates of M. avium, were examined by PCR and
immunoblotting for the presence of IS901/902 and expression of p40 respectively
(Table 3.1). Only those strains of M.avium which contained IS901/902 could be
shown to express p40. A single strain of M.avium (T133) could not be shown to
harbour either marker. This result was in agreement with the original observation
that only p40 positive isolates of M.avium could be shown to react positively for
IS901/902 (Inglis et al., 1994a). However, it was clear that a further and more
extensive study would be required to corroborate the association between p40 and
IS901/902. In order to extend and confirm these observations, and examine a greater
number of field isolates, a collaborative study was initiated with the Danish
Veterinary Laboratory, Copenhagen, Denmark. In this study a total of 184 MAC
type and field isolates were examined for 1. the presence of IS901/902 by PCR, 2.
the expression of p40 using an ELISA incorporating Mabs raised against HPLC-
purified p40 and 3. serotypic identity (Ahrens et al., 1995). Of the 184 isolates
examined, only 47 were shown to possess both p40 and IS901/902. None of
remaining 137 isolates could be shown to contain either marker alone. In addition, of
the marker positive isolates, >89% were typed as serotype 2 isolates and the majority
of these (74%) were of porcine origin. This latter observation contrasts with the
results of a Japanese study where none of 110 porcine MAC isolates examined by
PCR could be shown to contain IS901/902 (Nishimori et al., 1995). The authors
concluded that the absence of IS901/902 might be characteristic of porcine M.avium
isolates.
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A 30kDa protein, which was purified unexpectedly during size exclusion
chromatography of salt-precipitated M. avium proteins, was sent for amino-terminal
aa sequence analysis. A search of the OWL protein database revealed that the ten
residue sequence obtained shared up to 90% identity with the mature secretory
proteins of the "antigen 85 complexes" of several mycobacterial species (Fig. 3.18).
The antigen 85 complex comprises a group of closely related secretory molecules
which range in size from 28-32kDa (Matsuo et ah, 1988) following endoproteolytic
removal of a hydrophobic signal peptide (von Heijne 1984). The mature secretory
proteins are transported into the extracellular environment by actively metabolising
mycobacteria (Abou-Zeid et ah, 1988b; Nagai et ah, 1991). Three individual
components of the complex designated 85-A, 85-B and 85-C (Wiker et ah, 1990)
have been characterised and the corresponding genes cloned and sequenced for
M.leprae (de Mendonca Lima et ah, 1991; Rinke de Wit et ah, 1993) and
M.tuberculosis/M.bovis (Matsuo et ah, 1988; Borremans et ah, 1989; De Wit et ah,
1990; Content et ah, 1991; Nagai et ah, 1991). The genes encoding the 85-B antigens
of M.kansasii (Matsuo et ah, 1990a), M.avium (Ohara et ah, 1993), M.intracellulare
(Kitaura et ah, 1993) and M.scrofulaceum (Takano et ah, 1994) also have been
cloned and sequenced. The proteins of the antigen 85 complex are known to bind
fibronectin (Abou-Zeid et ah, 1988a; Thole et ah, 1992) and have been shown to be
potent inducers of both humoral and cellular immune responses (Huygen et ah,
1988; Rumschlag et ah, 1988; Turneer et ah, 1988; Andersen et ah, 1991; Horwitz et
ah, 1995; Burrells et ah, 1995). The close antigenic relatedness between the antigen
85 complex molecules of different species is reflected by their serological cross-
reactivity (Wiker et ah, 1986a). However, serological cross-absorption studies have
demonstrated species-specific antigenic determinants in M.kansasii, M.marinum,
M.scrofulaceum, M.gordonae and M.szulgai and group-specific antigenic
determinants within the M.tuberculosis complex and the MAC (Tasaka et ah, 1983;
Tasaka and Matsuo 1984; Tasaka et ah, 1985). The proteins of the antigen 85
complex have been usefully exploited in ELISAs designed to enable the
serodiagnosis of tuberculosis in humans (Sada et ah, 1990), leprosy (Das et ah, 1990;
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Fig. 3.18 Multiple alignment comparing the first 10 amino-terminal amino acids of
M.a.paratuberculosis p30 (M.para p30) with the first 40 residues of the "mature"
antigen 85 complex molecules currently listed in the OWL protein database. 85-A, 85-
B and 85-C antigens are shown in three separate blocks. Black boxing indicates
complete identity, shaded boxing indicates conserved substitutions. Note that an
apparent deletion of two amino acid residues from the 85-C antigens causes an overall
misalignment with the 85-A and 85-C antigens from position 30 onwards. The
sequences compared are as follows, with database accession numbers in parenthesis:-
the 85-A antigens of M.leprae (Q05861), M.bovis (P17996) and M.tuberculosis
(P17944), the 85-B antigens of M.leprae (P31951), M.bovis (P12942), M.avium
(Q06947), M.intracellulare (JN0897), M.a.paratuberculosis (A44892), M.scrofulaceum
(D26187) and M.kansasii (P21160) and the 85-C antigens of M.leprae (Q05862) and
M.tuberculosis (P31953). Only the first 26 amino acid residues were available for
M.a.paratuberculosis antigen A (Sugden et al., 1991).
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Pessolani et al., 1991; Yin et al., 1994) and paratuberculosis in sheep (Sugden et al.,
1991). Similarly, lymphoproliferation and IFN-y release have been used to measure
the response of peripheral blood mononuclear cells from cases of leprosy (Launois et
al., 1994), tuberculosis in humans (Launois et al., 1994; Roche et al., 1994) and
paratuberculosis in sheep (Burrells et al., 1995). By using a series of overlapping
synthetic oligopeptides representing the entire molecule, the T-cell epitopes
responsible for stimulating lymphocyte proliferation and cytokine release have been
mapped for the 85-A and 85-B antigens ofM. tuberculosis and M.bovis BCG (Leao et
al., 1993; Huygen et al., 1994; Launois et al., 1994; Roche et al., 1994; Silver et al.,
1995). In addition, peptide mapping studies have identified the fibronectin-binding
domains of the M.tuberculosis 85-A antigen (Leao et al., 1993) and helped to
elucidate the mechanism of interaction between human fibronectin and the 85-B
antigen of M.bovis (Peake et al., 1993). Analysis of secretory proteins purified from
mycobacterial culture filtrates has shown that the mature secretory molecules of the
antigen 85 complex can account for up to 30% of the protein secreted in culture
(Abou-Zeid et al., 1988a; De Bruyn et al., 1987; Wiker et al., 1986b). Subunit
vaccines incorporating purified secretory antigens have been shown to induce a CMI
response and significant protective immunity against pulmonary tuberculosis in mice
(Hubbard et al., 1992) and guinea pigs (Pal and Horwitz 1992) which were later
challenged with aerosolised M. tuberculosis. Similarly, purified secretory proteins in
combination with dimethyl dioctadecyl ammonium chloride (DDA) were shown to
confer a level of protective immunity comparable with that afforded by bacillus BCG
in mice subsequently challenged parenterally with virulent M. tuberculosis (Andersen
1994). In addition, this study demonstrated that the protection conferred upon
vaccinated mice was adoptively transferable to naive mice via CD4+ T-cells. More
recently, it was shown that vaccination with a single homogeneous 30kDa protein of
the antigen 85 complex can afford guinea pigs partial protection against challenge
with aerosolised M.tuberculosis (Horwitz et al., 1995). Very recently, naked DNA
vaccines, utilising the gene encoding the M.tuberculosis 85-A antigen, have
successfully stimulated protective immunity in mice challenged subsequently with
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live M.tuberculosis (Huygen et al., 1996; Montgomery et al., 1997). The high
immunoprophylactic efficacy of secreted antigens is intriguing, but might be
explained in terms of their earlier accessibility over somatic antigens. Because
mycobacteria are intracellular organisms and reside unchallenged in host
macrophages, somatic antigens are not available for antigen processing until
macrophage activity is triggered. The activation ofmacrophages however, is a direct
consequence of the antigenic stimulus of T-lymphocytes, which in the case of
mycobacterial infections is likely to result from exposure to secretory rather than
somatic antigens.
While the antigens of the complex themselves are of proven immunotherapeutic
potential, the mechanism by which they are actively exported out of the cell
represents a naturally occurring bacterial protein secretory system and a novel
approach to the construction of recombinant vaccines. To this end, bacillus BCG and
the antigen 85 complex secretory mechanism have been usefully exploited in the
construction of a recombinant vaccine vehicle and antigen delivery system. Bacillus
BCG transformants, containing recombinant E.coli-Mycobacterium shuttle plasmid
constructs, have been shown to express and actively secrete the M.kansasii 85-B
antigen and a 12 aa B-cell epitope ofHIV type 1 ^\lSaS as a chimeric fusion protein
(Matsuo et al., 1990b). More recently, a similar BCG transformant expressing the
M.kansasii 85-B antigen fused to a 15 aa peptide of HIV type 1 Env protein V3
region, has been shown to elicit a cytotoxic T-cell response towards the viral antigen
in recipient mice (Kameoka et al., 1994).
The work undertaken in this chapter resulted in the purification of two protein
components of an isolate of M.avium type A/I. The first of these, an antigen of
~40kDa, appears to be specific to strains of M.avium type A/I. As such, p40
represents a molecule which allows the two pathogenic and mycobactin dependent
members of the MAC to be distinguished from each other and from strains of
M.avium which do not harbour the IS901/902. The second is a known secretory
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antigen of ~30kDa which does not provide a species-specific immunological marker,
but is produced and secreted in significant quantities only by actively metabolising
mycobacteria. Therefore, the p40 and p30 antigens potentially provide the antigenic
basis of tests which could be used to distinguish between animals infected with one
or other organism and also between animals which are actively infected and those
which have received vaccination. In the following chapter, the two purified
mycobacterial proteins are used in assays designed to measure the specific reactivity
of T-lymphocytes taken from sheep experimentally infected with strains of M. avium
type A/I and M.a.paratuberculosis.
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CHAPTER 4
OVINE T-CELL RESPONSES TO TWO DEFINED
MYCOBACTERIAL ANTIGENS IN ANIMALS INFECTED
WITHM.avium TYPE A/I AND M.a.paratuberculosis
4.1 Introduction
Immune-based methodologies for the diagnosis of paratuberculosis remain unreliable
(reviewed by Chiodini et al., 1984a; Cocito et al., 1994; Collins, 1994). This is
partly attributable to the sequence of immunological events which follow exposure to
the organism and the onset of the disease process, but also to the lack of specific
immunodiagnostic reagents.
Two expressions of clinical paratuberculosis have been described; a paucibacillary
(tuberculoid) form and a multibacilliary (lepromatous) form and in this respect the
disease is analogous to leprosy (Stamp and Watt, 1954; Gilmour et al., 1965;
Gilmour et al., 1978; Clarke et al., 1996). These two disease states lie
characteristically at extreme ends of the immunological spectrum with the former
marked by strong CMI responses and low levels of circulating immunoglobulin, and
the latter characterised by anergy and high levels of circulating immunoglobulin
(Merkal et al., 1970; Davies et al., 1974; Bendixen, 1978; de Lisle and Duncan,
1981; Paliwal et al., 1985; Lepper et al., 1989). The clinical outcome of both forms
of paratuberculosis is the same however, with early CMI and late humoral immune
responses representing characteristic immunological features of the disease.
Accurate serological detection of paratuberculosis infection has been hampered by a
number of factors. Animals in the early stages of infection have little or no
circulating antibody and serological diagnosis of infection with M.a.paratuberculosis
is therefore of limited value. In addition, high levels of circulating antibody do not
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discriminate between actively and sub-clinically infected animals or those which
have recovered and acquired protective immunity. Continuous exposure to
M.a.paratuberculosis and related Mycobacterium spp. ensures that resistant animals
remain immunologically reactive on subsequent testing, with some exhibiting greater
reactivity than animals which are actively infected (Chiodini et al., 1984a). The
inevitable exposure of animals to ubiquitous environmental strains of non-pathogenic
M. avium often results in cross-reactive immunity and false positive diagnoses are
commonplace. In addition, vaccinated animals also are likely to have serum
antibodies which cross-react with components of the relatively crude antigen
preparations used in some serological assays. Cross-reactivity is not limited to
antigens of other Mycobacterium spp., but extends to include Actinomyces spp.,
Dermatophilus spp., Nocardia spp., Streptomyces spp., Corynebacterium spp. and a
number of fungi (Pier et al., 1968; Gilmour and Goudswaard, 1972; McKenzie and
Ward, 1981; Wilks et al., 1981; Chiodini et al., 1984a; Pepin et al., 1987; Cocito et
al., 1994).
Serological tests including complement fixation (CFT), agarose gel immuno¬
diffusion (AGID), fluorescent antibody (FA), haemagglutination (HA),
haemagglutination-lysis (HA-lysis) (Goudswaard et al., 1976) and more recently
enzyme-linked immunosorbent assay (ELISA) have been used in the serodiagnosis of
paratuberculosis and other mycobacterial infections. Of these, ELISA has proven to
be the more sensitive and has been developed for the diagnosis of human tuberculosis
(Daniel and Debanne, 1987; Sada et al., 1990), leprosy (Pessolani et al., 1991) and
paratuberculosis in cattle (Bech-Nielsen et al., 1991; Cox et al., 1991; McNab et al.,
1991a; Ritacco et al., 1991; De Kesel et al., 1993; Vannuffel et al., 1994a), sheep
(Brooks et al., 1988; Sugden et al., 1991) and goats (Molina et al., 1991).
The earliest detectable immune responses to mycobacterial infection are cell-
mediated, therefore an assay intended for identification of animals in early and
subclinical phases of disease should be designed to measure cellular immunity.
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Assays including the intradermal skin test (Kormendy, 1988), the secondary T-cell
proliferation assay (Buergelt et al., 1977 and 1978a) and the migration inhibition test
(Bendixen, 1977) have been used to measure the CMI responses of animals infected
with M.a.paratuberculosis. These assays offer variable levels of sensitivity, but
again the undefined antigen preparations used to stimulate lymphocytes result in an
overall lack of specificity. Recently, a A,gtll clone (a362) was isolated from a
M.a.paratuberculosis genomic DNA library. This clone expressed a carboxy-
terminal portion of a 34kDa protein antigen and appeared to carry
M.a.paratuberculosis-specific B-cell epitopes (De Kesel et al., 1993) (see section
1.12). The peptide encoded by clone a362 was used to develop an ELISA which
identified M.a.paratuberculosis infected animals and appeared to be specific in the
presence of serum antibody which cross-reacted with strains of M. avium (Vannuffel
et al., 1994a). However, when this peptide was tested using PBMC isolated from
experimentally infected sheep and red deer, the cells did not respond to stimulation in
either lymphocyte stimulation or interferon gamma (IFN-y) release assays (Burrells
and Stevenson, unpublished observations). Therefore, the recombinant a362 peptide
does not appear to be useful in assays designed to measure cell-mediated immune
responses.
The condition known as paratuberculosis was first described over a century ago
(Johne and Frothingham 1895), yet the immune-based identification of animals in the
early phase of the disease continues to present a challenge. This is partly due to a
background of cross-reactive immunity against related environmental species of
Mycobacterium, but also to the lack of species-specific immunodiagnostic reagents
as described above. Meanwhile, the percentage of cases of ruminant
paratuberculosis caused by infection with M. avium type A/I, rather than
M.a.paratuberculosis, remains unknown. The work presented in this chapter
describes a means by which this question might be addressed however. Two highly
purified protein antigens; a 30kDa secretory protein (p30) from M.a.paratuberculosis
and a 40kDa protein (p40) from a strain of M. avium type A/I, were compared with
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johnin PPD (JPPD) to assess their immunodiagnostic potential. The antigens were
used in assays measuring secondary T-cell proliferation (Burrells and Wells, 1977)
and release of IFN-y (Rothel et al., 1990).
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4.2 Materials and Methods
4.2.1 Culture ofmycobacteria for the preparation of antigens
M.a.paratuberculosis (strain JD88/107) and M.avium type A/I (strain JD88/118)
were cultured in vitro as described in Chapter 2.
4.2.2 Preparation of crude non-viable mycobacterial cell lysate for
immunisation
Approximately lOOmg of cultured M.a.paratuberculosis (strain JD88/107) was
scraped from the surface of solid growth medium and washed three times in DW
before finally resuspending in 400pl of DW containing the protease inhibitor PMSF
at a final concentration of ImM. Cells were disrupted by zirconium bead beating as
described in section 2.2.3. After cooling on ice the disrupted cells were transferred to
a fresh Eppendorf tube. Surviving cells and cellular debris were removed by
centrifugation at 20,000 x g in a refrigerated microcentrifuge (Ole Dich Instruments).
Protein concentrations were determined using the Micro BCA* Protein Assay
Reagent (see section 2.3). The final concentration of the antigen preparation was
adjusted to 2mg/ml protein and aliquots were stored at -80°C until required.
4.2.3 Antigens used to stimulate PBMC
Concanavalin A (Con A) (ICN-Flow Laboratories) at 75pg/ml.
M.a.paratuberculosis (johnin) PPD (JPPD) (Central Veterinary Laboratory,
Weybridge, UK) at 62.5pg/ml.
HPLC-purified p30 from M.a.paratuberculosis (strain JD88/107) at 25pg/ml.
HPLC-purified p40 from M.avium type A/I (strain JD88/118) at 25pg/ml.
4.2.4 Experimental animals
Eleven female Greyface lambs were divided into the following groups:-
Group (A) Five lambs (V1-V5) received subcutaneous inoculations of l.Omg crude
M.a.paratuberculosis cell lysate in 10% aluminium hydroxide at 12 and 21 weeks of
age;
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Group (B) Four lambs received oral doses of 108 live organisms at 24hr post-
parturition and then weekly for nine weeks: two lambs (PI and P2) received
M.a.paratuberculosis (strain JD88/107), while the remaining two (SI and S2)
received M.avium type A/I (strain JD88/118);
Group (C) Two untreated control lambs (CI and C2).
4.2.5 Lymphocyte stimulation assay
Secondary T-cell proliferation assays were performed as described by Burrells and
Wells (1977).
(i) Blood collection and preparation of peripheral blood mononuclear cells
(PBMC)
Peripheral blood was collected from the jugular vein by venepuncture into sterile
silicone-coated vacutainer tubes (Becton-Dickinson) containing lOOiu of
preservative-free heparin (Sigma-Aldrich). Heparinised blood was layered over 10ml
of Lymphoprep (Nycomed) in sterile plastic universal bottles. PBMC were separated
from erythrocytes and granulocytes by centrifugation at 400 x g for 30 min at room
temperature. Purified PBMC were removed from the plasma/Lymphoprep interface
using a sterile disposable pipette and transferred to a fresh universal bottle containing
15ml of wash solution (HBSS containing heparin at 5 iu/ml) (Appendix 2). PBMC
were pelleted at 200 x g for 10 min and the wash step repeated. The cell pellet was
resuspended in 1ml of RPMI-1640 tissue culture medium (Life Technologies)
(Appendix 4) and the number of viable cells determined by staining with Trypan blue
and counting in an improved Neubauer haemocytometer. The final concentration of
the cell suspension was adjusted to 1 x 106 cells/ml.
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(ii) Lymphocyte stimulation assay
All tests and control cultures were performed in triplicate in sterile, flat bottomed, 96
well, tissue-culture grade microplates (Nunc). Aliquots of lymphocyte suspension
(200pl) were added to sample wells containing:-
(a) 20pl ofRPMI-1640 culture medium (negative control);
(b) 20pl of con A at a final concentration of 7.5pg/ml (positive control);
(c) 20pl ofM.a.paratuberculosis JPPD at a final concentration of 6.25pg/ml;
(d) 20pi of HPLC-purified p30 from M.a.paratuberculosis (strain JD88/107) at a
final concentration of 2.5pg/ml;
(e) 20pl of HPLC-purified p40 from M.avium type A/I (strain JD88/118) at a final
concentration of 2.5pg/ml.
Cultures were incubated for 90hr at 37°C in a controlled moist atmosphere of 5%
C02/95% air. After 90hr the cultures were pulsed by the addition of 25pi of RPMI
-2
medium containing lpCi (0.037MBq) of methyl-[ H]-thymidine (Amersham
International) to each sample well and the plates returned to the incubator for a
further 16-18hr. Lymphocytes were harvested on to glass fibre discs using a semi¬
automatic cell harvester (Dynatech). Discs were washed three times with DW and
allowed to dry completely before transferring each to a clean scintillation vial
containing 1ml of liquid scintillation fluid ES299 (Canberra-Packard). Incorporation
of labelled thymidine was measured by liquid scintillation counting in a Packard
2500TR Liquid Scintillation Analyzer (Canberra-Packard). Individual samples were
counted for lOmin and the mean, expressed as counts per minute (cpm), was
calculated for each triplicate sample. Final figures were expressed as stimulation
indices (SI):-
SI = mean cpm stimulated cultures - mean cpm blanks
mean cpm control cultures - mean cpm blanks
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4.2.6 Interferon gamma (IFN-y) assay
IFN-y was detected in culture supernatant by using a sandwich ELISA (Rothel et al.,
1990) as follows.
Peripheral blood was collected from animals as described above. Undiluted
heparinised blood was cultured in duplicate 200pl aliquots in the presence of 20pl of
RPMI medium (unstimulated control), 20pl of JPPD, 20pl of HPLC-purified p30 or
20pl of HPLC-purified p40 as described for the lymphocyte stimulation assay.
Cultures were maintained for 24hr in a moist 5% C02/95% air atmosphere. After
incubation, cells were separated from the plasma by centrifugation at 450 x g for
20min. Duplicate plasmas were removed, pooled and stored at -20°C until required.
Two Mabs (IFN9 and IFN2) raised against bovine IFN-y were kindly provided by
Drs Paul Wood and Jim Rothel, CSIRO, Division of Animal Health, Animal Health
Research Laboratory, Victoria, Australia. ELISA plates were coated with Mab IFN9
by incubating lOOpl per well of Mab at 5pg/ml in CAB (Appendix 2) for 18hr at
4°C. Excess coating antibody was removed by washing x 3 with PWB (Appendix 2).
Supernatant plasmas (lOOpl) were added in triplicate to pre-coated ELISA plate
sample wells and incubated for 60min at 20°C. Following a further three washes in
PWB, lOOpl of HRP-conjugated Mab IFN2 at 5pg/ml was added to each test well
and the plates were incubated for 30min at 20°C. Excess conjugate was removed by
washing x 3 with PWB and lOOpl of ELISA substrate (Appendix 2) was added to
each well. The colour reaction was allowed to develop over 30min at 20°C before
being stopped by the addition of 50pl of 0.5M H2S04 per test well. Optical densities
(OD) were measured at 450nm using a Titretek Multiskan ELISA plate reader (ICN-
Flow Laboratories). Final values were expressed as corrected OD450 (OD450 test




PBMC from all sheep proliferated in response to stimulation with the T-cell mitogen
con A. Responses were generally high and fell within the values previously reported
for sheep (mean cpm of unstimulated cultures = 4.9 x 103; mean cpm of con A
stimulated cultures = 227.9 x 103) (Burrells and Wells 1977).
Responses to JPPD were greater in three of the infected animals (group B; SI, S2 and
PI) than in the immunised animals (group A; VI-V5) (Fig. 4.1). PBMC isolated
from the animals in the control group (group C) did not respond to stimulation with
JPPD.
PBMC isolated from three of the infected animals (SI, S2 and PI) proliferated in
response to stimulation with purified p30. One of the immunised animals (V5)
responded to p30 (SI = 3.0). PBMC from the control animals did not respond to p30.
None of the immunised sheep (group A) yielded PBMC which proliferated in
response to stimulation with purified p40. Similarly, PBMC isolated from animals
infected with M.a.paratuberculosis (group B) failed to respond to stimulation with
p40. Only PBMC isolated from sheep infected with M. avium type A/I (group B)
proliferated upon stimulation with p40. Stimulation indices of 38.0 and 93.7 were
recorded for lambs SI and S2 respectively. Animals in the control group were non-
reactive (SI < 2.0).
4.3.2 IFN-y production
JPPD induced the production of IFN-y in cultures of whole blood prepared from all
experimental animals irrespective of whether they received non-viable mycobacterial





















VI V2 V3 V4 V5 SI S2 PI P2 CI C2
Groups of Sheep
Fig. 4.1 Bar chart illustrating proliferation of PBMC isolated from three different
groups of sheep in response to stimulation with JPPD, HPLC-purified p30 from
M.a.paratuberculosis and HPLC-purified p40 from M.avium type A/I. Sheep in
group A (V1-V5), group B (SI, S2, PI and P2) and group C (CI and C2) are as























VI V2 V3 V4 V5 SI S2 PI P2 CI C2
Groups of Sheep
Fig. 4.2 Bar chart illustrating IFN-y release in whole blood cultures from three
different groups of sheep in response to stimulation with JPPD, HPLC-purified p30
from M.a.paratuberculosis and HPLC-purified p40 from M.avium type A/I. Sheep
in group A (V1-V5), group B (SI, S2, PI and P2) and group C (CI and C2) are as
described in section 4.2.4.
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Stimulation with purified p30 induced IFN-y release by PBMC from all infected
animals (group B). PBMC from four of the immunised animals (group A) produced
levels of IFN-y which were below the cut-off value (cut-off OD450 <0.200). IFN-y
released by PBMC from a single immunised animal (V4) was measured at OD450 =
0.205.
Only PBMC isolated from the sheep infected with M.avium type A/I (group B; SI
and S2) released IFN-y in response to stimulation with purified p40.
PBMC from the control lambs did not produce IFN-y in response to stimulation with
any of the three antigens tested.
115
4.4 Discussion
The diagnostic value of two defined mycobacterial antigens (p40 and p30) has been
demonstrated. Of these, p40 appears to concur with the presence of IS901/902 in
certain strains ofM. avium, and is capable of distinguishing between animals infected
with M.avium type All and M.a.paratuberculosis. As such, p40 is the first entire
protein molecule to be identified which has been shown subsequently to be specific
to a Mycobacterium species implicated in the aetiology of ruminant paratuberculosis.
The second of these defined antigens, p30, appears to stimulate CMI responses in
animals harbouring active and ongoing mycobacterial infections, but not in animals
which have received vaccination with killed organisms.
The results illustrated in Figs. 4.1 and 4.2 highlight the advantages of using defined
mycobacterial antigens as opposed to a crude antigenic extract to stimulate
lymphocytes in both secondary T-cell proliferation and IFN-y release assays. While
JPPD induced T-cell proliferation and IFN-y production in PBMC isolated from both
infected and immunised animals, the purified p30 antigen could be used to
distinguish between animals immunised with a non-viable cell lysate and those
harbouring an active infection. This could be explained by the fact that the p30 is a
secretory antigen (see section 3.4) which is produced and released into the
extracellular environment by actively metabolising mycobacteria. As such the
protein may not be present in cell lysates in quantities sufficient to induce significant
levels of cellular immunity. Conversely, animals harbouring active infections are
continuously exposed to the protein as it is synthesised and secreted by metabolising
cells. Infected animals are therefore more likely to mount a measurable immune
response against p30. Stimulation with purified p30 antigen did not appear to induce
a subspecies-specific immune response however, and could not distinguish between
animals infected with either M.avium type A/I or M.a.paratuberculosis. Species-
specific epitopes have been described for some members of the mycobacterial
antigen 85 complex (Tasaka et al., 1983; Tasaka and Matsuo, 1984; Tasaka et al.,
1985). However, the wide distribution and highly conserved nature of these
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secretory proteins precludes their use as markers of infection with any particular
organism. In addition, the deduced amino-terminal region of the PS1 secretory
protein of Corynebacterium glutamicum has been shown to share up to 33%
sequence identity (52% similarity) with the proteins of the mycobacterial antigen 85
complex (Joliff et al., 1992). It is conceivable therefore, that cross-reactivity
between Corynebacterium spp. and members of the MAC could continue to
contribute to false diagnoses, even when using highly purified p30.
Unlike the p30 antigen which stimulated T-cell responses in PBMC from all infected
animals, the p40 antigen was observed to stimulate T-cell responses specifically in
lambs infected with M.avium type A/I. Expression of p40 was not detected in any of
14 other species ofMycobacterium examined (see section 3.3.8 and Table 3.1) and it
is unlikely therefore, that exposure to environmental mycobacteria would generate a
background of cross-reactive immunity. Recently, a monoclonal antibody raised
against p40 was used successfully in a blocking ELISA designed to distinguish
between sheep infected with M. avium type A/I and M.a.paratuberculosis (Klausen et
al., 1997). The results of the study corroborate the findings presented here and in
Burrells et al. (1995), and provide further evidence that the immune response to in
vivo expression of p40 can be exploited as a subspecies-specific marker for the
detection of animals harbouring M. avium type A/I infections. In addition, serological
detection of p40 indicates that the protein carries B-cell as well as T-cell epitopes.
The blocking ELISA could be used to monitor the prevalence of M. avium type A/I
infection in conjunction with existing diagnostic assays for M.a.paratuberculosis.
Such a venture would go some way towards assessing the aetiological significance of
M.avium type A/I infection in paratuberculosis of domestic ruminants.
The detection of IFN-y produced by T-cells in response to antigen-specific
stimulation has been shown to correlate with secondary proliferative responses
(D'Andrea et al., 1986) and to be more sensitive (D'Andrea et al., 1986; Hao et al.,
1986). The data presented here confirm these findings. Despite exhibiting no, or
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only weak proliferative responses, PBMC isolated from lamb P2 produced IFN-y in
response to stimulation with johnin PPD and purified p30. Cellular anergy is
characteristic of advanced paratuberculosis (Merkal et al., 1970; Bendixen, 1978;
Chiodini et al., 1984b) and animals with suppressed lymphocyte activity cannot be
identified reliably using assays which measure T-cell proliferation.
As a diagnostic tool the IFN-y release assay has several advantages over the
lymphocyte stimulation assay. It is comparatively inexpensive, technically robust
and simple in operation. This makes screening the numbers of animals involved at
the herd or flock level logistically feasible. Using p40 as antigen, the assay
represents the first immune-based diagnostic test which has the potential to identify
animals in early and advanced stages of infection with M.avium type A/I.
Unfortunately, M.a.paratuberculosis-specific antigens capable of stimulating cellular
immune responses have not yet been identified and work towards their identification
continues. Once such antigens have been identified and their genes cloned and
expressed, it is conceivable that recombinant immunodiagnostic reagents, including
p40, will become available commercially. By identifying subclinically infected
animals early, the use of such recombinant antigens in conjunction with the IFN-y
release assay would have a significant impact on the management of
paratuberculosis-infected herds. Tighter controls on the movement of infected
livestock could be implemented and new stocks of disease-free animals established
and maintained.
The p40 is of interest not only as a diagnostic antigen, but also as one which may
prove to be of immunoprophylactic value. As such, p40 clearly merits further study
and the following chapter documents experiments undertaken to clone and
characterise the p40 gene.
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CHAPTER 5
EXPERIMENTS TO ISOLATE AND CHARACTERISE THE
GENE ENCODING p40
5.1 Introduction
The primary objective of the work presented in this chapter was to clone and
characterise the gene encoding the p40 antigen. This task was undertaken with a
view to obtaining nucleotide sequence information, an essential step towards
identifying a possible function for the protein and for generating specific DNA
probes to enable the distribution of the gene amongst other mycobacteria to be
assessed.
Since 1985, genes of a number of pathogenic mycobacterial species have been cloned
in E.coli using both plasmid and bacteriophage vectors (Clark-Curtiss et al., 1985
and 1990; Young et al., 1985a&b; Thole et al., 1985; Jacobs et al., 1986; Khandekar
et al., 1986; Morris et al., 1988; Rouse et al., 1991; Stevenson et al., 1991; DeKesel
et al., 1993; Cameron et al, 1994 and Inglis et al., 1994b). One particularly
successful strategy entailed the use of the bacteriophage vector, Xgtl 1, to clone and
express antigens of M.tuberculosis (Young et al., 1985a) and M.leprae (Young et al.,
1985b). This approach has allowed the isolation of foreign genes expressed in E.coli
when specific antisera were the only means of detection available. In this system,
randomly-generated genomic DNA fragments of up to 7.2kb are cloned into a unique
EcoRl site situated in the carboxy-terminus of the E.coli P-gal gene. The use of
randomly-generated fragments, as opposed to those produced by partial restriction, is
advantageous when constructing a DNA expression library, since it is important to
ensure that all the protein encoding sequences in the genome are expressed if the
library is to be truly representative. This requires the generation of a large number of
fragments with endpoints which occur at random and ideally at every base pair
throughout the genome. Provided the insert fragments are positioned in the correct
119
orientation and in frame with lacZ, expression of the chimeric genes as (3-gal fusion
proteins can be induced in a suitable supF host strain under the control of the native
E.coli upstream promoter region. Expressed antigens bound to a solid support are
then detected immunologically using specific primary antibody in combination with
an appropriate labelled secondary antibody. The Xgtll expression vector was an
appropriate choice of cloning vehicle for the gene encoding the p40 antigen, because
hyperimmune antisera already had been raised against HPLC purified protein (see
section 3.2.4).
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5.2 Materials and Methods
5.2.1 Disruption ofM.avium Type A/I Cells and Purification ofGenomic DNA
M.avium type A/I cells were propagated on 7H11+ medium. Washed cells (0.7g)
were pelleted and resuspended in 10ml of 4M GIT (Appendix 2) (Sambrook et al,
1989). The cells were disrupted mechanically in an Eaton press (Eaton 1962) as
described in section 2.2.1. The lysate was thawed and layered onto 5ml cushions of
40% (wt/wt) CsCl in TE buffer (Appendix 2). Nucleic acid was pelleted through the
CsCl at 113,000 x g in a Beckman SW40ti rotor (Beckman Instruments ) for 16hr at
20°C. Each of the resulting nucleic acid pellets was collected and resuspended in
5ml of TE buffer. Excess CsCl was removed by dialysis against 500ml of TE buffer
for 16hr at 4°C. Cellular RNA was removed by digesting with RNase A (Sigma-
Aldrich) at 20|a,g/ml for 60 min at 37°C. The DNA was extracted once with an equal
volume of Tris-buffered phenol pH7.5 and twice with equal volumes of chloroform.
Salt concentration was raised by the addition of sodium acetate to 0.3M and the DNA
was precipitated by the addition of two volumes of chilled ethanol and overnight
incubation at -20°C. Precipitated DNA was pelleted at 4800 x g and washed twice in
wash ethanol (Appendix 2). The pellets were desiccated in a vacuum chamber and
redissolved in TE buffer. After spectrophotometric quantitation at 260nm, the DNA
concentration was adjusted to 330pg/ml. This extraction procedure yielded a total of
1.9mg ofM.avium type A/I genomic DNA.
5.2.2 Construction of M.avium Type A/I Genomic DNA Expression Libraries in
Xgtll
(Method 1)
Preparation and Modification of Genomic DNA Fragments Using the Method of
Young et al. (1985a).
1. Generation of randomly sheared genomic DNA fragments
Randomly sheared genomic DNA fragments were prepared by repeated passage of
DNA through hypodermic needles. A total of 300pg of genomic DNA in 2ml of TE
buffer was forced through 27 gauge and 30 gauge needles 100 times each to generate
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smaller fragments. The sheared DNA was ethanol precipitated as described in
section 5.2.5, desiccated and redissolved in 200pl of TE buffer. The DNA fragments
were then size-selected by rate-zonal sucrose density gradient centrifugation as
described in section 5.2.6. The size distribution of DNA fragments was analysed by
agarose gel electrophoresis, and gradient fractions containing fragments ranging
between -3.5 - 8.0kb in size were selected for the purpose of preparing a library.
2. Methylation of internal jEcoRI sites
lpg of size-selected genomic DNA fragments was methylated in a 20pl reaction
mixture containing 50mM Tris/HCl pH7.5, ImM Na2 EDTA, 5mM dithiothreitol
(DTT), 10pM S-adenosyl-L-methionine (SAM) (Boehringer Mannheim) and 30 units
of EcoRI methylase (Northumbria Biologicals). DNA was methylated over 30 min
at 37°C and the reaction was terminated by heating at 70°C for 10 min. The reaction
was controlled by methylating an equal quantity of wild type X DNA under identical
conditions and demonstrating resistance to digestion with EcoYH.
3. Blunt-ending
Overhangs on DNA fragments were blunt-ended by the addition of 2.5pl of lOOmM
MgCl2, 2.5(0.1 of 200mM dNTPs and 5 units of T4 DNA polymerase (Boehringer
Mannheim) to the 20pl methylation reaction. Ends were blunted over 30 min at
37°C and the reaction was terminated by increasing the Na2EDTA concentration to
15mM and phenol/chloroform extraction. Sodium acetate was added to 0.3M and the
DNA was precipitated by the addition of two volumes of chilled ethanol and
overnight incubation at -20°C. Precipitated DNA was pelleted at 30,000 x g, washed
twice with wash ethanol and desiccated. In a control reaction run in parallel, DNA
fragments resulting from Hind III restriction of wild-type X DNA were blunt-ended
in the presence of [a-32P]-dCTP (Amersham International). Incorporation of labelled
dCTP was confirmed by TLC and autoradiography (see section 5.2.16).
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4. Ligation of EcoRI linkers to modified DNA fragments
The desiccated DNA was redissolved in 4.5pl of 50mM Tris/HCl pH 7.5, lOmM
MgCl2, lOmM DDT, 1.5mM ATP containing phosphorylated 8-mer EcoRI linkers
(Boehringer Mannheim) at lOOpg/ml. Once the DNA had dissolved, 5 units of T4
DNA ligase (Boehringer Mannheim) was added to the mixture and the reaction was
incubated at 12°C for 16hr. The enzyme was inactivated by heating at 70°C for 10
min. Enzyme activity was confirmed in a control reaction where linker molecules
were ligated to produce a ladder effect as visualised in a silver-stained 7.5%
continuous polyacrylamide gel.
5. Removal of excess EcoRI linkers from modified DNA fragments
Buffering conditions were altered to favour EcoRI digestion by the addition of 5pi of
conversion buffer (50mM Tris/HCl pH 7.5, lOmM MgS04, 200mM NaCl).
Concatenated linker molecules were digested to completion by the addition of 5 units
of EcoRI (Boehringer Mannheim) and incubation at 37°C for 3hr. The enzyme was
heat inactivated at 70°C for 10 min and the reaction mixture was increased to 200pl
with TN buffer (Appendix 2). The whole sample was injected onto a Beckman
Ultraspherogel SEC-3000 (7.5 x 300mm) size exclusion HPLC column (Beckman
Instruments ) pre-equilibrated with TN buffer. Linkers were separated from DNA
fragments over 30 min at a flow rate of 0.5ml/min. Material which eluted from the
column was monitored at 260nm. The DNA fragments were collected from the
column in 1ml as a single sharp peak at 10.4min. Salt concentration was increased to
0.5M NaCl and lpg of muscle glycogen was added prior to precipitation with two
volumes of chilled ethanol and overnight incubation at -20°C. The DNA was
pelleted at 30,000 x g, washed twice in wash ethanol and desiccated.
6. Ligation of modified fragments into kgtll arms
The DNA pellet was redissolved in 4pl of T4 DNA ligase buffer (Boehringer
Mannheim) containing lpg of co.v-ligated, EcoRI digested, dephosphorylated kgt 11
123
arms (Stratagene) and lOmM ATP. Once the DNA had dissolved, 5 units of T4
DNA ligase were added and the reaction was incubated at 12°C for 16hr.
7. In vitro packaging and amplification of the library
The library was packaged into phage heads using Gigapack II Gold (Stratagene)
packaging extracts and amplified on E.coli host strain Y1088 in accordance with the
manufacturer's recommendations.
8. Titration of the library
Pre- and post-amplification titres were obtained from the newly prepared library.
Log10 dilutions were prepared in SM buffer (Appendix 2). Equal volumes (lOOpl) of
library dilution and plating cells (see section 5.2.3) were mixed and incubated at
37°C for 15 min. The infected cells were added to supplemented L-B top agarose
(Appendix 4), spread out and incubated as described in section 5.2.4. L-B top
agarose contained 5mM IPTG and 2.5mM X-gal to allow differentiation between
recombinant (clear) and non-recombinant (blue) plaques. The titre of the library and
percentage of recombinants were calculated from the total number of pfu and the
ratio of blue to clear plaques. Confirmation of the number of recombinant phage in
32the library was obtained by hybridising [a- P]-dCTP-labelled genomic DNA
fragments to a plaque lift taken from the same plate. The plate was chilled to 4°C
and overlaid with a 90mm nitrocellulose circle (Schleicher & Schuell). After 2min
the membrane was lifted and placed in a petri-dish containing denaturing solution
(Appendix 2) for lmin. The membrane was transferred to a second petri-dish
containing neutralising solution (Appendix 2) for a further lmin before rinsing gently
in 6 x SSC. Excess moisture was removed and phage DNA was fixed to the
membrane under vacuum at 80°C for 2hr. The plaque lifts were pre-hybridised and
hybridised against labelled genomic DNA fragments as described in section 5.2.18.
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(Method 2)
Preparation and Modification of Genomic DNA Fragments Using the
RiboClone®EcoKl Adapter System (Promega)
1. Generation of randomly sheared genomic DNA fragments
Genomic DNA was mechanically sheared by sonication. Randomly generated
fragments of ~l-3kb resulted from sonication at 25% amplitude for 1 second using a
Vibra-cell model VCX 600 sonicator (Sonics & Materials).
2. Blunt-ending
DNA fragments were blunt-ended in a T4 DNA polymerase reaction as described in
Method 1.
3. Ligation ofEcoRl adapters to blunt-ended DNA fragments
EcoRl adapters were blunt-end ligated to genomic DNA fragments in a 30pl reaction
containing 30mM Tris/HCl pH 7.8, lOmM MgCl2, lOmM DTT, 5mM ATP,
100pg/ml acetylated BSA, a 20-fold molar excess of adapter molecules, 250ng of
blunt-ended genomic DNA fragments and 2.5 units of T4 DNA ligase. The reaction
was incubated at 15°C for 18hr. Ligase was heat inactivated at 70°C for lOmin.
4. Phosphorylation of 5' ends of adapter molecules
Adapter molecules were phosphorylated by adding the following to the above heat-
inactivated ligation reaction; 4pl of 10 x T4 PNK buffer (Appendix 2), ATP to
0.1mM, 10 units of T4 PNK (Boehringer Mannheim) and DW to a final volume of
40pl. The reaction was incubated at 37°C for 30min prior to phenol and chloroform
extractions.
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5. Removal of excess LcoRI adapter molecules
Excess adapter molecules were separated from modified genomic DNA fragments by
size exclusion chromatography using a 1ml Sephacryl S-400 spin-column in
accordance with the manufacturer's instructions.
6. Ligation of modified fragments into A,gtll arms
Ligation of modified genomic fragments into A,gt 11 arms, in vitro packaging
reactions and titration of the library were performed as described in Method 1.
5.2.3 Preparation of Plating Cells
E.coli host strains Y1088 and Y1090 used for the propagation of Xgtl 1 were grown
on L-B media supplemented with maltose at 0.2% (wt/v), MgS04 at lOmM and
ampicillin at 50pg/ml final concentrations. An overnight culture of an appropriate
E.coli host strain was sub-inoculated into fresh pre-warmed (37°C) supplemented L-
B broth (Appendix 4) and incubated in an Aerotron shaking incubator (Infors) at
37°C until the OD600 reached a value of 0.6. Cells were pelleted and resuspended in
ice cold lOmM MgS04 to yield an OD600 of 0.5. The cell suspension was stored at
4°C and used within 48hr.
5.2.4 Immunoscreening of Genomic DNA Expression Libraries
Libraries were immunoscreened for specific antigen-producing recombinant phage
using a modification of the method described by Young and Davies (1983a).
Approximately 5 x 104 pfu were plated on lawns of E.coli host strain Y1090 in 20 x
20cm culture plates by the top agarose method (Sambrook et al, 1989). Plates were
incubated at 42°C until pin-prick size plaques became visible. Plates were overlaid
with dry 20 x 20cm nitrocellulose (Schleicher & Schuell) impregnated with lOmM
IPTG and incubated at 37°C for a further 16hr. Plates were chilled to 4°C and
positions of filters marked by needle stabs. Filters were removed and washed in
several changes of WFB (Appendix 2) over 60min. Filters were incubated in
primary antibody (rabbit anti p40) diluted '/go in WFB for 60min at RT. Excess
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primary antibody was removed by 3 x 5min washes in WFB prior to incubating in
secondary antibody (swine anti rabbit-HRP conjugate) (Dako) diluted '/1000 in WFB
for 60min at RT. Excess secondary antibody was removed by a further 3 x 5min
washes in WFB. Recombinants expressing antigens recognised by the primary
antibody were visualised by incubating the filters in a solution containing lOOmM
Tris/HCl pH 7.5, ImM DAB and 60mM H202. Filters were aligned with their
corresponding plates and agarose plugs containing clones of interest were collected
into 1ml each of SM buffer containing 50pl of chloroform. Recombinant phage in
this suspension were re-plated and immunoscreened in an identical manner on 90mm
plates. Approximately 5 x 10 pfu per 90mm plate were screened and the process
was repeated picking an individual expressing clone each time until all the plaques
on subsequent filters were positive. These "plaque purified" clones were used to
prepare high titre stocks of recombinant phage by either plate lysate or liquid lysate
methods as described by Sambrook et al, 1989 (see section 5.2.5).
5.2.5 Preparation of recombinant phage DNA
1. Large scale preparation of lambda DNA
Quantities of lambda DNA ranging between 30 jag and 70pg were extracted from
recombinant phage harvested from plate or liquid lysates and purified by isopycnic
ultracentrifugation using CsCl density gradients (Sambrook et al., 1989).
(i) Plate culture method:-
Approximately 1 x 105 pfu were mixed with 1ml of fresh E.coli host strain Y1090
plating cells and incubated at 37°C for 20min. Infected cells were mixed with 33ml
of supplemented L-B top agarose cooled to 45 °C and spread evenly over the surface
of a pre-warmed (37°C) 20 x 20cm L-B agar plate. Once the L-B top agarose had
solidified, plates were inverted and incubated overnight at 37°C. Each plate was
overlaid with 30ml of SM buffer and incubated at RT for 3hr on a rocking platform.
The phage eluate was transferred to a 50ml centrifuge tube by pipette and cleared of
bacteria and other debris at 4800 x g at 4°C for 20min. The supernatant was
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transferred to a fresh tube and chloroform added to 0.5% (v/v). The lysate was stored
at 4°C until required.
(ii) Liquid culture method:-
A single well-isolated plaque was picked from an L-B agar plate and transferred to a
1.5ml tube containing lOOpl of SM buffer. After overnight incubation at 4°C, 20pl
of the phage eluate was mixed with lOOpl of fresh E.coli host strain Y1090 plating
cells and incubated at 37°C for 20min. The infected cells were used to inoculate
100ml of pre-warmed (37°C) supplemented L-B broth and the culture was incubated
in a shaking incubator at 37°C for 5-7hr. Chloroform was added to 0.5% (v/v) and
shaking was continued for a further 15min. The lysate was cleared of debris by
centrifugation at 4800 x g for 20min at 4°C and the supernatant transferred to
chloroform-resistant plastic tubes. Chloroform was added to 0.5% (v/v) and the lysate
stored at 4°C until required.
(iii) Purification of phage by isopycnic ultracentrifugation:-
Recombinant phage in either plate or liquid lysates was pelleted in a type 45
ultracentrifuge rotor (Kontron Instruments ) at 100,000 x g for 60min at 4°C. Pellets
were resuspended in 3ml of SM buffer and layered carefully onto a 3-step density
gradient consisting of 3ml each of 90%, 60% and 40% (wt/v) CsCl in SM buffer.
Phage particles were banded at 61120 x g for 2hr at RT in an SW40ti ultracentrifuge
rotor (Beckman Instruments ). A band of phage was collected from the interface
separating the 90% and 60% layers of the gradient by puncturing the tube with a 21 -
gauge hypodermic needle. The preparation was diluted to 5ml with SM buffer and
phage particles were pelleted at 100,000 x g in a SW55ti ultracentrifuge rotor for
60min at 4°C.
(iv) Extraction ofDNA from purified phage particles:-
The phage pellet was resuspended in 500pl of SDS extraction buffer (Appendix 2)
containing 50pg/ml Proteinase K (Sigma-Aldrich) and incubated at 37°C for 30min.
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The preparation was extracted once with an equal volume of Tris-buffered phenol
pH7.5 and twice with equal volumes of chloroform. Sodium acetate was added to
0.3M and the lambda DNA was precipitated by the addition of 2.5 volumes of chilled
ethanol and overnight incubation at -20°C. Precipitated DNA was pelleted in a
refrigerated microcentrifuge (Ole Dich Instruments) at 20,000 x g for lOmin and
desiccated prior to dissolving in TE buffer. DNA concentration was determined
spectrophotometrically at 260nm and adjusted to 3pl/pg.
2. Small scale preparation of lambda DNA
Smaller quantities of recombinant lambda DNA (l-5pg) were prepared using the
Wizard™ Lambda Preps DNA Purification System (Promega) in accordance with the
manufacturer's recommendations.
5.2.6 Size Selection of DNA Fragments by Rate-Zonal Centrifugation
Size selection of genomic DNA fragments generated by mechanical shearing or
restriction endonuclease digestion was achieved by rate-zonal ultracentrifugation
using continuous sucrose density gradients as described by Nevins and Darnell,
(1978). In a final volume of 200pl, 50pg of genomic DNA fragments was layered
onto a 12ml sucrose gradient of 5-20% (wt/v) in 1 x TE buffer. DNA fragments were
separated at 78,925 x g over 18hr at 4°C in an SW40ti rotor (Beckman Instruments).
Gradients were fractionated into 24 x 0.5ml fractions using a Model 185 Density
Gradient Fractionator, a Model UA-5 Absorbance Monitor and a Model 1200 Golden
Retriever Fraction Collector (Instrumentation Specialities Company). Gradients
were pumped out from the bottom using 30% (wt/v) sucrose at a flow rate of
0.5ml/min at a sensitivity of 0.5 full scale deflection. The size distribution of DNA
fragments was analysed by agarose gel electrophoresis.
5.2.7 Agarose Gel Electrophoresis
DNA fragments were resolved in horizontal agarose slab gels as described by
Sambrook et al. (1989). Gels of 75 x 50 x 6.5mm (mini-gels), 140 x 110 x 8.0mm
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(midi-gels) and 247 x 200 x 10mm (maxi-gels) were cast in "Agarose Gel
Electrophoresis Apparatus", Models H6, H5 and H4 (Life Technologies)
respectively. Gels of 0.6%-1.0% (wt/v) nucleic acid grade "Ultrapure" agarose (Life
Technologies) and 0.5pg/ml ethidium bromide were prepared and run in 1 x TBE
buffer (Appendix 2). Gels, from which DNA fragments were later recovered, were
prepared from nucleic acid grade "Low Melting Point" (LMP) agarose (Life
Technologies) (see section 5.2.12). DNA samples were mixed with 0.1 volume of
gel loading buffer (Appendix 2) prior to electrophoresis. The duration of
electrophoretic separation and the precise current densities were adjusted to allow for
gel format, agarose concentration and the size of the DNA fragments under analysis.
Molecular weight markers used were Hind Ill-digested phage-X, DNA and/or a lkb
DNA ladder (Life Technologies). Resolved DNA fragments were visualised and
photographed over a Model TM20 short wave ultraviolet transilluminator (Ultra
Violet Products).
5.2.8 Polyacrylamide Gel Electrophoresis of DNA Fragments
Polyacrylamide gel electrophoresis of small PCR-generated DNA fragments was
carried out using a continuous TBE buffer system. Mini gels (see section 2.4) of
7.5% (wt/v) acrylamide and 0.2% (wt/v) bis-acrylamide in 1 x TBE were prepared.
Typically, gel loadings ranged between 10-100ng of DNA. DNA samples were
mixed with 0.1 volume of gel loading buffer (Appendix 2) prior to electrophoresis.
Bands were visualised using a highly sensitive silver staining procedure (see section
5.2.9).
5.2.9 Silver Staining of DNA Fragments Resolved in Polyacrylamide Gels
Visualisation of DNA fragments resolved in polyacrylamide gels was carried out
using a modification of the method of Herring et al. (1982). The procedure was
based on the method previously described by Sammons et al. (1981). Following
electrophoresis, gels were soaked in 10% (v/v) methanol, 0.5% (v/v) glacial acetic acid
for 20min. The gels were then equilibrated in 12mM silver nitrate for a further
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20min. After a brief rinse in DW, gels were soaked in developer solution (0.75M
sodium hydroxide containing 0.75% (v/v) formaldehyde 37-42% solution) until the
desired level of staining was attained. The developer was discarded and the colour
reaction was stopped by soaking the gels in 70mM sodium carbonate for 30min.
Typically, 50ml of each solution was used at each stage of the staining procedure.
All stages of the procedure were carried out with gentle agitation on an orbital
shaker. Gels were preserved as described in section 2.6.
5.2.10 Southern Transfer
Southern transfer of DNA fragments from agarose gels to Hybond nylon membrane
(Amersham International) was carried out in accordance with the method described
by Sambrook et al. (1989). The procedure was based on the method devised by and
named after Southern (1975). Prior to transfer, d/s DNA fragments were reduced to
single strands by soaking gels in denaturing and neutralising solutions (Appendix 2)
sequentially for lhr in each at RT. Gels were inverted and placed on a 3MM filter
paper (Whatman Scientific) wick connected at both ends to a reservoir of 10 x SSC
(Appendix 2). Peripheral areas of the wick not covered by the gel were blanked off
with strips of polythene in order to avoid short-circuiting the transfer. A sheet of
Hybond cut to the exact size of the gel was wetted in 10 x SSC and placed directly on
top of the gel taking care to avoid trapping air bubbles. Positions of sample wells
were marked using a black ball-point pen. Two sheets of 3MM filter paper, also cut
to the size of the gel, were placed on top of the membrane. A stack of paper towels
~15cm thick was then positioned over the filter paper and a weight of ~lkg was
placed on top to compress the towels. Transfer was allowed to take place overnight
at RT. Membranes were removed, rinsed gently in 6 x SSC for a few seconds and
the transferred DNA was fixed to the nylon by baking at 80°C in a vacuum oven.
5.2.11 DNA Dot-Blotting
DNA dot-blots were prepared in a Bio-Dot 96 well Microfiltration Apparatus (Bio-
Rad Laboratories). A sheet of Hybond (Amersham International) nylon membrane
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was cut to the size of the microfiltration unit and wetted in 6 x SSC prior to
assembling the apparatus. Approximately 10-25ng of plasmid DNA, or up lpg of
genomic DNA, was applied to the membrane in lOOpl of 6 x SSC. Samples were
drawn onto the membrane under gentle vacuum and washed with a further 200pl of 6
x SSC. The membrane was removed and the DNA fixed to the nylon in a vacuum
oven at 80°C for 2hr. Hybridisation was performed as described in section 5.2.18.
5.2.12 Recovery of DNA Fragments From LMP-Agarose Gels
Fragments of interest were excised from 0.8% LMP-agarose gels under ultraviolet
illumination using a clean disposable scalpel. Excess agarose was trimmed away and
the block was transferred to a pre-weighed plastic tube. The weight of the block was
determined and 0.04 volumes of 25 x Agarase buffer (Appendix 2) added to the tube.
The tube and its contents were incubated at 65°C until the agarose was completely
molten. After cooling to 45°C, two units of Agarase (Boehringer Mannheim) were
added for each lOOmg of agarose and the digestion was incubated at 45°C for 2-3hr.
Enzyme protein and remaining oligosaccharides were removed by extracting once
with Tris-buffered phenol pH7.5 and twice with chloroform. Salt concentration was
raised by the addition of sodium acetate to 0.3M and the DNA was precipitated by
the addition of 2 volumes of chilled ethanol and overnight incubation at -20°C.
5.2.13 DNA Manipulations
Recombinant phage genomic DNA was prepared and sub-cloned into the plasmid
vectors pMSIS, pGEXlXT, pBS and pUC 18 (Appendix 3) using standard laboratory
procedures (Sambrook et al., 1989). Sub-cloning directly from A.gt 11 into pMSIS or
pGEXlAT conserved the ORF and enabled expression of cloned sequences as P-gal
or GST fusion proteins respectively.
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5.2.14 Preparation of Plasmid DNA
1. Large scale preparations
Plasmid DNA was extracted from E.coli host cells using the alkaline-SDS procedure
and purified subsequently by isopycnic ultracentrifugation using CsCl-ethidium
bromide density gradients as described by Sambrook et al. (1989).
2. Small scale preparations
Small scale preparations "minipreps" of plasmid DNA were prepared from E.coli
host cells using the QIAprep™ Spin Plasmid Miniprep Kit (Qiagen) or Wizard™ Plus
Minipreps Plasmid DNA Purification System (Promega). Both kits were used in
accordance with the manufacturer's recommendations.
5.2.15 Preparation and Transformation of Competent E.coli Host Cells
The preparation and transformation of competent E.coli host cells were carried out in
accordance with protocols described by Hanahan (1985).
1. Calcium chloride method
A single colony of an appropriate host strain was picked from an L-B agar plate and
inoculated into 10ml of L-B broth. The culture was incubated overnight at 37°C in a
shaking incubator. The overnight culture was diluted V10 in 10ml of fresh L-B broth
and grown to an OD600 of 0.5 at 37°C in a shaking incubator. The culture was chilled
on ice for 15min and the cells pelleted at 1500 x g for lOmin at 4°C. The cells were
resuspended in 3ml of chilled CCTB (Appendix 2) and incubated on ice for lhr. The
cells were pelleted as before and resuspended in 0.8ml of chilled CCTB. Aliquots of
200pl of competent cells were transferred to pre-chilled tubes and transforming DNA
was added in a volume not exceeding 20pl. The cells and DNA were mixed by
gentle swirling and the tubes incubated on ice for a further lhr. The cells were heat
shocked in a water bath for 90 seconds at 42°C, then immediately re-chilled on ice.
Each transformation was mixed with 800pl of pre-warmed (37°C) SOC broth
(Appendix 4) and incubated at 37°C for lhr in a shaking incubator. Aliquots of
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200pl of each transformation were spread out on each of five 90mm plates of an
appropriate selective medium and incubated overnight at 37°C.
2. High efficiency method
A single colony of an appropriate host strain was picked from an SOB agar plate
(Appendix 4) and inoculated into 10ml of SOC broth (Appendix 4). The culture was
incubated overnight at 37°C in a shaking incubator. The overnight culture was
diluted V10 in 10ml of fresh SOC broth and grown to an OD600 of 0.5 at 37°C in a
shaking incubator. The culture was chilled on ice for 15min and the cells pelleted at
1500 x g for lOmin at 4°C. The supernatant was drained thoroughly and the cells
resuspended in 3ml ofHETB (Appendix 2) prior to incubating on ice for 15min. The
cells were pelleted as before and resuspended in 0.8ml of HETB. Exactly 28pi of
DnD (Appendix 2) was mixed gently into the cell suspension before incubating the
tubes on ice for lOmin. A second 28pl aliquot ofDnD was added to the cells and the
tubes returned to ice for a further 20min. Aliquots of 21 Opl were transferred to pre-
chilled tubes and transforming DNA was added in a volume not exceeding 20pl. The
tubes were incubated on ice for 40min before heat shocking the cells at exactly 42°C
for 90 seconds in a water bath. The cells were transferred immediately to ice for
2min before adding 800pl of pre-warmed (37°C) SOC broth and incubating at 37°C
for lhr in a shaking incubator. Aliquots of 200pl of each transformation were spread
out on each of five 90mm plates of an appropriate selective medium and incubated
overnight at 37°C.
3. Commercially prepared competent cells
Commercially prepared competent E.coli host strains were used in accordance with
the manufacturer's recommendations.
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5.2.16 Radio-Isotopic Labelling of DNA
1. Random priming of double-stranded DNA fragments
Double-stranded DNA was labelled to high specific activity in accordance with the
method described by Feinberg and Vogelstein, (1983 and 1984). The DNA to be
labelled was denatured to single strands by heating at 100°C for lOmin and
subsequent cooling on ice. The following labelling reaction was assembled on ice.
In a total reaction volume of 20pl, 200ng of denatured DNA was mixed with dATP,
dGTP and dTTP (Boehringer Mannheim) at 0.5mM each, 400ng of random
hexanucleotides (Oswel DNA Service), 25pCi (0.925MBq) of [a-32P]-dCTP (sp.act.
>3000Ci/mmole) (Amersham International) and 2 units of DNA polymerase 1
Klenow fragment (Boehringer Mannheim) in 50mM Tris/HCl pH7.2, lOmM MgCl2,
O.lmM DTT, 0.2pg/ml BSA. The reaction was incubated at 37°C for 30min.
Incorporation of labelled dCTP was monitored by TLC and autoradiography (see
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below). Labelled DNA was separated from unincorporated [a- P]-dCTP by size
• • (r)
exclusion chromatography using disposable Sephadex G-50 (NICK™) columns
(Pharmacia Biotech) in accordance with the manufacturer's recommendations.
Double stranded DNA probes were heat-denatured as described above immediately
prior to use.
2. End-labelling of synthetic oligonucleotides
Synthetic oligonucleotides were labelled by transfer of the terminal phosphate group
32of [y- P]-ATP to the 5' hydroxylated terminus of single-stranded DNA. The
following labelling reaction was assembled on ice. In a total reaction volume of
50pl, ~20pmol of 5'-OH-termini (sl50ng of 21mer oligonucleotide) (Oswel DNA
Service) was mixed with 16pmol (= 50qCi or 1.85MBq) of [y-32P]-ATP (sp.act.
>3000Ci/mmole) (Amersham International) and 10 units of T4 PNK (Boehringer
Mannheim) in 1 x T4 PNK buffer (Appendix 2). The reaction was incubated at 37°C
for 30min. Incorporation of radioactive phosphate was monitored by TLC and
autoradiography (see below). Unincorporated isotope was removed on Sephadex®
G-50 columns as described above.
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3. Monitoring of isotope incorporation by TLC and autoradiography
Approximately 0.2pl of the labelling reaction mixture was applied as a single spot to
one end of a strip (10 x 1.5cm) of Polygram® CEL (0.1mm) 300 PEI cellulose
MN300 TLC sheet (Macherey-Nagel). The strip was held vertically in a beaker
containing TLCB (Appendix 2) to a depth ~5mm below the sample spot and
separation was allowed to proceed for 20min at RT. The chromatogram was
removed and blotted dry before wrapping in cling-film. The chromatogram was then
placed in an X-ray cassette (B. Rosenberg ) containing a Hi-Speed-X blue-emitting
intensifying screen (Genetic Research Instrumentation) and exposed to a 13 x 18cm
sheet of X-Omat S film (Kodak) for 20min at RT. Autoradiographs were processed
using D-19 developer and Unifix liquid-fixer (Kodak) in accordance with the
manufacturer's recommendations.
5.2.17 Colony Array Screening of Bacterial Transformants
Duplicate plates of bacterial transformants were prepared in grid-arrays of 100
transformants per 90mm plate by picking and streaking individual colonies with
sterile cocktail sticks. One of the plates was overlaid with a sterile 90mm Hybond
(Amersham International) circle and the plates were incubated overnight at 37°C.
The identification of recombinants of interest was achieved by oligonucleotide
hybridisation in combination with a rapid procedure which allowed colony lysis,
DNA denaturation and fixation of DNA to the nylon membrane in a single step
(Buluwela et al. 1989). Membranes were removed from plates and placed face down
onto 3MM filter paper (Whatman Scientific) soaked in colony lysis solution
(Appendix 2). Once the colonies became visibly mucoid in appearance (~2-4min),
the filter paper and membranes were transferred to the glass turntable of a Matsui
Model Ml80 TC microwave oven and irradiated for 2-3min at full power. The
membranes were then washed in membrane washing solution (Appendix 2) for 2hr at
42°C in a shaking water bath. Any residual material was removed by wiping the
surface of each membrane manually with a wad of tissues soaked in the wash
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solution. The filters were then pre-hybridised and hybridised as described in section
5.2.18.
5.2.18 Hybridisation of Labelled DNA Probes to Membrane-Bound Target DNA
Membranes from Southern blots, dot blots, plaque lifts or colony arrays were wetted
in 6 x SSC and pre-hybridised for 2hr in pre-hybridisation solution (Appendix 2).
Pre-hybridisation fluid was discarded and replaced with 5-10ml (depending on the
size of the membrane) of hybridisation fluid (Appendix 2) containing ~40ng/ml of
labelled probe DNA (see section 5.2.16). Hybridisation took place over 18hr in
sealed cylindrical Pyrex flasks in a hybridisation oven equipped with a rotisserie
(Hybaid). Pre-hybridisation and hybridisation temperatures varied depending on
whether a d/s DNA probe or oligonucleotide probe was in use. Generally, both pre-
hybridisation and hybridisation were carried out at 65°C if a d/s DNA probe was
used. However, in situations where an end-labelled oligonucleotide was the probe of
choice, temperatures 10°C below the Tm of individual oligonucleotides were
calculated. Following hybridisation, excess probe was removed initially, and in all
cases, by 3 x 5min washes in 1 x SSC, 0.1% (wt/v) SDS at RT. For d/s DNA probes,
initial washes were followed by 3 x 15min washes in 0.1 x SSC, 0.1% (wt/v) SDS at
42°C. For oligonucleotide probes, additional washes were carried out in 1 x SSC,
0.1% (wt/v) SDS at 10°C below the Tm. If non-specific hybridisation was observed
after an initial autoradiographic exposure, further washes were carried out, increasing
the temperature by increments of 2-3 °C between subsequent autoradiographic
exposures.
5.2.19 Nucleotide Sequencing
All clones were sequenced on both strands by the dideoxy-chain-termination method
(Sanger et al., 1977) using Sequenase Version 2.0 (Amersham International) in
accordance with the manufacturer's recommendations. dCTP labelling mix and
[3>S]-dCTPaS were chosen in order to achieve higher levels of incorporation into the
G-C rich mycobacterial DNA. The Sequenase enzyme was used routinely at a
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dilution of '/4, but the concentration was increased to V2 where compressions were
encountered. In order to help overcome problems associated with compressions,
sequencing reactions were resolved in polyacrylamide gels consisting of 7.6% (wt/v)
acrylamide, 0.4% (wt/v) bis-acrylamide, 40% (v/v) deionised formamide and 7M urea
in GTSB (Appendix 2). Electrophoretic conditions were set at 2980V, 40mA
(constant current) and 149W. Sequencing reactions were primed using Ml3
universal forward and reverse primers, a pMSIS specific primer and a series of
internal 18-21mer oligonucleotides. Gels were fixed in 20% (7V) methanol, 7% (v/v)
glacial acetic acid for 20min prior to lifting onto a sheet of 3MM filter paper
(Whatman Scientific) and drying in a slab gel drier (Hoefer Scientific Instruments).
Autoradiography was performed at RT in an X-ray cassette (B. Rosenberg) with the
dried gel in direct contact with a 35 x 43cm sheet of RX medical X-ray film (Fuji
Photo Film). Exposure times varied between 18hr and several days depending on the
band intensities of initial autoradiographs.
5.2.20 Cyanogen Bromide (CNBr) Cleavage of HPLC Purified p40
Chemical cleavage of p40 was performed using CNBr as described by Matsudaira,
(1990). Approximately 100pg of HPLC purified p40 was dialysed against DW and
lyophilised in a Super Modulyo freeze dryer (Edward's High Vacuum). Working in
a fume cupboard, the lyophilised protein was solubilised in 200pl of 70% (v/v) formic
acid and a single crystal of CNBr (Janssen Pharmaceuticals ) was dissolved in the
solution. Oxygen was removed from the tube by flushing with nitrogen and the
capped tube was incubated in total darkness for 18hr. The formic acid concentration
was reduced to 7% by diluting with DW and the sample was lyophilised a second
time. Cleaved lyophilised protein was stored at RT in a nitrogen flushed tube until
required.
5.2.21 Ammo-Terminal Amino Acid Sequencing
Approximately 20pg of HPLC purified protein was run into a 16 x 14cm 10% SDS-
PAGE gel under standard electrophoretic conditions (see section 2.4). Gels were
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equilibrated in sodium borate blot buffer (Appendix 2) for 20min prior to
electrophoretic transfer of protein (see section 2.7.1) onto PVDF membrane in fresh
borate blot buffer. Transfer took place over lhr at 100V/1.0A (constant voltage).
Membrane-bound protein was visualised by staining with Coomassie Brilliant Blue
(see section 2.8.2). Bands of interest were excised and amino-terminal amino acid
sequence was determined by sequential Edman degradation at the Microchemical
Facility, Institute of Animal Physiology and Genetics Research, Babraham,
Cambridge, UK.
5.2.22 Preparation of Fusion Proteins
1. Expression and purification ofGST-fusion proteins
Expression and purification of GST-fusions was carried out essentially as described
by Smith and Johnson, (1988). A fresh overnight culture of E.coli host strain AD202
transformed with a pGEXl^T construct of interest was diluted '/10 in fresh pre-
warmed (37°C) L-B broth supplemented with Amp at 50pg/ml final concentration.
(E.coli host strain AD202 carries a mutation in the ompl outer membrane associated
protease (Nakano et al., 1994) and has been reported to yield higher quantities of
some GST-fusion proteins.) The sub-culture was incubated at 37°C for lhr in a
shaking incubator before IPTG (Boehringer Mannheim) was added to a final
concentration of ImM. Incubation was continued for a further 4hr and the cells were
harvested by centrifugation at 4°C for 20min at 4,800 x g. The cell pellet was
resuspended in V10 volume of NETN buffer (Appendix 2). The cells were lysed on
ice by sonication at 50% amplitude for 8 x 15 seconds using a Vibra-cell model VCX
600 sonicator (Sonics & Materials), allowing lmin cooling on ice between each
round of sonication. The sonicate was cleared of intact cells and cell debris by
centrifugation at 10,000 x g for 5min at 4°C. Glutathione-Sepharose® (Pharmacia
Biotech) was added to the bacterial supernatant at 25pl/lml and incubated at 4°C for
lhr on a rocking platform. The sepharose beads were pelleted at 1500 x g, washed x
3 in NETN buffer and finally resuspended in 1 volume of NETN buffer containing
0.5% (wt/v) powdered milk. Bound fusion protein was analysed by PAGE after
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heating a sample of the beads at 100°C for 90 seconds in 1 x LDB (Appendix 2).
Proteins were visualised by Coomassie Blue or silver staining.
2. Expression and purification of (3-gal fusion proteins
A fresh overnight culture of an E.coli host strain transformed with a pMSIS
construct of interest was diluted V100 in fresh pre-warmed (37°C) L-B broth
supplemented with Amp at 50pg/ml final concentration. The sub-culture was
incubated at 37°C in a shaking incubator until the OD600 measured 0.5-0.6. IPTG
was added to a final concentration of lOmM and incubation was continued for a
further 4hr. Cells were pelleted at 4,800 x g for 20min at 4°C and resuspended in
Buffer-A (Appendix 2). The cells were disrupted in a Mini French Pressure Cell as
described in section 2.2.2 and the lysate was cleared of debris by centrifugation at
10,000 x g for lOmin at 4°C. P-gal fusion protein was purified from the cleared cell
lysate by affinity chromatography on p-aminobenzyl 1-thio-P-D-galactopyranoside
(ABTG) agarose (Sigma-Aldrich) (Steers et al. 1971). The cleared cell lysate was
applied to a 2ml Econo-Column (Bio-Rad Laboratories) packed with ABTG-agarose
and equilibrated with Buffer-A. The column was washed sequentially with 10ml of
Buffer-A, 10ml of Buffer-B (Appendix 2) and 10ml of Buffer-C (Appendix 2).
Bound fusion protein was eluted from the affinity matrix with 10ml of lOOmM
sodium borate pH 10.0 and collected into a tube containing 1ml of 2M Tris/HCl
pH7.0. The column eluate was dialysed against lOmM Tris/HCl pH8.0 overnight at
4°C. The fusion protein was concentrated by placing the dialysis bag on a bed of
PEG 20,000 (Merck) until the volume had reduced to ~2ml. Protein concentration
was determined as described in section 2.3.
5.2.23 Affinity Purification ofMono-Specific Polyclonal Antibodies
1. From western blotted antigens
Mono-specific polyclonal antibodies were affinity-purified from sera as described by
Beall and Mitchell (1986). Approximately 200-250pg of absorbing antigen was run
into a 16 x 14cm 10% SDS polyacrylamide gel (see section 2.4) using a single large
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sample well. Following electrophoresis, the antigen was blotted onto nitrocellulose
(Schleicher and Schuell) by western transfer (see section 2.7.1). The blotted antigen
was visualised by staining with Ponceau-S solution (Sigma-Aldrich) and bands of
interest were cut out as individual strips. Up to 4 individual strips of absorbing
antigen were prepared in this way for each affinity purification run. Strips were
washed for 60min in WFB (Appendix 2) prior to incubating for 3hr at RT in 10ml of
serum diluted '/40 in WFB. Excess antibody was removed by 3 x 5min washes in
fresh WFB, 1 x 30min wash in 0.1M boric acid, 0.5M NaCl pH8.0 and 1 x 30min
wash in 1 x PBS (Appendix 2). Specifically bound antibody was eluted from the
absorbing antigen by incubating the strips in 2ml of 0.1M glycine, 0.15M NaCl
pH2.6 for 3min. The strips were removed and the pH of the eluate was immediately
adjusted to 8.0 by the addition of 200pl of 2M Tris/HCl pH8.0. The elution step was
repeated and the two resulting eluates were pooled. Sodium azide was added to
0.02% (wt/v) and the affinity-purified antibody was stored at 4°C until required.
2. From plaque lifts of induced recombinant Xgtll clones
Approximately 103 pfu of a plaque-purified recombinant Agt 11 clone were mixed
with 100pl of fresh E.coli host strain Y1090 plating cells and plated out on a 90mm
L-B agar plate using the top agarose method as described in section 5.2.4. Plates
were incubated at 42°C until pin-prick plaques became visible. Expression of P-gal
fusion protein was induced by overlaying each plate with a nitrocellulose circle
(Schleicher & Schuell) impregnated with lOmM IPTG (Boehringer Mannheim) and
incubating at 37°C overnight. Filters were removed and washed in several changes
of WFB over 60min. Incubation in serum and antibody elution were carried out as
described above.
5.2.24 Polymerase Chain Reaction
1. Amplification of a 311bp internal fragment ofM.avium type A/I bfr
25ng of template plasmid DNA (clone pBS/R692/3.1/2) was added to pre-prepared
reaction mixtures of 50pl (final volume) containing lOmM Tris/HCl pH8.8, 50mM
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KC1, 2.5mM MgCl2, 200pg/ml gelatin, 25mM each of dATP, dCTP, dGTP and
dTTP, 20pmol primers (forward primer, 5'-GCA CTC CAA GAT GCA GGA CAA-
3'; reverse primer, 5'-TGT GCT TTT CCT CGT CGG-3') (see Fig. 5.3 for positions),
and 1 unit of Taq polymerase (Boehringer Mannheim). The reactions were covered
with lOOpl of mineral oil (Sigma) to prevent evaporation. PCR conditions consisted
of an initial denaturation step of 5min at 94°C and 30 cycles of annealing at 55°C for
30sec, extension at 72°C for 60sec and denaturation at 94°C for 30sec. The final
cycle included an extension at 72°C for 120sec.
2. Amplification of the 5' end of the p40 gene from genomic DNA
lOOng of M. avium type A/I genomic DNA was added to pre-prepared reaction
mixtures of 50pl (final volume) containing lOmM Tris/HCl pH8.8, 50mM KC1,
200pg/ml gelatin, 25mM each of dATP, dCTP, dGTP and dTTP, and 1 unit of Taq
polymerase (Boehringer Mannheim). In a series of reactions designed to determine
the optimum conditions for amplification of the target sequence, MgCl2
concentrations were adjusted between 0.5-4.0mM in increments of 0.5mM, and
primer concentrations were varied between 0.2-4.0pM. The reactions were covered
with lOOpl of mineral oil (Sigma) to prevent evaporation. PCR conditions were
varied, and annealing temperatures were dictated by the Tm of chosen pairs of
primers. Positions of primers, as predicted from a hypothetical CNBr cleavage map
of p40, and their nucleotide sequences, as deduced from amino acid sequence data,
are shown in Figs. 5.12c and 5.13 respectively. Generally, PCR conditions consisted
of an initial denaturation step of 5min at 94°C and 30-35 cycles of annealing between
40-55°C for 30sec, extension at 72°C for 60sec and denaturation at 94°C for 30sec.
The final cycle included an extension at 72°C for 120sec. Many permutations of
MgCl2 and primer concentration were used in combination with different annealing
temperatures and primer pairs in both conventional and hemi-nested PCR
experiments. The reader is referred to tables 5.3a and b (see section 5.3.14) for
precise details of experimental conditions.
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3. Amplification of the 5' end of the p40 gene from the amplified A.gtll library
lOOng of recombinant DNA, extracted from the amplified A,gtll library, was added
to pre-prepared reactions mixtures of 50pl (final volume) containing lOmM Tris/HCl
pH8.8, 50mM KC1, 200pg/ml gelatin, 25mM each of dATP, dCTP, dGTP and dTTP,
and 1 unit of Taq polymerase (Boehringer Mannheim). MgCl2 and primer
concentrations were varied as described above. The A,gtl 1 forward primer (5'-GGT
GGC GAC GAC TCC TGG AGC CCG-3') (Promega) was used in combination with
the p28-derived (M5018) reverse primer in conventional PCR experiments, or with
the p31-derived (M5806) reverse primer in hemi-nested reactions. PCR conditions
were similar to those described above, consisting of an initial denaturation step of
5min at 94°C and 30-35 cycles of annealing between 55-65°C for 30sec, extension at
72°C for 60sec and denaturation at 94°C for 30sec. The final cycle included an
extension at 72°C for 120sec.
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5.3 Results
5.3.1 Construction of a Xgtll Expression Library (Method 1)
Following amplification in E.coli host strain Y1088, a pre-amplification titre of 8.5 x
104 pfu in total was increased to 1.5 x 1010 pfu/ml. A sample of 5 x 102 pfu was
plated out in the presence of the chromogenic substrate X-gal and shown to
comprise 82.6% recombinant phage by blue/white colour differentiation.
Confirmation of this value was obtained by hybridising a plaque lift of the same 5 x
102 pfu with a [a-32P]-dCTP-labelled DNA probe prepared from the genomic DNA
fragments used to construct the library. A mean insert fragment length of 3.96kb was
calculated on the basis of sizing twenty randomly selected recombinant phage
genomes by EcoRI digestion and agarose gel electrophoresis (data not shown).
5.3.2 Immunoscreening the Amplified Library
A total of 4 x 105 pfu and 1.2 x 106 pfu were screened using antisera from rabbits
R696 and R692 respectively. Immunoscreening yielded a total of five expressing
clones, TR696/1 and TR692/1-4. All five recombinants were plaque purified and
high titre stocks prepared. Digestion with EcoRI and electrophoretic analysis of
DNA prepared from these clones revealed that clone A.R696/1 contained an insert
fragment of 2.3kb and that all four A.R692 recombinants contained an insert fragment
of 7.1kb. The larger inserts each contained two internal CcoRl sites resulting in
cleavage fragments of 3.1, 2.5 and 1.5kb (Fig. 5.1).
5.3.3 Selection of a Clone for Further Study
The expression products of all five X clones were screened with a panel of five mabs
raised against HPLC purified p40 (see section 3.2.4). The results of screening plaque
lifts of each recombinant are shown in Table 5.1. On the basis of the results of mab
screening , clone TR692/2 was selected for further analysis. In order to assign the
expressing region (5' end) of the 7.1kb insert to one of the three restriction fragments
resulting from digestion with EcoRI, the individual fragments were recovered from







































Fig. 5.1 Agarose gel showing restriction digests of DNA prepared from each of five
expressing Agtl 1 clones. Cleavage of the recombinant genomes with EcoRI revealed
a single fragment of ~2.3kb in clone R696/1 and identical inserts of ~7.1kb in clones
R692/1-4. The ~7.1kb insert contained two internal EcoRI sites yielding fragments of
—3.1, ~2.5 and ~1.5kb. M.wt markers include a lkb ladder and wild type A, DNA






XR692/1 A.R692/2 kR692/3 XR692/4
6.26 -ve +/-ve +ve +/-ve -ve
6.36 -ve -ve -ve -ve -ve
6.56 -ve -ve -ve -ve -ve
6.65 -ve -ve -ve -ve -ve
6.66 -ve -ve -ve -ve -ve
Table 5.1 Results of screening plaque lifts of clones A.R696/1 and XR692/1-4
with a panel of five mabs raised against HPLC purified p40. Signals observed
to score positive are marked by +ve, while weaker or negative signals are
marked +/-ve and -ve respectively.
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Transformation of competent E.coli host strain NM522 cells yielded five
transformants containing the 3.lkb fragment, two containing the 2.5kb fragment and
four containing the 1.5kb fragment. Cell lysates of induced bacterial transformants
were western blotted and immunoscreened with the same antiserum used to identify
the original A clone (Fig. 5.2). Two clones, both containing 3.lkb insert fragments,
were shown to express P-gal fusion proteins recognised by R692 antiserum. This
result indicated that the 3. lkb EcoRl fragment was situated at the 5' end of the parent
clone. One of these clones (pMSlS/692/3.1) was selected for nucleotide
sequencing.
5.3.4 Nucleotide Sequencing of Clone pMSlS/692/3.1
A study which compared the quantity and quality of sequencing template obtained
from a number of different E.coli host strains revealed inconsistencies in the quality
of template DNA prepared from different host strains (Taylor et al., 1993). Template
DNA amplified in strains NM522 and TGI was noted to suffer from abnormally high
backgrounds and band shadowing on sequencing gels, while that obtained from
strains DH5a, JM109 and SURE was of high quality. The study concluded that
strains NM522 and TGI should be avoided for the purpose of generating sequencing
template.
Initial attempts to obtain nucleotide sequence for clone pMSlS/692/3.1 were
hampered by problems similar to those described by Taylor et al (1993) and low
yields of template DNA from both small and large scale plasmid preparations. In an
attempt to circumvent these difficulties, the 3.lkb insert fragment was subcloned into
the high copy number plasmid Bluescript (pBS) and the new construct (clone
pBS/692/3.1) was amplified in E.coli host strain JM109 instead of NM522. The
implementation of these changes enabled the first 725bp of the 5' end of clone
pBS/692/3.1 to be determined for both strands using the dideoxy-chain termination







9 CO l/o *—< £3
«—" >—' «—1 in in













Fig. 5.2 A western blot showing cell lysates of induced pMSIS transformants
immunoscreened for expression of P-gal/fusion protein using NM522-absorbed
R692 antiserum. Five clones (3.1/1-5) contained a 3.1kb fragment, two clones
(2.5/1-2) contained a 2.5kb fragment, and a further four clones (1.5/1-4)
contained a 1.5kb fragment resulting from ZscoRI digestion of the parent 7.1kb
insert of clone /J1692/2. Two expressing clones, 3.1/1 and 3.1/2, were detected
indicating that the 3. lkb EcoR\ fragment was situated at the 5' end of the parent
clone. No background signal was detected in control lysates of induced NM522
cells or transformed NM522 cells containing the empty pMSIS vector.
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5.3.5 Nucleotide Sequence Analysis and Identification of a Gene Encoding the
bfr Subunit ofM.avium Type A/I
Analysis of the sequence revealed an ORF of 477bp that translated to a peptide of
159 aa residues with a theoretical mass of 17.4kDa. The predicted ATG initiation
codon was preceded by a potential Shine-Dalgarno sequence from nucleotide 66-71
(Fig. 5.3).
A FASTA search of the EMBL database revealed that the 725bp cloned sequence
(EMBL Acc.No. X76906) shared 80% homology with 500bp of a M. leprae genomic
DNA sequence contained in cosmid mlb38 (Acc.No. L01095), 59% homology with
455bp of the gene encoding an iron storage protein of Azotobacter vinelandii
(Acc.No. M83692) and 56% homology with 598bp of the E.coli bfr (Acc.No.
M27176). DAP and SWEEP searches of the OWL database using the deduced 159
aa sequence of the cloned DNA revealed sequence identity with six bacterial
proteins, the bfr subunits of Azotobacter vinelandii (Andrews et al., 1989a),
Nitrobacter winogradskyi (Kurokawa et al., 1989), Escherichia coli (Andrews et al.,
1989b) M.a.paratuberculosis (antigen D) (Brooks et al., 1991) Synechocystis P.C.C.
6806 (Laulhere et al., 1992) and Brucella melitensis (Denoel et al., 1995). Three
additional bacterial proteins which are not yet available in the databases were also
shown to share sequence similarity, the bfr subunit of Rhodobacter capsulatus
(Ringeling et al., 1994) and the a and p bfr subunits of Pseudomonas aeruginosa
(Moore et al., 1994). The deduced aa sequence of clone pBS/692/3.1 also shared
92% sequence identity with 162 aa residues of the translated M. leprae sequence
(positions 20960-21439), reverse strand on cosmid mlb38). There was only a single
aa substitution between this translated cosmid sequence and the first 14 amino-
terminal aa residues reported for the M. leprae 22kDa major membrane protein
(MMP-II) (Hunter et al., 1990). The identity of the M. leprae MMP-II has been
confirmed recently as a bfr (Pessolani et al., 1994; Deshpande et al., 1995). The first





































Fig. 5.3 Nucleotide sequence of the first 725bp of clone pMSIS/692/3.1
(^R692/2), showing an ORF of 477bp (76-552) translated to a peptide of
159 aa residues. The predicted ATG initiation codon is preceded by a
potential Shine-Dalgarno sequence (double-underlined) from nucleotide
66-71. Forward (157-177) and reverse (467-450) priming positions, used
for PCR-amplification of a 31 lbp internal fragment of the bfr (see section
5.2.24), are underlined.
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the deduced sequences of the M. leprae genomic sequence L01095 and clone
pBS/692/3.1 (Fig. 5.4).
Additional evidence for an antigenic relationship between the expression product of
clone pBS692/3.1 and the bfr proteins of mycobacteria was provided by a serological
cross-reactivity study. Antibody from the serum of a sheep with clinical
paratuberculosis was affinity-purified on strips of western blotted pBS692/3.1 fusion
protein (see section 5.2.23). When used to probe a western blot, the affinity-purified
antibody was observed to recognise purified M.a.paratuberculosis antigen D
(~20kDa) (Brooks et al., 1991), cellular antigens of ~20kDa and ~400kDa in lysates
ofM.a.paratuberculosis and M.avium type A/I (Inglis et al., 1994b), and an antigen
of approximately 20-22kDa in a M.leprae cell sonicate (Pessolani et al., 1994;
Deshpande et al., 1995) (Fig. 5.5).
5.3.6 Are bfr and p40 Antigenically Related?
The isolation of clones encoding bfr using an antiserum raised against HPLC purified
p40 suggested that the two proteins might be related. In order to establish whether
this apparent relationship between bfr and p40 was one resulting from genuine
antigenic similarity or artefactual, specific polyclonal R692 antiserum was prepared
by affinity purification on western blots of P-gal/bfr fusion protein and HPLC
purified p40. The antibodies eluted from these proteins were used to probe western
blots of M.avium type A/I and M.a.paratuberculosis cell lysates. Antibody eluted
from the P-gal/bfr fusion protein reacted with proteins of ~20kDa in both M. avium
type A/I and M.a.paratuberculosis, but did not recognise the p40 antigen (Fig. 5.6a).
Antibody eluted from HPLC purified p40 reacted only with the 40kDa protein in
M. avium type A/I with no evidence of any specific cross-reactivity with any other
protein (Fig. 5.6b). In addition, neither of these affinity-purified antibodies
recognised the P-gal fusion protein expressed by the 2.3kb insert contained in clone
/J1696/1. This result suggested that clone LR696/1 encoded a protein antigen
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
A.R692 M M GDP E V L R L L N E Q L T TH! T A
mlb38cos M B| G D P D V 111 R L L N E Q L T S E L T A
M.ptb MH G D P E V L R L L N E Q L T S E L T A
Nit.wi M K. G D P K V n D Y L N K A L R H E L T A
Syny. 3 K la A V in A Q L H K L L R G E L A A
Azo.vi 1MA.1 K I V i Q H L N K I L G N E L 1 A
E.coli M K G D Q K V i N Y L N K L L G N E L V A
B.meli M K G. 13 P K V i E R L N E A L F L E L G A
R.caps M K G D Q K V i E F - - - - - - - - - - -
P.aeru a 13 oB n 12 E V i D Y L N T L L T G E L A A
P.aeru p M K G D| K V i Q H L N K I L G N E L I A
22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42
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mlb38cos 1 >J 0 Y F L H s 111 M Q 111III W G F T E L llx 1 E
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Fig. 5.4 Multiple alignment of the first 42 amino-terminal amino acid
residues of known bacterioferritins. Black boxing indicates complete
identity, shaded boxing indicates conserved amino acids. Accession
numbers for the OWL database are given in parenthesis. Symbols: LR692,
translation of the M. avium type A/I genomic sequence contained in clone
LR696/2 (X76906); mlb38cos, translation of the M.leprae genomic
sequence L01095, reverse strand; M.ptb, M.a.paratuberculosis (A44893);
Nit.wi, Nitrobacter winogradskyi (P13570); Syny. 3, Synechocystis P.C.C.
6803 (P24602); Azo.vi, Azotobacter vinelandii (P22759); E.coli,
Escherichia coli (PI 1056); B.meli, Brucella melitensis 16M strain
(U19760); R.caps, Rhodobacter capsulatus (no accession number
available); P.aeru a and P.aeru (3, Pseudomonas aeruginosa Bfr alpha
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Fig. 5.5 Western blot of mycobacterial proteins reacted with affinity purified ovine
antibody. Lane 1, purified A,R692/p-gal fusion protein; lane 2, purified
M.a.paratuberculosis antigen D; lane 3, M.a.paratuberculosis cell lysate; lane 4,
M.avium type A/I cell lysate; lane 5, M.leprae cell sonicate. Bands of ~20kDa and
~400kDa in lanes 3 and 4 probably represent the monomeric and multimeric forms of
bacterioferritin respectively. The additional faint bands visible at ~25kDa and
~55kDa in lanes 3 and 4 are artefacts of the antibody elution protocol. They appear






















Fig. 5.6 Identical western blots showing cell lysates of M. avium type A/I and
M.a.paratuberculosis probed with antibodies affinity purified on R692/2 fusion
protein or HPLC purified p40. Block A, a band of ~20kDa, corresponding to the bfr
subunit, was recognised by R692/2-purified antibody in both M. avium type A/I and
M.a.paratuberculosis. Block B, a single band of 40kDa was recognised by p40-
purified antibody in M.avium type A/I only. Block C, molecular weight markers
stained with Ponceau S. No evidence to support any antigenic relatedness between
the bfr subunit and p40 was obtained.
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other than the bfr encoded by clones A.R692/1-4, but yet another which did not appear
to be antigenically related to p40 (see sections 5.3.8 and 5.3.9).
5.3.7 Do All Five X Clones Contain the bfr?
A PCR was designed to amplify a 31 lbp internal region of the 477bp bfr ORF. The
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resulting amplification product was labelled with [a- P]-dCTP by random priming
and used to probe a dot blot containing DNA prepared from all five X clones. Clones
A.R696/1-4 reacted positively whilst clone XR696/1 was negative Both M. avium type
A/I and M.a.paratuberculosis genomic DNA reacted positively whilst wild type X
DNA and a clone containing the M.a.paratuberculosis hsp70 (Stevenson et al.,
1991), which was included as a G/C rich control, were negative (data not shown).
5.3.8 Further Immunoscreening of the Genomic DNA Library Using Antiserum
Absorbed With a M.a.paratuberculosis Cell Lysate
Exhaustive absorption of R696 antiserum with crude cell lysates of E.coli host strain
Y1090 and M.a.paratuberculosis yielded an immune reagent which could not be
seen to react with any proteins other than p40 in western blots of M. avium type A/I
and M.a.paratuberculosis (data not shown). Further immunoscreening of the library
resulted in the isolation of 15 additional expressing clones (XR696/2-16). In order to
establish the M.wt. of the corresponding M. avium type A/I antigens encoded by these
clones, antibody eluted from plaque lifts of each of the 15 recombinants was reacted
against strips of western blotted M. avium type A/I cell lysate. The results of this
experiment were inconclusive, as multiple faint bands, covering a broad size range,
were observed (Fig. 5.7).
In order to eliminate the possibility that further bfr clones had been isolated, the
31 lbp /^--specific PCR fragment was hybridised against a dot-blot of DNA prepared
from all 15 recombinants. None of the clones were recognised by the 6/r-specific
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Fig. 5.7 Western blotted M. avium type A/I cell lysate cut in to strips and probed with
one each of 16 individual affinity-purified antibodies prepared on plaque lifts of each
of 16 induced A.gtl 1 recombinants (XR696/1-16). Antibody affinity-purified on
native (non-recombinant) A.gtl 1, and a V80 dilution of whole R696 antiserum were
included as negative and positive controls respectively. Multiple faint bands were
observed on all strips, including the A,gtl 1 control. Only the R696 antiserum control
was observed to recognise the p40 antigen.
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probe, whereas clone pBS/692/3.1 and M.avium type A/I genomic DNA reacted
positively (data not shown).
Digestion with £coRI and electrophoretic analysis of the 15 recombinant genomes
revealed that all contained a single insert fragment of ~2.3kb, the same size of insert
fragment as that contained in clone A.R696/1 (see Fig.5.1). Insert DNA from
AR696/1 was purified and hybridised against a dot-blot of DNA prepared from
clones LR696/2-16. All 15 clones reacted positively indicating that the clones
LR696/1-16 contained identical insert fragments (data not shown).
The insert fragment from clone LR696/1 was subcloned into plasmid pGEXILT
(clone pGEX/696/2.3) and expressed as a GST fusion protein in E.coli host strain
AD202 (see section 5.2.22). Purified GST fusion protein (~80kDa) was western
blotted and used to affinity-purify antibody from R696 antiserum. A series of cross-
reactivity experiments was designed, primarily to ascertain whether an antigenic
relationship between p40 and the A.R696/1 expression product could be
demonstrated, but also to identify the corresponding natural antigen in western blots
ofM. avium type A/I cell lysates:-
1. antibody affinity-purified on pGEX/696/2.3 GST/fusion protein was used to probe
a western blot containing M.avium type A/I and M.a.paratuberculosis cell lysates,
and pGEX/696/2.3 GST/fusion protein (Fig. 5.8a). The affinity-purified antibody did
not recognise HPLC purified p40 in either denatured (western blotted M. avium type
A/I cell lysate) or non-denatured (dot blotted HPLC-purified p40) states, but did
detect a cellular protein of ~65kDa on western blots of both M. avium type A/I and
M.a.paratuberculosis cell lysates.
2. antibody affinity-purified on western blots of HPLC-purified p40 was used to
probe a western blot containing pGEX/696/2.3 GST/fusion protein and HPLC-




























Fig. 5.8 Western and dot-blots to establish whether serological cross-reactivity
exists between p40 and the recombinant protein of clones AR696/1-16, and to
identify a corresponding cellular antigen in mycobacterial lysates.
a) Western blot of M.avium type A/I and M.a.paratuberculosis cell lysates, and
pGEX/696/2.3 GST/fusion protein probed with R696 antiserum affinity-purified
on pGEX/696/2.3 GST fusion protein. The affinity-purified antibody recognised
the GST/fusion protein (positive control) and a cellular antigen of ~65kDa in both
M.avium type A/I and M.a.paratuberculosis, but did not react with p40 in the
M.avium type A/I cell lysate or in a dot blot of non-denatured HPLC purified p40.
b) Western blot of HPLC purified p40 and pGEX/696/2.3 GST fusion protein
probed with R696 antiserum affinity-purified on western blots of HPLC purified
p40. The affinity-purified antibody recognised both denatured (western blotted)
and non-denatured (dot blotted) p40, but did not react with the GST fusion
protein.
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GST/fusion protein, but detected p40 in both denatured (western blotted) and non-
denatured (dot-blotted) states (Fig. 5.8b).
5.3.9 Do Clones /JR696/1-16 Encode a M.avium type A/I Heat Shock Protein?
In order to investigate whether the 65kDa cellular antigen recognised by
pGEX/696/2.3 affinity-purified antibody was a hsp, four anti-hsp mabs, CosII and
Hat 3 (hsp71, M.tuberculosis) and Y1.2 and D7C (hsp65, M.leprae), were reacted
against western blotted pGEX/696/2.3 GST/fusion protein. Two of the four mabs
(Y1.2 and D7C) detected the fusion protein (Fig. 5.9), indicating that clones
A.R696/1-16 encoded a protein related to the M.avium type A/I hsp65. To support
this possibility a 20mer oligonucleotide (982J), derived from the 5' end (positions
240-259) of the M.avium hsp65 (Hance et al., 1989), was end-labelled and hybridised
against the R696/1 insert fragment. However, oligonucleotide 982J failed to
hybridise with R696/1 DNA, but reacted positively with M.avium type A/I genomic
DNA (data not shown). In addition, none of the four anti-hsp mabs could be shown
to recognise HPLC-purified p40 (data not shown). In view of the lack of
demonstrable identity between p40 and the expression product of clone
pGEX696/2.3, the discrepancy between the mab and hybridisation results was not
investigated further as it was considered to lie beyond the remit of this project.
5.3.10 Preparation and Immunoscreening of a Second "Unamplifled" M.avium
Type A/I Genomic DNA Expression Library in Xgtll
In an attempt to circumvent the possibility that clones expressing p40 could be toxic
to the host cell and lost or underrepresented following amplification of the library, a
second genomic DNA expression library was prepared in A,gtl 1 using randomly
generated fragments ranging from ~l-3kb in size. It was established that this library
contained a total of 6.38 x 105 pfu. The entire library was immunoscreened without
amplification using an M.a.paratuberculosis-absorbed antiserum which recognised
only p40 in western blots ofM.avium type A/I cell lysates. No clones expressing the
p40 antigen were detected.
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Fig. 5.9 Strips of Western blotted pGEX692/2.3 GST fusion protein each probed
with one of four anti-hsp mabs:- Cos II and Hat 3, anti M. tuberculosis hsp71; Y1.2
and D7C, anti M.leprae hsp65. Two of the four mabs, Y1.2 and D7C, recognised the
recombinant protein although the reaction between mab D7C and the fusion protein
was weak.
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5.3.11 Chemical Cleavage of HPLC Purified p40
The lack of success in immune-based detection of recombinants expressing p40
necessitated consideration of different cloning strategies, one of which was detection
by nucleic acid hybridisation. Unfortunately, the absence of any nucleotide sequence
data for the p40 gene precluded the design and synthesis of suitable DNA probes.
However, together with knowledge of mycobacterial codon usage, the deduction of
nucleotide sequences from aa sequence data represented a means by which the
absence of nucleotide sequence data could be circumvented. To this end, purified
p40 was cleaved into a series of smaller peptides and both amino-terminal and
internal aa sequences obtained by Edman degradation.
Protein molecules, denatured by formic acid treatment, can be cleaved specifically on
the carboxyl side of methionine residues by CNBr (Matsudaira, 1990). As the
average number of methionine residues in any given protein is relatively low (~1-
2%), CNBr cleavage normally yields a smaller and more manageable number of
peptides than would result from proteolytic digestion with trypsin, for example.
CNBr treatment of p40 resulted in the generation of a number of smaller fragments,
including three at ~12kDa (pl2), ~28kDa (p28) and ~31kDa (p31), which were
recovered and submitted for aa sequencing, and a faint band of ~15kDa which was
not present in quantities sufficient for sequencing (Fig. 5.10). Amino acid sequence
was obtained for the pl2, p28 and p31 peptides by Edman degradation (Fig. 5.11).
One of these (pi2) shared an identical sequence with that of uncleaved p40.
However, none of the three aa sequences obtained were shown to share any
significant degree of sequence identity with any peptide sequence available in the
OWL database at that time, including the ORF contained within the genomic
insertion sequence IS901/902.
A hypothetical map of p40 was postulated on the basis of the sequence data obtained
















Fig. 5.10 Coomassie blue stained Western blot of HPLC purified p40 following
chemical cleavage with CNBr. Cleavage peptides can be seen at -31, -28, -15 and
~12kDa.
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p40 T S D G Y A R I R EGGPYFDDLSV (20)
P12 TSDGYARIRE (10)
P28 L P A S P E F T A E A G S V (14)
P31 ITIDQADQLVP DFYRG G G L P (20)
Fig. 5.11 Amino terminal amino acid sequences obtained by Edman degradation for
p40 and the pi2, p28 and p31 CNBr cleavage peptides. Stretches of seven























Fig. 5.12 (A) Diagrammatic representation of the peptides resulting from CNBr
cleavage of HPLC purified p40. (B) A hypothetical map of p40 was formulated on
the distribution of the fragments and amino acid sequence data obtained on the p40
amino-terminus and the pi2, p28 and p31 cleavage products. (C) Arrows indicate
positions and 5'-3' direction of four oligonucleotides deduced from amino terminal
and internal amino acid sequence data (see Fig. 5.13).
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5.3.12 Deduction of Oligonucleotides From Amino-Terminal and Internal
Amino Acid Sequences
A mycobacterial codon usage table (Table 5.2) was compiled using information
derived from the translations of 19 MAC gene sequences currently held in the EMBL
database, and the UWGCG program "Codon Frequency" available on the SEQNET
node, SERC, Daresbury laboratory. One non-degenerate (Z196) and three
degenerate (M5805, M5806 and M5018) oligonucleotides of 20 or 21bp in length
were deduced from the amino-terminal and internal amino acid sequences obtained
(see Figs. 5.12c and 5.13). These oligonucleotides were used subsequently :-
1. as end-labelled probes to screen the amplified Xgtl 1 library by DNA hybridisation,
2. as primers in reactions designed to amplify the 5' end of the p40 gene from
genomic DNA by PCR,
3. as end-labelled probes to screen Southern blots of restriction endonuclease
digested genomic DNA for fragments carrying all or part of the p40 gene.
5.3.13 Screening of the Genomic DNA Library By Hybridisation Using End-
Labelled Oligonucleotide Probes
A further 2.4 x 106 pfu of the amplified library were screened with individual end-
labelled oligonucleotides, but no hybridising clones were detected.
5.3.14 Experiments To Amplify the 5' End of the p40 Gene From Genomic DNA
by PCR
Oligonucleotide primers deduced from internal aa sequences, have been used in
combination with PCR to isolate the M.tuberculosis ribonucleotide reductase gene
from genomic DNA (Yang et al., 1994) and the M. leprae bfr from one of a series of
overlapping cosmid clones (Pessolani et al., 1994). This type of approach was
adopted in an attempt to amplify the 5' end of the p40 gene from M.avium type A/I
genomic DNA in a series of PCR experiments which spanned a broad range of
different reaction conditions. All the reactions used combinations of forward and
reverse primers whose positions on the p40 gene were presumed from a hypothetical
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a.a. codon E.coli MAC M.tb M.lep a.a. codon E.coli MAC M.tb M.lep
Phe TTT 0.26 0.06 0.08 0.20 Ser TCT 0.36 0.02 0.04 0.19
Phe TTC 0.74 0.94 0.92 0.80 Ser TCC 0.34 0.25 0.22 0.19
Leu TTA 0.03 0.00 0.01 0.01 Ser TCA 0.02 0.03 0.04 0.16
Leu TTG 0.04 0.10 0.18 0.20 Ser TCG 0.05 0.35 0.35 0.20
Leu CTT 0.06 0.05 0.02 0.09 Pro CCT 0.10 0.04 0.06 0.17
Leu CTC 0.08 0.27 0.19 0.17 Pro CCC 0.01 0.37 0.28 0.18
Leu CTA 0.01 0.01 0.04 0.10 Pro CCA 0.12 0.10 0.08 0.17
Leu CTG 0.79 0.57 0.57 0.44 Pro CCG 0.77 0.49 0.58 0.47
He ATT 0.20 0.09 0.19 0.23 Thr ACT 0.36 0.04 0.06 0.15
lie ATC 0.79 0.88 0.77 0.66 Thr ACC 0.48 0.67 0.64 0.46
He ATA 0.01 0.02 0.04 0.11 Thr ACA 0.05 0.05 0.06 0.15
Met ATG 1.00 1.00 1.00 1.00 Thr ACG 0.10 0.24 0.24 0.23
Val GTT 0.44 0.06 0.10 0.11 Ala GCT 0.37 0.08 0.09 0.18
Val GTC 0.09 0.44 0.43 0.47 Ala GCC 0.10 0.50 0.49 0.43
Val GTA 0.27 0.06 0.05 0.11 Ala GCA 0.25 0.07 0.09 0.13
Val GTG 0.19 0.43 0.42 0.31 Ala GCG 0.28 0.34 0.33 0.26
a.a. codon E.coli MAC M.tb M.lep a.a. codon E.coli MAC M.tb M.lep
Tyr TAT 0.26 0.15 0.14 0.26 Cys TGT 0.36 0.27 0.26 0.44
Tyr TAC 0.74 0.85 0.86 0.74 Cys TGC 0.64 0.73 0.74 0.56
Trp TGG 1.00 1.00 1.00 1.00
His CAT 0.20 0.31 0.24 0.19 Arg CGT 0.67 0.10 0.18 0.27
His CAC 0.80 0.69 0.76 0.81 Arg CGC 0.30 0.49 0.46 0.47
Gin CAA 0.18 0.17 0.18 0.27 Arg CGA 0.01 0.09 0.10 0.06
Gin CAG 0.82 0.83 0.82 0.73 Arg CGG 0.00 0.29 0.21 0.16
Asn AAT 0.08 0.15 0.13 0.22 Ser AGT 0.04 0.05 0.04 0.04
Asn AAC 0.92 0.85 0.88 0.78 Ser AGC 0.19 0.30 0.31 0.22
Lys AAA 0.71 0.14 0.10 0.25 Arg AGA 0.01 0.01 0.00 0.02
Lys AAG 0.29 0.86 0.90 0.75 Arg AGG 0.00 0.02 0.05 0.02
Asp GAT 0.36 0.19 0.17 0.29 Gly GGT 0.54 0.22 0.25 0.35
Asp GAC 0.64 0.81 0.83 0.71 Gly GGC 0.42 0.60 0.54 0.48
Glu GAA 0.76 0.28 0.19 0.31 Gly GGA 0.01 0.07 0.07 0.06
Glu GAG 0.24 0.72 0.81 0.69 Gly GGG 0.03 0.12 0.14 0.10
Table 5.2 A comparison of codon usage in genes of members of the MAC,
M.tuberculosis, M.leprae and E.coli. The data for E.coli were based on those of Grosjean
and Fiers (1982) and the values shown are for genes which are known to be highly
expressed, namely the RNA polymerase subunits, the ribosomal proteins, the translation
elongation factor EF-Tu, the RecA protein and a number of outer membrane proteins.
The data for the MAC members were compiled using information derived from the
translations of MAC genes currently in the EMBL database and the UWGCG program
"Codon Frequency" available on the SEQNET node, SERC, Daresbury laboratory. The
data for M.tuberculosis and M.leprae are based on the codon usage of nine and five
genes respectively and are quoted directly from Dale and Patki (1990). Frequency of
codon usage is expressed as a fraction of the total number of occurrences of each triplet.
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3 4 5 6 7 8 9
(P40/pl2) Asp Gly Tyr Ala Arg He Arg
GAC GGC TAC GCC CGC ATC CGC
T T T G G T G
G T T A T
A A A A
A G A G
A A A A
Z196 5' GAC GGC TAC GCC CGC ATC CGC 3'
M5805 5' GAY GGY TAY GCS CGI ATY CG 3'
12 13 14 15 16 17 18
(p31) Asp Phe Tyr Arg Gly Gly Gly
GAC TTC TAC CGC GGC GGC GGC
T T T G T T T
T G G G
A A A A
A G
A A
M5806 3' CTG AAG ATG GCS CCI CCI CC 5'
5 6 7 8 9 10 11
(P28) Pro Glu Phe Thr Ala Glu Ala
CCG GAG TTC ACC GCC GAG GCC
C A T G G A G
A A T T
T T A A
M5018 3' GGS CTC AAG TGG CGS CTC CGS 5'
Fig. 5.13 Deduction of oligonucleotides (20 or 21mers) from aa sequence data.
Stretches of seven contiguous residues were selected from the amino-terminal aa
sequences obtained for p40 and the p31, p28 and pi2 CNBr cleavage peptides (see
Fig. 5.12). Preferred codons (see Table 5.2) and degeneracy are shown below the
amino acids. Non-degenerate oligonucleotides were designed from preferred codons
only, while degenerate oligonucleotides were based on preferred codons but
incorporated "S" where either C or G was the preferred third position, "Y" where C
or T was the preferred third position and "I" (inosine) where the third position
exhibited four fold degeneracy and C or G were not the two preferred bases.
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CNBr cleavage map of the purified protein (see Fig. 5.12). Various permutations of
primer, Mg and template concentration and different annealing temperatures were
used in both conventional and hemi-nested PCRs. Multiple bands were observed in
reactions using primers derived from the p40 amino-terminus and p28 internal
region, especially in those where degenerate oligonucleotide M5805 (Tm = 43°C in
0.1M NaCl) was used, and annealing temperatures were set in favour of the primer
with the lower Tm (see Table 5.3a and b). Based on the assumption that the CNBr
cleavage map of p40 (Fig. 5.12b) was correct, Southern blotting experiments to
confirm the identity of the PCR products were undertaken using oligonucleotide
M5806, (p31, degenerate), a primer predicted to be internal to the region amplified
by the p40- and p28-derived primers (Fig 5.12c). However, Southern blotting
analysis did not detect any amplified product that hybridised to oligonucleotide
M5806, including two prominent bands of 300-350bp (Table 5.3a) and 200bp (Table
5.3b) which were observed in some reactions. Similarly, hemi-nested PCR, using
primers derived from the p40 and p31 regions, was unsuccessful in further
amplifying product from first round amplifications using primers derived from p40
and p28 regions of the protein (data not shown). Particular sets of reaction
conditions (see Table 5.3a) were observed to produce only two or three bands as
observed by PAGE and silver staining. However, all of these amplification products
were larger than the ~300bp and ~400bp fragments expected to correspond to
peptides of 12kDa and 15kDa respectively (see Fig. 5.12c).
The results of PCR experiments, aimed at amplifying the 5' end of the p40 gene from
recombinant Xgtll DNA, were similar to those described above. Analysis of
amplified products resulting from reactions based on a combination of Agtl 1 -derived
forward and p28-derived reverse primers, revealed multiple bands which decreased
in number as the annealing temperature was increased from 55°C to 65°C. Once
again however, Southern blotting analysis did not reveal any amplified product that
hybridised to oligonucleotide M5806. Similarly, hemi-nested PCR, using A,gtl 1- and
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Primers [pM]
Mg2+ (mM) Temp (°C) 0.2 0.4 0.6 0.8 1.0 1.5 2.0 2.5 3.0 4.0
0.5 55 0 0 0 0 0 0 0 0 0 0
1.0 55 0 0 5 >10 >10 >10 0 >10 >10 Iliii
1.5 55 0 7 >10 >10 >10 >10 >10 >10 >10 >10
2.0 55 3 6 8 >10 >10 >10 >10 >10 >10 >10
2.5 55 2 6 >10 III01 >10 >10 >10 >10 >10 >10
3.0 55 2 8 >10 >10 >10 >10 >10 >10 >10 >10
3.5 55 6 >10 >10 >10 >10 >10 >10 >10 >10 >10
4.0 55 6 >10 >10 >10 >10 >10 >10 >10 >10 >10
2+
Table 5.3a Results of PCR experiments using different permutations of Mg and
primer concentration. Forward and reverse primers were Z196 (Tm = 74°C) and
M5018 (Tm = 57°C) respectively. Annealing temperature was fixed at 55°C and
genomic DNA template concentration was 100ng/50pl reaction. Numbers shown
indicate the number of amplified fragments per reaction as analysed by PAGE and
silver staining. Shaded values indicate reactions which amplified a prominent band
of ~300-350bp.
Primers [pM]
Mg2+ (mM) Temp (°C) 0.2 0.4 0.6 0.8 1.0 1.5 2.0 2.5 3.0 4.0
0.5 40 0 0 0 0 0 0 0 0 0 0
1.0 40 0 0 7 >10 >10 o::*"W
:
Al >10 >10 >10 >10
1.5 46 0 0 0 4 8 8 8 8 8 8
1.5 50 0 0 0 0 3 4 3 3 3 3
1.5 55 0 0 0 0 0 0 0 0 0 0
9+
Table 5.3b Results of PCR experiments using different permutations of Mg
concentration, primer concentration and annealing temperature. Forward and reverse
primers were M5805 (Tm = 43°C) and M5018 (Tm = 57°C) respectively. Annealing
temperature was varied between 40-55°C while genomic DNA template
concentration was fixed at 100ng/50pl reaction. Numbers shown indicate the
number of amplified fragments per reaction as analysed by PAGE and silver staining.
Shaded values indicate reactions which amplified a prominent band of ~200bp.
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p31-derived primers, failed to further amplify any products from first round
amplifications (data not shown).
5.3.15 Identification ofM.avium Type A/I Genomic DNA Restriction Fragments
Recognised By End-Labelled Oligonucleotides
At this juncture neither immunoscreening or oligonucleotide hybridisation had
succeeded in detecting ^gtll recombinants encoding the p40 in either of two
genomic DNA libraries. Similarly, attempts to amplify the 5' end of the gene by
PCR had yielded products which could not be proven to contain p40 sequences.
Therefore the alternative strategy of probing Southern blots of restriction
endonuclease digested genomic DNA with labelled oligonucleotides was adopted in
an attempt to identify restriction fragments which could be targeted for cloning.
Table 5.4 shows the results of washing four strips of £coRI digested M.avium type
A/I DNA at three different temperatures following hybridisation with one of four
end-labelled oligonucleotide probes. Only one of the four available oligonucleotide
probes (M5018) continued to emit a detectable signal after lOmin at 65°C in 1 x SSC
and 15hr exposure at -70°C. Five bands at ~5.2kb, ~4.5kb, ~4.0kb, ~3.7kb and
~450bp were visible in M.avium type A/I DNA, but only the largest three of these
were common to the M.a.paratuberculosis genome (Fig. 5.14).
5.3.16 Experiments To Clone jEcoRI Restriction Fragments ofM.avium Type A/I
Genomic DNA Recovered From LMP agarose
Initial efforts to clone the EcoRl restriction fragments recognised by oligonucleotide
M5018 focused on those that emitted the strongest signals on Southern blots, i.e. the
5.2 and 3.7kb fragments. M.avium type A/I genomic DNA was digested to
completion with LcoRI and the resulting fragments resolved on a LMP agarose gel.
Restriction fragments ranging from ~3.5kb to ~6.5kb were excised from the gel in
seven contiguous blocks. The DNA was recovered by agarase digestion and
analysed by further agarose gel electrophoresis and Southern blotting prior to ligation







Z196 (p40/pl2) multiple bands single band at
~20kb
-ve
M5805 (p40/pl2) multiple bands -ve -ve
M5806 (p31) multiple bands -ve -ve
M5018 (p28) black smear multiple bands
including five
strong signals at
5.2, 4.5, 4.0 and
3.7kb and 450bp
five bands, two
strong signals at 5.2
and 3.7kb and three
weaker signals at 4.5
and 4.0kb and 450bp
Table 5.4 Results of washing Southern blots of £coRI digested M. avium genomic
DNA sequentially at 42°C, 60°C and 65°C following hybridisation with four
individual end-labelled oligonucleotide probes. All Southerns were washed in 1 x














Fig. 5.14 Autoradiograph of EcoRl digested M. avium and M.a.paratuberculosis
genomic DNA following Southern transfer and hybridisation with end labelled
oligonucleotide M5018. The Southern blot was washed in 1 x SSC, 0.1% SDS at
65°C for lOmin and autoradiography took place at -70°C over 15hr. Fragments of
-5.2, -4.5 and ~4.0kb were seen in both M.avium and M.a.paratuberculosis, but
additional bands of~3.7kb and ~450bp were seen only in M.avium.
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Fig. 5.15a and b Agarose gel (A) and autoradiograph (B) showing M.avium type A/I
genomic DNA fragments recovered from LMP agarose by digestion with agarase.
DNA was digested to completion with £coRI and the resulting fragments resolved
electrophoretically. Restriction fragments ranging from ~3.5kb to ~6.5kb were
excised from the gel in seven contiguous blocks. A Southern blot of the recovered
DNA probed with oligonucleotide M5018 revealed the fragments of interest at ~3.7,
~4.0, -4.5 and ~5.2kb and their corresponding bands in whole genomic DNA
digested with £coRI. M.wt. markers include a lkb ladder and wild type X DNA
digested with Hind III.
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Initial experiments to clone the genomic DNA fragments directly into the plasmid
vectors pBS and pUC18 were unsuccessful. This was in spite of the fact that all the
usual controls were noted to be satisfactory; vector DNA (pBS or pUC18 linearised
with EcoRI and dephosphorylated with CIP) produced a background transformant
level of -2 cfu/50ng DNA and could not be seen to ligate to itself as viewed by
agarose gel electrophoresis; wild type X DNA digested with Hind III was observed to
ligate to itself indicating the efficacy of the T4 DNA ligase and the reaction buffer
supplied by the manufacturer (Boehringer Mannheim); transformation controls using
empty circular plasmid DNA yielded approximately 5 x 103 cfu/50ng DNA (-105
cfu/pg) and the competent cells in use (E.coli host strain DH1 prepared by the CaCl2
method) were shown to be sensitive to Amp containing medium.
The use of different vector to insert ratios failed to increase the efficiency of
transformation from zero. The CIP treated pBS and pUC18 vectors were replaced
with pGEX 1 A.T (Pharmacia), which was supplied ready to use linearised with fscoRI
and dephosphorylated with BAP. The use of this vector improved transformation
efficiencies only slightly, resulting in values of 5-10 cfu/50ng DNA. Complete DNA
ligase buffers from two other commercial sources (Promega and Invitrogen) and an
"in house" buffer, using ATP concentrations ranging from 5-20mM, failed to
improve on the efficiencies achieved using the original buffering conditions.
Interestingly however, ATP concentrations in excess of 5mM were noted to inhibit
rather than enhance ligation efficiency (data not shown). The use of competent host
cells prepared using HETB rather than CCTB increased transformation efficiencies
marginally to -75 cfu/50ng DNA.
Electrophoretic analysis of a test ligation designed to ascertain whether the agarose-
recovered EcoRI fragments were of a quality suitable for ligation showed that only a
small percentage of the DNA had undergone a noticeable shift in migration and that
there was little visible difference between ligated test DNA and unligated control
DNA. Conclusive evidence that the genomic DNA fragments could not be ligated
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efficiently was obtained when a commercially prepared £coRI-ended test insert
fragment of 3.5kb (Amersham International) was successfully ligated into pGEXl AT
using the same reaction conditions and vector to insert ratios. Transformation of
HETB-prepared DH1 cells using these constructs was achieved at an efficiency of
5.4 x 105/pg DNA.
5.3.17 Sucrose Gradient Purification of Genomic DNA Restriction Fragments
In an attempt to generate fragments of a quality suitable for ligation, fscoRI digested
genomic DNA was purified by sucrose density gradient centrifugation (Nevins and
Darnell, 1978). Fractionation of the gradient yielded 24 x 0.5ml fractions containing
a series of overlapping fragment sizes (Fig. 5.16). Although all the fractions between
9 and 16 were seen to contain a range of fragment sizes which included the 3.7-5.2kb
fragments of interest, fraction 16 was selected because it contained fewer low M.wt.
DNA fragments than any of the preceding fractions. Smaller DNA fragments tend to
be ligated preferentially over larger ones, thus the selection of a fraction containing a
minimum fragment size of ~3kb theoretically increased the likelihood of cloning the
fragments of immediate interest. Fraction 5 was the only one observed to contain
fragments in the 400-600bp size range and was selected for the purpose of cloning
the ~450bp fragment recognised by oligonucleotide M5018.
Confirmation of the quality of the sucrose-purified restriction fragments was
obtained when a sample of the DNA purified from fraction 16 was ligated to itself
and electrophoretic analysis revealed an obvious shift in migration (Fig. 5.17).
5.3.18 Cloning and Sequencing of Genomic ZscoRI Fragments Purified By
Sucrose Density Gradient Centrifugation
Sucrose purified EcoKl fragments from fraction 16 were ligated into pGEXlAT at a
vector to insert ratio of 1:1. The resulting constructs transformed high efficiency
competent E.coli host strain HB101 cells (Promega) at an efficiency of 5.2 x 103

















Fig. 5.16 Agarose gel showing a series of fractions resulting from the purification of
£coRI digested M. avium type A/I genomic DNA by sucrose density gradient
centrifugation. Fractionation of the gradients yielded 24 x 0.5ml fractions, 17 of
which (5-21) were shown to contain restriction fragments of overlapping sizes. M.wt.








Fig. 5.17 Agarose gel demonstrating the quality of sucrose purified DNA fragments
for the purpose of ligation. Ligated EcoRl fragments from gradient fraction 16
showed a marked shift in migration when compared to non-ligated control DNA.
Bars representing M.wt. are derived from wild type A. DNA digested with Hind III.
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hybridisation using oligonucleotide M5018, yielded four clones containing the 5.2kb
fragment, a single clone containing the 4.5kb fragment, five clones containing the
4.0kb fragment and three clones containing the 3.7kb fragment (Figs. 5.18a and b).
A single clone containing the ~450bp EcoRl fragment was isolated in an identical
manner after screening a further 500 transformants (data not shown).
In order to determine whether any of the cloned EcoRI fragments contained the p40
gene, it was necessary to obtain sequence information across the M5018 recognition
site for a representative clone containing each insert (Table 5.5). The sequencing
procedure was simplified for clones pGEX16/84 (~3.7kb insert) and pGEX22/41
(~4.0kb insert) by virtue of the fact that oligonucleotide M5018 was capable of
priming an initial sequencing reaction on these inserts. Further primers designed
from new sequence data were then used to prime second and third reactions on
opposite strands (Fig. 5.19). This meant that sequence data over the recognition site
and flanking regions was obtained in both directions.
Sequencing reactions on clones pGEX3/14 (~5.2kb insert), pGEX42/70 (~4.5kb
insert) and pUCl/28 (~450bp insert) could not be primed by oligonucleotide M5018.
As the insert fragments of clones pGEX3/14 and pGEX42/70 were considered too
large to sequence in their entirety, insert DNA was purified from each clone and
digested to completion with Sau3a. Southern blots probed with oligonucleotide
M5018 revealed Sau3a cleavage fragments of ~500bp and ~300bp from clones
pGEX3/14 and pGEX42/70 respectively. Two subclones, pUC3/46 (~500bp) and
pUC4/33 (~300bp) were selected from a total of eight produced by shotgun-ligating
Sau3a digests of purified 5.2kb and 4.5kb fragments into pUC 18/BamH 1 /BAP
(Pharmacia) and transforming high efficiency E.coli host strain HB101 cells
(Promega). Clones pUC3/46, pUC4/33 and pUCl/28 were then sequenced in both
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Fig. 5.18a and b Agarose gel and autoradiograph showing EcoRI digests of 14
pGEXlAT recombinants containing M. avium type A/I genomic EcoKl fragments
identified by hybridisation with oligonucleotide M5018. Clones 2/91, 3/14, 9/98,
12/89 and 34/41 contain an insert fragment of ~5.2kb, clone 42/70 contains an insert
fragment of ~4.5kb, clones 22/41, 36/22, 40/2, 43/17 and 44/80 contain an insert
fragment of ~4.0kb and clones 16/84, 39/36 and 40/33 contain an insert fragment of
~3.7kb. In addition to a reactive fragment of ~3.7kb, clones 39/36 and 40/33 also
contain a larger fragment of ~8.0kb which was not recognised by oligonucleotide
M5018. Bands corresponding to the cloned EcoRI fragments can be seen in EcoKl
digests ofM.avium type A/I and M.a.paratuberculosis genomic DNA. M.wt markers
include a lkb ladder, empty pGEX 1 XT linearised with EcoKl (4.7kb) and wild type A,










pGEX3/14 5.2 pUC3/46 0.5




Table 5.5 Five recombinant plasmids containing M.avium type A/I genomic EcoRI
fragments identified by hybridisation with oligonucleotide M5018. Cloning vectors
used and insert sizes are shown. The insert fragments of clones pGEX3/14 (5.2kb)
and pGEX42/70 (4.5kb) were digested to completion with Sau3a and sub-cloned into
pUC18/ZEwzHI/BAP. Subclones containing 500bp and 300bp Sau3a insert fragments
of interest were identified by hybridising with M5018.
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Fig. 5.19 Diagrammatic representation of strategies used to obtain bi-directional
nucleotide sequence data for five M.avium type A/I genomic DNA fragments 1.
two pGEX/AcoRI constructs (pGEX16/84 and pGEX22/41) were sequenced in three
steps, using three oligonucleotide primers, beginning with M5018; 2. the insert
fragments of two further pGEX/EcoRI constructs were further digested with Sau3a,
ligated into pUC18/5awHI/BAP generating two pUC subclones (pUC3/46 and
pUC4/33) and sequenced using Ml3 -40 and reverse primers; 3. a single pUC
construct (pUCl/28), containing an iscoRI fragment of ~450bp, was sequenced using
Ml3 -40 and reverse primers also.
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The five sequences generated were matched against the sequence of oligonucleotide
M5018 using the UWGCG program "BESTFIT". A multiple alignment of the
homologous sequences and comparison with oligonucleotide M5018 is shown in Fig.
5.20. Table 5.6 shows values of percentage similarity and percentage identity
between the degenerate sequence of oligonucleotide M5018 and the homologous
sequences on each of the five clones. Similarity values ranging between 61.9% and
90.5% were calculated awarding a full match where "S" (C/G) aligned with either
"C" or "G". Identity values between 52.4% and 76.2% were calculated on full
matches only, making no allowance for degenerate matches. In frame translations of
the five homologous 21 bp nucleotide sequences and their immediate flanking regions
were compared with the 14 aa sequence of the p28 CNBr cleavage peptide (Fig.
5.21). Translations over the seven contiguous amino acid residues, from which
oligonucleotide M5018 was originally deduced, revealed levels of amino acid
sequence identity ranging between a single mismatch, and two mismatches plus two
conservative substitutions. However, the sequences flanking the seven amino acid













Fig. 5.20 Multiple alignment of homologous sequences obtained from five cloned
genomic fscoRI fragments and comparison with the 21bp complement of
oligonucleotide M5018. Black boxing indicates complete identity, shaded boxing
indicates degenerate matches where "C" or "G" aligns with "S" on the M5018
sequence.
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pUC3/46* 500bp Sau3a 174 2 3 90.5% 76.2%
pGEX 16/84 3.7kb£coRI 230 3 2 85.7% 76.2%
pUC4/33** 300bp Sau3a 222 3 3 85.7% 71.4%
pGEX22/41 4.0kb EcoRI 219 2 3 90.5% 76.2%
pUCl/28 450bp £coRI All 8 2 61.9% 52.4%
Table 5.6 M. avium type A/I genomic DNA fragments cloned in plasmid vectors
pGEXlAT and pUC18. Constructs pUC3/46* and pUC4/33** are subclones of
pGEX3/14 (5.2kb EcoRI insert) and pGEX42/70 (4.5kb EcoRI insert) respectively.
Approximate sizes of insert fragments and length of sequence obtained are shown.
Percentage identity and similarity values were calculated from numbers of complete
















Fig. 5.21 Multiple alignment of translations across the M5018 hybridisation site of
five cloned genomic £coRI fragments and comparison with the 14 amino-terminal
residues of the p28 CNBr cleavage peptide. Residues 5-11 represent the 7 contiguous
amino acids from which oligonucleotide M5018 was derived. Black boxing indicates
complete identity, shaded boxing indicates conserved amino acids.
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5.4 Discussion
The A-gtll expression vector has been a particularly useful cloning vehicle in
situations where nucleotide sequence information on a given gene has yet to be
established and immune reagents represent the only available means of detecting
clones (Young and Davis, 1983a). A number of different immunoscreening strategies
have been used to target mycobacterial genes expressed in Xgtll libraries. These
include mabs raised against the antigens comprising crude or partially purified cell
lysates (Young et ah, 1985b; Morris et ah, 1990; Rouse et al., 1991); convalescent
sera taken from naturally infected humans or animals to enable the identification of
proteins expressed in vivo which may be important in the host immune response, or
whose expression might be down regulated during propagation on artificial culture
media (Clark-Curtiss et ah, 1990; Sathish et ah, 1990; DeKesel et ah, 1993;
Cameron et ah, 1994; Wieles et ah, 1994); hyperimmune polyclonal antisera raised
against either intact or disrupted cells (Thole et ah, 1985; Khandekar et ah, 1986;
Stevenson et ah, 1991; DeKesel et ah, 1993); and specific hyperimmune polyclonal
antisera raised against highly purified individual antigens (Inglis et ah, 1994b).
The strategy adopted in this study entailed the extraction and chromatographic
purification of a 40kDa antigen from disrupted M. avium type A/I cells, raising
specific hyperimmune polyclonal antisera against the purified antigen in rabbits and
using the newly generated immune reagents to screen for expression of the antigen in
a A-gtl 1 library.
5.4.1 Detection and Characterisation of a ^gtll Clone Encoding the bfr Subunit
ofM.avium Type A/I
Using antiserum pre-absorbed with E.coli host strain Y1090, five expressing clones
were isolated from the original amplified Xgtl 1 library. Analysis of these revealed
that four clones (AR692/1-4) contained a 477bp ORF representing the complete
nucleotide sequence of the gene encoding the 159 aa residues of the M.avium type
A/I bfr subunit.
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Bacterioferritins and ferritins are proteins which are involved in the storage of iron in
prokaryotic and eukaryotic organisms respectively, although prokaryotic ferritins
(pfr) also have been reported to occur in Escherichia coli (Izuhara et al., 1991),
Bacteroides fragilis (Rocha et al., 1992) and Helicobacter pylori (Frazier et al.,
1993). Both proteins are multimeric molecules of ~400kDa which are assembled
from 24 subunits of ~17-22kDa each to form a rhombic dodecahedral protein shell
surrounding a central iron storage cavity (Mann et al., 1987). Amino acid sequence
analysis of the subunits has revealed a high degree of identity between the bfrs of
different bacterial genera. Also, all the key aa residues, which specify the unique
structural motifs of eukaryotic ferritin, are conserved or conservatively substituted in
bfr (Grossman et al., 1992) in spite of an otherwise complete lack of identity between
the primary structures of bfr and ferritin. Thus the subunits of both bfr and ferritin
share a common tertiary structure consisting of four a-helices which come together
to form a bundle (Andrews et al., 1991; Smith, 1991; Stiefel et al., 1994). Both bfr
and ferritin contain ferric iron, although the former also contains haem groups in the
form of protoporphrin IX (Moore et al., 1986).
Bacterioferritin, also known as cytochromes fy and b557 5, (Smith et al., 1988) has
been reported in at least twelve diverse genera to date. These include Azotobacter
(Bulen et al., 1973; Stiefel and Watt, 1979; Chen and Crichton, 1982), Brucella
(Denoel et al., 1995), Cyanobacterium (Laulhere et al., 1992), Escherichia (Yariv et
al., 1981; Andrews et al., 1989b), Mycobacterium (Brooks et al., 1991; Pessolani et
al., 1994; Inglis et al., 1994b), Nitrobacter (Kurokawa et al., 1989), Pseudomonas
(Moore et al., 1994), Rhodobacter (Ringeling et al., 1994), Rhodopseudomonas
(Meyer and Cusanovich, 1985), Rhodospirillum (Bartsch et al., 1971), Streptomyces
(Inoue and Kubo, 1965) and Yersinia (Perry et al., 1993).
The fact that an ORF of 477bp represented approximately half the coding capacity
required for the synthesis of a 40kDa protein raised a number of possibilities. The
first of these was that p40 might be a dimer composed of two bfr subunits and that its
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apparent M.wt of 40kDa is artefactual and a direct consequence of routine
denaturation prior to PAGE and western transfer. However, this theory could not be
supported experimentally and bands of ~400kDa (multimeric form) and ~17-22kDa
(monomeric form) were the only two forms of the protein visible on western blots
probed with affinity-purified anti-bfr antibody (see Fig. 5.5). These findings were in
complete concordance with those currently in the literature where there are no reports
of the occurrence of any intermediate between the monomeric and complete
multimeric forms of bfr. A second possibility was that one or more epitopes were
common to both proteins resulting in the recognition of clones encoding and
expressing bfr. Although the likelihood of shared epitopes was supported by the
recognition of clone ?Jl692/2 by one of five mabs raised against p40, the results of
serological cross-reactivity experiments using two different affinity-purified
antibodies strongly suggested that the two proteins were unrelated. Thirdly, it was
conceivable that the HPLC purified p40 used to immunise rabbits was not
homogeneously pure, but contaminated with other mycobacterial antigens at a level
below the sensitivity of the silver staining technique used to visualise purified
proteins resolved in polyacrylamide gels. The presence of such contaminants could
have resulted in the recipient rabbits mounting a humoral immune response to
antigens other than p40 and would explain why clones encoding bfr were isolated
from the library. This third possibility was supported by a complete lack of cross-
reactivity between the expression product of clone AJR696/1 and either p40 or the
recombinant bfr encoded by clones A.R692/1-4. In addition, the recognition of the
A.R696/1 fusion protein by two of four anti-hsp mabs suggested a possible
relationship between this clone and the hsp65 ofM.avium type A/I.
5.4.2 Further Immunoscreening of the Amplified Library Using Antiserum
Absorbed With M.a.paratuberculosis Cell Lysate
Further immunoscreening of the library with R696 antiserum, which had been pre-
absorbed with cell lysates of both E.coli host strain Y1090 and M.a.paratuberculosis
to remove extraneous anti-mycobacterial antibody, yielded a further fifteen
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expressing clones (A.R696/2-16). However, subsequent analysis revealed that all 15
clones contained an identical insert fragment to that of clone XR696/1 and encoded
the same putative hsp65 protein. It is likely that, for the purpose of antibody pre-
absorption, the in vitro grown M.a.paratuberculosis cells contained insufficient
quantities of hsp65 antigen to absorb all traces of anti-hsp65 immunoglobulin, as
they had not experienced either nutritional or physical stresses during their
propagation. Indeed, antibody affinity-purified on pGEX/696/2.3 GST/fusion
protein revealed small but demonstrable quantities of the corresponding cellular
protein, possibly hsp65, in lysates of cultured M.a.paratuberculosis cells (see Fig.
5.8a). This could explain why residual anti-hsp65 antibody had not been removed
from the antiserum during pre-absorption, and why clones encoding a hsp65 were so
readily isolated from the library.
5.4.3 Why Was the Immunoscreening Strategy Unsuccessful In Isolating p40
From Xgtll Expression Libraries?
A number of possible reasons can be put forward to explain why extensive
immunoscreening with high titre hyperimmune antisera was unsuccessful in
detecting clones encoding p40 in a genomic DNA expression library which was
perceived to be representative of the M. avium type A/I genome.
1. Is p40 expression toxic to phage or host cell propagation?
It is conceivable that the expression of p40 may be toxic to either phage or host cell
propagation resulting in the under-representation of these recombinants in an
amplified library. It is accepted that a level of inequality in the growth of A,gtl 1
recombinants persists even in the presence of the lacl repressor which represses
transcription from the p-gal promoter in the absence of IPTG (Huynh et al., 1984).
An effect of this "leakage" on amplified libraries is a bias towards non-toxic and
rapidly growing recombinants which multiply to high titres and tend to be over-
represented. With this in mind, a second A.gtl 1 library was prepared and
immunoscreened in its entirety without amplification. However, no clones encoding
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the p40 antigen were detected in the unamplified library. Therefore, based on the
assumption that the unamplified library represented the genome comprehensively,
the possibility of p40 toxicity cannot be ruled out. However, it seems unlikely that
all p40-derived peptides should be lethal to either host cell or phage propagation, and
alternative explanations must be considered also.
2, Could p40 codon usage be incompatible with isoaccepting tRNA population
profiles in E.coli host strain Y1090?
A second explanation might be drawn from differences in codon usage between
M.avium type A/I genes and those of the E.coli host strain Y1090 used while
screening the expression library. In the "wobble hypothesis" (Crick, 1966) it is
proposed that a single tRNA has the ability to respond to more than one codon. In
spite of this degeneracy in the genetic code however, it is generally accepted that
codon choices, particularly for certain amino acids, can be heavily biased and that the
choice of synonymous codons varies between different organisms (Grantham, 1980).
Such organism-specific codon preferences are related to the population profiles of the
isoaccepting tRNAs for individual species (Ikemura, 1985) and the correlation
between the usage frequency of particular codons and the relative abundance of their
respective tRNAs is especially evident for highly expressed genes, eg E.coli RNA
polymerase subunits, ribosomal proteins, the elongation factor EF-Tu, the recA
protein and a number ofmembrane proteins (Grosjean and Fiers, 1982).
Although the choice between synonymous codons does not affect the nature of the
protein synthesised, it will influence the translation efficiency ofmRNAs transcribed
from these genes (Ikemura, 1981). A high degree of codon bias has been reported for
mycobacterial genes (Dale and Patki, 1990) and a feature of this bias is the large
number of preferred codons which contain C or G in the third position (Table 5.2).
This bias is more pronounced amongst members of the MAC and M.tuberculosis
than it is in M. leprae, whose G+C content is markedly lower than those of other
mycobacteria, and whose codon usage is more akin to that of E.coli. It is reasonable
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to assume therefore that the population profiles of isoaccepting tRNAs will reflect
codon preference in M. avium type A/I and that highly expressed genes, as is the case
in E.coli, will exhibit a higher degree of codon bias than genes which are expressed
at a lower level. Given that p40 would appear to be present in relative abundance in
M. avium type A/I cell lysates (see Chapter 3), it is conceivable that, as a
mycobacterial gene which may be highly expressed in its natural environment, its
lacZ driven expression in E.coli may not be compatible with the isoaccepting tRNA
populations of the host cell and that rapid depletion of particular tRNA species
results in the early truncation of the foreign polypeptide. Alternatively, if low
concentrations of certain tRNAs force ribosomes to pause frequently at particular
codons during the translation of p40 messages, the downstream mRNA may be left
exposed and thus able to fold into secondary structures. At best, events such as this
would slow down translation considerably, but may even cause further transcription
of the gene to be aborted (Piatt and Bear, 1982).
3. Could post-translational modification of p40 result in masking of protein
epitopes?
A humoral immune response biased towards non-protein antigens, which may be
added to the p40 protein as post-translational modifications, offers a third possible
explanation. Although post-translational events are not yet well characterised in the
mycobacteria, both biotinylation (Henrikson and Allen, 1979; Collins et al., 1987;
Norman et al., 1994) and glycosylation (Fifis et al., 1991; Garbe et al., 1993; Lopez
et al., 1994; Dobos et al., 1995) of proteins have been reported. If, for example, the
p40 antigen exists as a heavily glycosylated globular protein, it is possible that
antibody raised against non-denatured p40 would be directed predominantly against
carbohydrate moieties and only weakly, or not at all, against protein epitopes masked
by non-protein antigens. As it is unlikely that post-translational glycosylation of a
mycobacterial protein would take place in an E.coli host cell, such an antibody might
not be capable of recognising clones expressing the protein component of the p40
molecule. However, a study conducted on the immunogenicity of the polysaccharide
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components of the thermostable macromolecular antigen (TMA) group of M. avium,
M.a.paratuberculosis and M.bovis presents evidence to oppose this argument. A
number of immunological laboratory procedures were used to demonstrate a
negligible immunogenicity of the glucans examined (that is, "the inability to
produce, upon injection, the synthesis of specific immunoglobulins") and the authors
concluded that the high immunogenicity of the TMA complex is attributable to
protein and not to carbohydrate (Bruneteau et al., 1992).
4. Could the M.avium type A/I genome have been under-represented in the
amplified library?
Firstly, at 8.5 x 104 pfu in total, the pre-amplification titre of the library was
considerably lower than those described previously (M.tuberculosis A,gtl 1 library at 4
x 106 pfu and M.leprae A,gtl 1 library at 2 x 106 pfu) (Young and Davis, 1985a and b).
Secondly, when factors including genome size, average insert size and percentage
recombinants are taken into consideration, the M. tuberculosis and M. leprae genomes
are represented -2560 and -1250 times respectively. Even allowing for the fact that
the M.avium type A/I library contained a higher percentage of recombinants (80%)
than either the M.tuberculosis (40%) or M.leprae (25%) libraries, the M.avium type
A/I genome was represented only -90 times. Thirdly, given that all the protein-
encoding sequences in the genome must be expressed if the library is to be truly
representative, it is essential that a large number of genomic DNA fragments, ideally
with endpoints which occur at random and at every base pair throughout the genome,
are used in the construction of an expression library (Young and Davis, 1985a and b).
The relationship between the average insert fragment size of a genomic DNA library
and the number of random endpoints attained is reciprocal, and total representation of
the protein-encoding regions will be favoured by a large number of smaller insert
fragments. Therefore, it is possible that 90 genomic representations, using insert
fragments with an average size of 4kb, is insufficient to ensure that all ORFs
contained within the genome are expressed.
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5.4.4 Why Was Screening the Amplified Library by DNA-Hybridisation
Unsuccessful in Detecting Clones Containing the p40 Gene?
Possible explanations as to why the DNA hybridisation screening strategy was
unsuccessful in identifying homologous sequences in the amplified library should be
considered under the separate headings of library related, and screening related
factors.
1. Library related factors
While leakage of a toxic expression product during amplification of the A,gtl 1 library
cannot be ruled out, the other arguments presented above cannot be used to explain
why end-labelled oligonucleotides did not detect clones encoding p40 by DNA
hybridisation. In contrast to an antibody, a nucleic acid probe does not rely on gene
expression and will detect its homologous target sequence in a library regardless of
insertional orientation or reading frame in the vector, and thereby offers a six times
greater chance of isolating clones of interest. Therefore, unlike an expression library,
which requires a large number of small insert fragments to ensure that all ORFs
contained within the genome are expressed (see above), a library intended for
screening by nucleic acid hybridisation need not be so comprehensively
representative. In this particular case, a library of ~90 genomic representations
should have been adequate for the purpose of screening with an end-labelled
oligonucleotide. However, it is of interest that, although clones expressing bfr and a
putative hsp65 antigen were isolated from the library (four and sixteen clones
respectively) by immunoscreening, in each case an identical clone was isolated
several times over. This was surprising given that the library was prepared from
randomly sheared genomic DNA fragments and it is clear that the amplified library
was heavily biased towards certain recombinants. In addition, in spite of the fact that
oligonucleotide M5018 was shown to hybridise to five different fragments on
Southern blots of EcoRI restricted genomic DNA (see Fig. 5.14), no recombinants
containing these homologous sequences were recognised in the amplified Xgtl 1
library. Based on the assumption that the amplified library contained ~90 genomic
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representations, it is reasonable to expect that screening with the same
oligonucleotide would have identified the same five genomic sequences recognised
on Southern blots. These points suggest that the library may have been under-
representative of the M. avium type A/I genome and sub-optimal for the purposes of
screening with either immune- or nucleic acid-based probes.
2. Screening related factors
The oligonucleotides used to screen the library were deduced from small stretches of
p40-derived amino-terminal and internal amino acid sequence. Consequently, a
considerable degree of redundancy at the third position of certain codons had to be
allowed for (see Fig. 5.13). In addition, G+C rich oligonucleotides of only 21bp in
length with built in degeneracy were not considered ideal for the purpose of
screening a genome which has itself been estimated to be inherently G+C rich at
-65%. It is conceivable therefore, that oligonucleotide M5018 shared greater levels
of homology with certain other genomic sequences (see Fig. 5.20) than with its
intended p40 target sequence which remains unknown at this time.
5.4.5 Why Did Attempts to PCR-Amplify p40 Gene Sequences From Genomic
DNA Yield No Detectable Products?
Degenerate oligonucleotides have been used in combination with PCR to amplify
entire or partial gene sequences from genomic DNA. In many cases, such as the
response regulator genes phoB, phoP and creB of Yersinia spp., Campylobacter
jejuni, Listeria monocytogenes, M. tuberculosis and E.coli (Wren et al., 1992); the
amikacin-resistance "aac(6')-1 genes" of Acinetobacter spp. (Ploy et al., 1994); and
the flagellum protein gene "fill" of Legionella pneumophila (Merriam et al., 1997),
the target genes are highly conserved and related sequences are accessible in gene
and protein databases. In such situations the design of oligonucleotide primers for
the amplification of specific target sequences is facilitated by pre-existing nucleotide
sequence data on related genes. However, primer design is more difficult where no
related gene sequences are available, and the only available sequence information is a
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limited amount of aa sequence data obtained by Edman degradation of a purified
protein. Nevertheless, oligonucleotide primers deduced from aa sequences have been
used successfully to amplify a portion of the gene encoding the MMPII
bacterioferritin subunit of M. leprae (Pessolani et al., 1994); a novel 23kDa in vivo-
expressed protein of Francisella tularensis (Golovliov et al., 1997); and the heat
shock proteins chaperone-10 (Cpn-10) and Cpn-60 of the groE operon of Francisella
tularensis (Ericsson et al., 1997). This "reverse genetics" approach was applied to
the p40 gene using a MAC-derived codon usage table and pairs of degenerate
oligonucleotides, deduced from p40 aa sequences, as forward and reverse primers.
However no PCR products, either in the predicted size range or which could be
identified by hybridisation using a putative interior oligonucleotide, were detected.
1. Oligonucleotide primer design and related factors
Working within the constraints imposed by limited aa sequence, where most residues
were encoded by more than one codon, necessitated a degree of degeneracy in
oligonucleotide design. All four oligonucleotides were designed to meet a number of
criteria. Each had to be a minimum of 20bp in length, be derived from a stretch of
seven aa residues exhibiting the highest degree of codon preference possible, include
a 3' G/C clamp for the purpose of PCR and display little or no complementarity. No
attempt was made to pre-determine Tm. Working within these constraints required a
degree of compromise however. For example, selecting a stretch of seven
contiguous aa residues with the highest possible codon bias did not automatically
yield an oligonucleotide with a 3' G/C clamp which also could be guaranteed not to
fold back on itself. Ultimately, of the four resulting oligonucleotides, whether "best
guess" or degenerate, each represented a compromise relative to the set criteria. In
addition, the Tm of individual oligonucleotides was observed to range from 59.6° to
74°C in 1M NaCl, a level of disparity which required that PCR annealing
temperatures were adjusted in favour of the primer with the lower Tm. In turn, this
allowed the primer with the higher Tm to anneal to the genomic template non-
specifically and resulted in the amplification ofmultiple areas of the genome.
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2. Presumption of PCR priming sites based on CNBr cleavage of p40
For the purpose of amplifying the 5' end of the p40 gene by PCR, the presumed
priming sites of forward and reverse primers were based on a hypothetical CNBr
cleavage map of purified p40 (see Fig. 5.12c). Logically, the oligonucleotides
derived from the amino-terminal aa sequence were designed as forward primers and
those derived from internal aa sequences as reverse primers. Although the proposed
CNBr cleavage map can be rationalised, it remains hypothetical and the presumed
positions of the two internal aa sequences cannot be guaranteed. This raises the
possibility that the target sequence was successfully amplified but that the specific
amplified product was not identified by the chosen screening strategies. If the p31-
derived oligonucleotide (M5806) used for screening was not interior to the amplified
region of the p40 gene as presumed, but exterior, then neither hemi-nested PCR nor
DNA hybridisation would have detected the product of the first round amplification.
3. Could a lack of co-linearity between the gene encoding p40 and the mature
protein have resulted in the inappropriate selection of PCR priming sites?
Protein splicing has been shown to occur in the post-translational processing of the
RecA proteins of Mycobacterium tuberculosis (Davis et al, 1992) and
Mycobacterium leprae (Davis et al, 1994) as well as in a number of other unrelated
gene products of such phylogenetically diverse species as Saccharomyces cerevisiae
(Hirata et al., 1990; Kane et al., 1990), Thermococcus litoralis (Perler et al., 1992;
Hodges et al., 1992), Candida tropicalis (Gu et al., 1993) and Pyrococcus spp.strain
GB-D (Xu et al., 1993). More recently, a second mycobacterial protein splicing
event has been reported to occur in the DNA gyrase A-subunit of Mycobacterium
leprae and some, but not all, strains of M.flavescens, M.gordonae and M.kansasii
(Fsihi et al., 1996). It is conceivable therefore, that protein splicing may be more
widespread amongst the mycobacteria than at first thought, and the possibility that
the p40 antigen might be processed in this way merits consideration.
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In a post-translational modification analogous to the removal of an intron from
mRNA, protein splicing involves the precise excision of an embedded in-frame
internal protein sequence (intein) from a larger precursor polypeptide and the ligation
of the flanking amino- and carboxy-terminal sequences (exteins) to yield a
functionally active mature protein. Protein splicing demonstrates that the aa
sequence of a protein need not be co-linear with the encoding gene, the mRNA
transcript or the primary translation product and that the regions of the gene which
encode the mature protein can be more widely separated than could be predicted
from the M.wt of the protein alone. Therefore, given that the reverse primers were
deduced from two internal aa sequences of the p40 antigen, it is conceivable that one
or both of these are internal to the carboxy-terminal extein of the mature protein.
This being the case, premature termination of any PCR using either of these reverse
primers, in conjunction with an amino-terminus deduced forward primer, may be the
consequential result of the additional distance imposed by the intervening region of
the gene encoding the spliced intein. Alternatively, a successfully amplified product
would not have fallen into the predicted size range and may have been overlooked as
one of a number of non-specific amplified products. Finally and as mentioned above,
even if a p40 specific gene product had been successfully amplified, it would not
have been recognised by either DNA hybridisation or hemi-nested PCR if the third
oligonucleotide was exterior to the amplified region of the gene.
5.4.6 Cloning and Nucleotide Sequencing of Genomic .EcoRI Fragments Which
Hybridised With Oligonucleotide M5018
Attempts to clone genomic DNA restriction fragments recovered from LMP agarose
gels were unsuccessful in comparison with attempts to clone the same fragments
purified on sucrose density gradients. This reflects the difference in quality between
agarose and sucrose recovered DNA, where, for the purposes of ligation, sucrose
purified DNA was shown to be superior. DNA recovered from agarose was used
successfully where large numbers of a single fragment, eg. an insert fragment excised
from a recombinant plasmid, were extracted for the purpose of subcloning into an
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alternative cloning vehicle. Transformation efficiencies were generally low but
could not be attributed to low quality competent cells. However, because all the
DNA fragments were identical, very few transformants were required to ensure that
one containing a correctly orientated fragment was obtained. Much higher ligation
efficiencies were required for shotgun cloning restriction fragments into plasmids
however. In this study, two sucrose density gradient fractions containing a broad
range of fragment sizes were used to target EcoRI fragments of ~5.2kb, 4.5kb, 4.0kb,
3.7kb and 450bp. All five fragments were cloned at the first attempt and sequenced,
either partially or completely, in order to determine the level of homology each
shared with oligonucleotide M5018. "Bestfit" analyses revealed that the reason why
oligonucleotide M5018 failed to prime sequencing reactions on clones pGEX3/14
(~5.2kb fragment) and pGEX42/70 (~4.5kb fragment) was poor homology at the 3'
end of the primer. Comparative analysis of the sequence data generated showed that
none of the homologous regions on any of the five clones provided an identical
match (see Fig 5.20), with identity and similarity values ranging between 52.4%-
76.2% and 61.9%-90.5% respectively (see Table 5.6). Translations across the
M5018 recognition site and flanking regions of all five clones yielded aa sequences
exhibiting varying levels of identity with the original p28 amino-terminus (see Fig
5.21). Over the seven contiguous residues from which oligonucleotide M5018 was
deduced, the observed levels of identity ranged between a single mismatch
(pGEX22/41) and three full matches plus two conservative substitutions (pUCl/28).
Over the flanking regions however, no significant identity could be demonstrated
between any one of the five translations and the 14 amino-terminal aa residues of the
p28 CNBr cleavage peptide. It was clear that none of the five cloned genomic EcoRI
fragments identified by oligonucleotide M5018 contained the gene encoding the p40
antigen.
Given that oligonucleotide M5018 identified five similar sequences in M.avium type
A/I genomic DNA, translations of which exhibited significant levels of identity with
the original p28-derived seven aa residue template, it is surprising that the intended
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p40 target sequence was not identified also. While the absence of ambiguities in the
readings obtained from Edman degradation of the p28 effectively precluded the
possibility of an incorrect aa sequence (Barker, pers. comm.), it is conceivable that
the codon preference of the p40 gene was inconsistent with the table used to design
the four oligonucleotides. If this was indeed the case, then the identification of five
similar sequences could be attributed to a combination of degeneracy, high G+C
content and the likelihood that oligonucleotide M5018 shares greater homology with
other genomic sequences than with the intended p40 target sequence.
5.4.7 Uncovered Areas
While hybridising each of the four p40-derived oligonucleotides to Southern blots of
EcoRI digested genomic DNA, a single fragment of ~20kb was identified by the non-
degenerate or "best guess" oligonucleotide Z196 (see Table 5.4). The 20kb fragment
remained visible by autoradiography at a washing stringency of 1 x SSC/0.1% SDS
at 60°C, but not at 65°C. Although attractive in that it was the only hybridising
band on a Southern blot of total M.avium type A/I genomic DNA, the 20kb fragment
was overlooked in favour of the five smaller EcoRl fragments identified by
oligonucleotide M5018 for a number of reasons. Firstly, the degenerate
oligonucleotide M5805, which was derived from the same seven amino terminal aa
residues as Z196, did not recognise the 20kb fragment even at lower washing
stringencies. This observation reduced the likelihood that the apparent homology
between Z196 and the 20kb fragment was absolute. Secondly, oligonucleotide
M5018 remained hybridised to each of its five homologous EcoRI fragments at a
stringency 5°C higher than Z196 and the 20kb fragment. This observation indicated
that the degree of homology between M5018 and each of the homologous sequences
was greater, and therefore more attractive, than the association between Z196 and the
20kb fragment. Thirdly, at 20kb, the Z196 homologous fragment was too large to
shotgun-clone into a convenient plasmid vector. However, this problem could have
been overcome by shotgun-cloning into the phage lambda vector EMBL3, and
screening plaque lifts of recombinant phage with end-labelled Z196 in the same
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manner described for screening the amplified ^gtl 1 library (section 5.2.2, Method 1.,
subsection 8.).
It is not inconceivable that the 20kb EcoRl fragment may still hold the key to the p40
gene, and any future work in this area would almost certainly have to eliminate this




The work covered in this thesis focuses primarily on a novel protein of 40kDa (p40)
identified in IS901/902-positive strains of M. avium, but not in M.a.paratuberculosis
or in any of 13 other species of Mycobacterium examined. Soluble p40 antigen was
purified to homogeneity, using a series of chromatographic separations, and used
subsequently to generate both polyclonal and monoclonal immune reagents. In vitro
stimulation of ovine T-cells demonstrated that the p40 is an M. avium type A/I-
specific immunological marker which can be used to distinguish between animals
infected with M.avium type A/I or M.a.paratuberculosis. The p40 is therefore the
first entire protein molecule to be identified in a pathogenic member of the MAC
which has subspecies specificity and the potential to form the basis of a diagnostic
immunoassay. As such, the p40 merited further study, and experiments were
undertaken to clone and characterise the encoding gene. However, in spite of many
attempts using a number of different cloning and screening strategies, all efforts to
clone the p40 from M. avium type A/I genomic DNA were unsuccessful, and several
important questions remain unanswered.
6.1 Why was p40 not cloned?
Of the questions left unanswered the first of these is why all attempts to clone the
p40 gene in Agt 11 proved unsuccessful, and these include an independent attempt to
isolate the gene from a further A,gtl 1 expression library by immunoscreening with
mabs raised against HPLC-purified p40 (Ahrens, pers. comm.). Possible
explanations including expression product toxicity, codon incompatibility, post-
translational modification and under-representation of the M. avium type A/I genome
already have been covered in the preceding chapter, but none of these explain why
translations of all five genomic EcoKl restriction fragments, identified by
oligonucleotide M5018, lacked overall sequence identity with p40 internal amino
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acid sequence data. Following the lines of currently accepted dogma, it can be
assumed that where a protein is expressed there must also be a gene encoding that
protein. The gene in question may be located on the chromosome of the organism, or
on an autonomously replicating genetic element such as a plasmid, insertion
sequence or transposon. Whichever of these applies in the case ofM. avium type A/I
and p40, the method of total nucleic acid extraction and purification used to prepare
DNA was the same for both library construction and genomic Southern blotting.
Theoretically, all cellular nucleic acid, including plasmid DNA, is pelleted through a
CsCl cushion following cell disruption. Cellular RNA is removed selectively by
digestion with ribonuclease A and the resulting DNA preparation should contain all
cellular DNA species. It is therefore difficult to reason why a fragment containing
the p40 gene was not identified on Southern blots by oligonucleotide M5018 along
with the other five EcoR\ fragments recognised. However, it could be argued that
p40 might be encoded by a gene present on a very low copy-number plasmid, and
that its low concentration, relative to the chromosomal DNA, is not detectable on
Southern blots using an end-labelled oligonucleotide probe. Alternatively, the
nucleotide sequence of oligonucleotide M5018 may have been deduced inaccurately
from internal p40 amino acid sequence relative to actual p40 codon usage.
Consequently, it is possible that M5018 may hybridise preferentially to sequences
which are not actually related to the p40 gene. Indeed, oligonucleotide M5018 was
observed to hybridise to many more genomic fragments at lower stringency washes,
but only to the five cloned and sequenced here at 65°C in 1 x SSC. Further amino
acid sequence data on the p40 antigen would provide templates for a wider range of
"best guess" and degenerate oligonucleotides which could be used to highlight and
confirm the identity of restriction fragments on Southern blots of genomic DNA. If
for example, a genomic DNA fragment could be identified which hybridised with
two or more oligonucleotides deduced from different internal amino acid sequences,
the techniques and cloning strategy described in this thesis could be usefully applied
to its isolation and characterisation.
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6.2 What Is The Nature of The Apparent Association Between p40 and The
Genomic Insertion Element IS901/902?
The expression of the p40 antigen appears to be inextricably linked to the presence of
IS901/902 in M.avium type A/I. However, translations of the insertion element in all
six reading frames did not yield amino acid sequences which bore any resemblance
to the amino terminal or internal amino acid sequences obtained for the p40 antigen.
Therefore, the relationship between the insertion element and the protein cannot be
direct, and the precise nature of their close association remains to be elucidated. One
possibility is that the p40 gene exists in a repressed state and under the control of a
gene encoding a repressor protein in IS901/902-negative strains ofM.avium. Given
that genomic insertion of IS901/902 is site-specific, it is conceivable that one copy of
the insertion element may recognise an insertion site within the repressor gene.
Insertion of IS901/902 at this site would disrupt expression of the repressor protein,
which would in turn up-regulate expression of the p40 antigen. The effects of
knocking out one gene and activating another may manifest themselves
phenotypically and could alter the pathogenic potential of the organism. For
example, it has been demonstrated that strains of M.avium type A/I are more virulent
than strains of M.avium type A when inoculated into BALB/c mice (Kunze et al.,
1991; Pedrosa et al., 1994). The authors associated the observed increase in
virulence with the presence of the IS901/902 in M.avium type A/I strains, but did not
address differences between the two types ofM.avium at the polypeptide level. It is
conceivable therefore that unrepressed expression of p40 may be partly responsible
for the greater virulence observed in strains ofM.avium type A/I.
The likelihood of such a repressor mechanism existing in M.avium type A/I is given
credence by recent observations in M.a.paratuberculosis. Studies on the genomic
regions flanking IS900 insertion have revealed that a gene of ~12kDa is disrupted by
a copy of IS900 (Tizard, pers. comm.). Whilst there is no direct evidence that this
12kDa protein has any repressor function, the size of the molecule and limited amino
acid sequence identity are apparently consistent with those of other such molecules.
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Clearly, if IS900 insertion has indeed inactivated the expression of a putative
repressor molecule, its effect on the phenotype of M.a.paratuberculosis does not
include expression of p40. However, as the respective recognition sequences of
IS900 and IS901/902 are not identical, it is possible that the p40 gene may be present
in M.a.paratuberculosis and the other members of the MAC, but maintained in a
repressed state in the absence of IS901/902. Unfortunately, the lack of success in
cloning and characterising the p40 gene precluded any opportunity to assess its
distribution within the members of the MAC, and among more distantly related
species ofMycobacterium.
6.3 Is The p40 Gene Widely Distributed Throughout The Members of The
Genus Mycobacterium, and Is Expression Repressed In Species Other Than
IS901/902-Positive Strains ofM.aviuml
Western immunoblotting analysis showed that, of the 15 species of in vitro-grown
Mycobacterium examined, only IS901/902-positive strains ofM. avium expressed p40
in detectable quantities (see Table 3.1 and Fig. 3.14a,b&c). However, it is not
inconceivable that homologous genes may be present, but silent, in other species of
Mycobacterium. If p40-like genes are indeed present in other species, it would be of
interest to establish whether they are maintained in a repressed state, and under what
environmental conditions their expression might be induced. In addition, if future
studies on IS901/902 flanking sequences reveal putative repressor gene disruption, it
would be of interest to ascertain whether reconstruction of the gene in an expression
plasmid could restore repression of p40 expression in M. avium type A/I
transformants. If successful, such transformants could be used to assess the effect of
p40 repression on the virulence of M. avium type A/I strains in BALB/c mice.
However, given that IS901/902 is a mobile genetic element, it is not inconceivable
that a copy of the insertion sequence may insert into the vacant site on the
reconstructed gene, and care would have to be exercised in monitoring any
transformant for reversion to the p40 phenotype.
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6.4 Alternative Cloning Strategies
Given that all attempts to clone the p40 gene in an E.coli-based expression system
were unsuccessful, the future realisation of that objective will necessitate the
consideration of alternative cloning strategies. Cloning and expression in a
mycobacterial cell such as M.smegmatis could eliminate many of the potential
problems associated with expression in E.coli. Cloning in M.smegmatis already has
been successfully applied to isolating and characterising ser2, a gene cluster
responsible for the biosynthesis of the oligosaccharide segment of the M. avium
serovar 2-specific GPL (Belisle et al., 1991 and 1993). This was achieved by
constructing a M. avium serovar 2 (strain TMC 724) genomic DNA library in the
E.coli-Mycobacterium shuttle cosmid pYUB18, and immunoscreening M.smegmatis
transformants for expression of the ^er2-specific GPL with the serovar 2-specific
mab CS-17. Interestingly, work carried out at the MRI demonstrated that strain
TMC 724 was positive for both IS901/902 and p40 (Sharp, pers. comm.). It would
be interesting and potentially valuable to screen this M. avium serovar 2 library for
expression of p40 with the immune reagents generated in this study.
Cloning genes from one species of Mycobacterium in another offers a number of
advantages. Firstly, codon usage is more likely to be compatible between two
species belonging to the same genus than between genera as distantly related as
Mycobacterium and E.coli. This would circumvent the problem of rapid tRNA
depletion and early truncation of peptides relying on tRNA species which may be
rare in E.coli. Secondly, post-translational modifications such as glycosylation (Fifis
et al., 1991; Garbe et al., 1993; Lopez et al., 1994; Dobos et al., 1995), biotinylation
(Henrikson and Allen, 1979; Collins et al., 1987; Norman et al., 1994) and protein
splicing (Davis et al, 1992 and 1994; Fsihi et al., 1996) would be more likely to
occur in a mycobacterial host cell than in E.coli where these events have not been
reported. Thirdly and finally, expression of p40 would be less likely to exert any
toxic effects in a mycobacterial host cell. Consequently, and given that the immune
reagents generated during this study were not observed to cross-react with any other
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antigen in M.smegmatis, successful expression of p40 could be detected easily in
lysates ofmycobacterial transformants.
A second alternative cloning strategy is offered by phage display. This technique
entails the expression and display of a foreign peptide, as a fusion with a viral capsid
protein, on the surface of the phage particle. The first phage vectors designed for
surface display were filamentous phages (Scott and Smith, 1990), but a more
versatile system based on the T7 phage has since been developed for the same
purpose (Rosenberg et al., 1997). Traditionally, phage display has been used to
create libraries of short peptides (~6 amino acid residues), which have been used to
help identify cell receptor molecules, enzyme active sites, enzyme inhibitors,
antibody binding sites and linear epitopes of various antigens (O'Neil and Hoess,
1995). However, 415 copies of a foreign peptide of up to 50 aa in length can be
expressed and displayed on the surface of the T7 phage, a number which corresponds
to the total number of capsomeric fusions per recombinant virion. This provides both
a useful source of the peptide of interest, and up to 150bp of nucleotide sequence of
the encoding gene. The phage vector relies on E.coli as a host cell and would not
totally overcome the problem of rare tRNA species. However, the short length of the
expressed peptides would reduce the likelihood of both early tRNA depletion and
expression product toxicity.
6.5 Immunoprophylactic Potential of p40
As a unique antigen of an organism known to cause a paratuberculosis-like disease in
ruminants, the p40 antigen merits consideration as a potential component of any
future subunit paratuberculosis vaccine. This would necessitate assessing the
immunoprophylactic potential of the p40 antigen in combination with different
adjuvants and delivery systems. Preliminary results of immunisation experiments
have not been encouraging however. Vaccination of BALB/c mice with p40 in
incomplete Freund's adjuvant failed to impede bacterial proliferation upon
subsequent intravenous challenge with live M.avium type A/I (Inglis et al., 1994a).
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No significant reductions in the numbers of organisms recovered from the spleens
and livers of immunised and placebo mice were observed. Similarly, vaccination
with p40 in combination with the adjuvant dimethyl dioctadecyl ammonium bromide
(DDA) was ineffective in eliciting protective CMI (Inglis, unpublished observations).
However, techniques for presenting defined mycobacterial antigens to the murine
immune system have been described which stimulate protective CMI responses
comparable with those afforded by vaccination with BCG (Andersen, 1994; Silva
and Lowrie, 1994). The success of those experiments serves to illustrate the point
that antigens identified as potential vaccine components must be delivered and
presented to the immune system appropriately if their true immunoprophylactic value
is to be accurately assessed. Such work needs to be repeated with the p40 antigen.
6.6 Are Strains of IS901/902-Positive M.avium of Major Aetiological
Significance in Ruminant Paratuberculosis?
There is currently no information in the scientific literature which apportions
responsibility for the total number of clinical paratuberculosis cases recorded each
year, between M.a.paratuberculosis and M.avium type A/I. This is primarily because
reagents enabling simple, rapid and accurate immunodiagnoses have not been
generally available. Even among the few potentially subspecies-specific antigens
identified to date, the carboxyl terminus on the 34kDa antigen of
M.a.paratuberculosis (De Kesel et al., 1993; Vannuffel el al., 1994a) does not
stimulate in vitro secondary T-lymphocyte proliferation in its recombinant form, and
is therefore of no value in detecting early stage infections (Burrells and Stevenson,
pers. comm.). The p40 antigen is the first entire protein molecule to show
subspecies-specificity within the MAC, and as such provides the means to
distinguish between animals infected with M.avium type A/I or
M.a.paratuberculosis, even in the early stages of infection when circulating antibody
is absent. Consequently, it is conceivable that the aetiology of clinical
paratuberculosis, especially in species such as deer and goats, may require re-
evaluation.
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6.7 Identification ofFurther Subspecies-Specific Antigens: The Future
Both antigenic complexity and close relatedness between the members of the MAC
have made the task of identifying subspecies-specific proteins arduous. In addition,
further difficulties in the identification, purification and analysis of candidate
antigens arise from the complexing of many mycobacterial protein antigens with
other biomolecules to form insoluble cell wall components. However, recent
developments in the comprehensive analysis of protein expression "proteome
analysis" may offer a means by which subspecies-specific proteins of two or more
antigenically similar organisms can be readily identified (Pennington et al., 1997).
The proteome can be regarded as a comprehensive expression profile of all the
protein encoding sequences in the genome of a given organism. There are two
phases to proteome analysis. First, all the proteins expressed by a given organism
under defined conditions are identified and mapped to positions on a standardised
two-dimensional (2-D) gel format. This defines the constitutive proteome, and the
information generated can be used to produce a 2-D reference map and protein
database for the organism in question. There are several 2-D reference maps and
protein databases already available and these are accessible through the world wide
web and internet (see Pennington et al., 1997). The 2-D reference maps serve as the
foundation on which differences between closely related organisms can be
established at the level of protein expression. The second phase of proteome analysis
involves measuring both qualitative and quantitative changes in the proteome of an
organism in response to alterations in environmental conditions. An example of this
would be the comparative analysis of the proteomes of organisms grown on
laboratory media, and those recovered from macrophages of an infected host.
Alternatively, comparative proteome analysis of pathogenic and non-pathogenic
bacterial strains, e.g. M.tuberculosis and M.bovis BCG, may provide new
information leading towards the elucidation of bacterial virulence mechanisms. This
type of comprehensive expression product analysis allows the identification of
antigens which are selectively expressed under different sets of conditions, the
occurrence of, and changes in, post-translational modification events and even
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changes in subcellular localisation of proteins where appropriate cellular
fractionation has been performed prior to analysis.
In the longer term, it is anticipated that the 2-D reference maps and protein sequence
databases will become integrated with genome sequence databases. Once fully
developed, such an integrated system should provide a direct link from an
unidentified spot on a 2-D gel to a full nucleotide sequence of the corresponding
gene and positive identification of the protein in question. Protein identification at
this level will revolutionise the search for new species- and subspecies-specific
mycobacterial proteins, and the identification of candidate antigens for the diagnosis
and effective immunoprophylaxis of paratuberculosis may be on the horizon after
more than a century since the disease was first described.
6.8 Addendum
6.8.1 Identification of a p40 homologue
Prior to the submission of this thesis, a final search of the OWL database was
performed to check recent submissions for aa sequences related to the p40-derived
CNBr cleavage peptides. This last database search revealed two cosmid clones
(M. tuberculosis MTCY8D5 and M.leprae MLCL622), both ofwhich contain positive
strand ORFs encoding similar proteins of 337 and 339 aa residues respectively
(~38.5kDa). The M.tuberculosis protein, for which no identity or biological function
has been proposed, is encoded by ORF 11 which is located between positions 13842-
14855 on cosmid MTCY8D5 (OWL accession number Z92669). The M.leprae
protein has been identified as a putative phosphoenolpyruvate carboxykinase
(PEPCK), and is encoded by ORF 22 on cosmid MLCL622 between positions
31504-32523 (OWL accession number Z95398).
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6.8.2 Alignment of p40-derived peptides with the M.tuberculosis and M.leprae
ORFs supports the hypothetical CNBr cleavage map of p40
Significantly, the p40 amino-terminal aa sequence and both the p31 - and p28-derived
internal aa sequences were shown to share identity with the translated ORFs in a
pattern which corroborated the hypothetical CNBr cleavage map of p40 proposed in
the previous chapter (see Figs. 5.12 and 6.1). The p40 amino terminal aa sequence
was shown to share 72% (13/18) identity and 77% (14/i8) similarity across 18 amino
terminal aa residues of the M.tuberculosis hypothetical protein, and 70% (14/20)
18
identity and 90% ( /20) similarity across 20 residues of the M.leprae putative
12PEPCK. The p31-derived internal aa sequence was shown to share 63% ( /19)
identity and 73% (14/i9) similarity across 19 aa residues of the M.tuberculosis protein,
12 13and 63% ( /19) identity and 68% ( /19) similarity across the same 19 aa residues of
the M.leprae protein. Whilst identity and similarity values were observed to be
lower for the p28-derived internal sequence, there was visible overlap between the
carboxyl terminus of the p31, and the amino terminus of the p28 CNBr cleavage
fragments. However, even though the area covered by the overlapping region was
conserved between all three proteins, the absence of a methionine residue at the
carboxyl terminus of the p31, and immediately preceding the amino terminus of the
p28, indicates that the overlap between the two peptides may not be authentic. Even
so, it is conceivable that the conserved methionine at position 156 on both
M.tuberculosis and M.leprae proteins is slightly displaced on p40, and that the p31
and p28 peptides represent genuine contiguous sequences.
On the basis of the alignment shown in Fig. 6.1, it was calculated that CNBr cleavage
peptides spanning positions 1-138, 139-156 and 157-340 would have respective
M.wts of ~15.6kDa, ~2kDa and ~20.8kDa (~38.4kDa). These values compare with
~12kDa, ~3kDa and ~28kDa (~43kDa) as proposed in Fig. 5.12. Such a favourable
comparison supports not only the hypothetical cleavage map of p40, but also the
PCR strategy used in terms of priming positions relative to the gene. In turn, this






































Fig 6.1 Multiple alignment showing sequence identity between p40-derived amino
acid sequences (p40, p31 and p28) and translations of ORFs contained within
M.tuberculosis cosmid MTCY8D5 (M.tb)and cosmid MLCL622 (M.lep).
Amino acids highlighted in bold represent residues which are conserved between
all three proteins. Methionine residues, highlighted in red, represent CNBr
cleavage sites.
211
in reactions using lower annealing temperatures, but not detected subsequently.
Given that this was indeed the case, it must be assumed that the internal p31 -derived
degenerate oligonucleotide, M5806, was either inaccurately deduced from the
available aa sequence data and codon usage table, or too degenerate to detect specific
amplified product by either hemi-nested PCR, or by hybridisation with Southern
blots of first-round amplification products. Alternatively, given that the p28-derived
oligonucleotide, M5018, was observed to hybridise preferentially to genomic
sequences other than the p40 gene, especially at low stringencies, it could be argued
that first round amplifications using this particular primer had only a limited chance
of success. In this event, screening with a third oligonucleotide, presumed to be
internal to a first round amplification product, could not have been expected to detect
a sequence of interest.
6.8.3 Distribution and expression of the p40 homologue within the genus
Mycobacterium
Clearly, a p40-related gene is present in M.tuberculosis and M.leprae, and this fact
provides reason to believe that similar sequences may be present in other species of
Mycobacterium also. In this study however, 15 different species of Mycobacterium
were examined, including M.tuberculosis and M.leprae, but only IS901/902-positive
strains of M.avium could be shown to express p40. Unless the related genes are
silent in other species when propagated in vitro, or expressed at a level which cannot
be detected by the immune reagents generated in this study, expression of a p40-like
protein was not apparent in any of the 14 other species tested. Whilst it is
conceivable that the p40-related gene may be expressed in vivo by other species of
Mycobacterium, the data presented in chapter 4 demonstrate that p40-specific T-cell
responses can be used to distinguish between one group of sheep infected with
IS901/902-positive M. avium, and a second group infected with its closest relative,
M.a.paratuberculosis. Given the close similarity shared by these two organisms, it
seems more likely that M.a.paratuberculosis, or the other members of the MAC,
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would express a p40 homologue than species which are phylogenetically more
distant.
6.8.4 Elucidation of the association between p40 and IS901/902
Unfortunately, the identification of a p40 homologue in other species of
Mycobacterium does not provide any information to help elucidate the nature of the
apparent association between p40 and IS901/902. A first step towards that goal will
require the cloning and sequencing of the flanking regions of every IS901/902
insertion site in the M.avium type A/I genome. Characterisation of these regions and
identification of disrupted genes may provide vital clues, especially if the disrupted
repressor gene theory, referred to earlier (see section 6.2), is proven correct. The
recent proposal to sequence the M. avium genome in its entirety will not only
complement the existing M.tuberculosis and M.leprae genome projects, but in the
absence of any independent attempt to characterise IS901/902 flanking regions, will
provide all the information necessary to perform such an analysis. However, since
IS901/902-positive strains ofM.avium do not appear to be of medical importance, it
is more likely that the strain chosen for genomic sequencing will be of human origin
and most probably an AIDS associated isolate.
6.8.5 Is p40 a phosphoenolpyruvate carboxykinase?
The translation product of the M.leprae p40-homologous gene has been identified as
a putative PEPCK. PEPCK is an enzyme which catalyses the decarboxylation and
mononucleotide-dependent phosphorylation of oxaloacetate (OAA) to form
phosphoenolpyruvate (PEP). This conversion forms part of the gluconeogenic
pathway in organisms across the phylogenic spectrum, and represents the second step
in a biosynthetic pathway which synthesises glucose from non-carbohydrate
precursor molecules such as lactate, pyruvate, citric acid cycle intermediates, most
amino acids, and HC03". In bacteria such as E.coli, PEPCK is utilised during
gluconeogenic growth at times when sugar levels are low (Goldie and Sanwal,
1980a). Traditionally, PEPCKs have been divided into two groups based on their
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mononucleotide-specificity, with the ATP-dependent enzymes found in prokaryotes,
yeasts, Trypanomastid parasites and plants, and the GTP-dependent PEPCKs in a
wide variety of other eukaryotes and mammals (Utter and Kolanbrander, 1972).
Whilst performing the same biological function, there are important differences and
similarities between ATP- and GTP-dependent PEPCKs. With the exception of
bacterial PEPCKs, which are monomeric (Goldie and Sanwal, 1980b), the ATP-
dependent enzymes are predominantly multimeric, with two, four, or six subunits per
enzyme. Conversely, all known GTP-dependent PEPCKs, are monomeric (Matte et
al., 1997). Although enzymes of either class show significant (40-80%) aa sequence
identity within their respective divisions, there is no overall sequence homology
between the ATP- and GTP-dependent PEPCKs. However, both groups of enzymes
contain similar mononucleotide and OAA binding consensus motifs which are
thought to be involved in substrate binding.
There are three conserved regions, within the ATP-dependent PEPCKs, including
2+those of E.coli and S. aureus, which are known to interact with ATP-Mg (Matte et
al., 1997). The first of these is the "Kinase-la" sequence (GLSGTGKT) which
interacts with the phosphoryl oxygen of ATP through electrostatic interactions and
hydrogen bonds. The second conserved region is the "Kinase 2" sequence (LIGDD)
. fm . . 2+whose specific function is the binding of the Mg cation. The third, "Adenine-
binding region", is not as highly conserved as the Kinase la and Kinase 2 sequences
(RISIKDT in E.coli, and RISLHYT in S.aureus), and is involved in interactions with
the adenine base and ribose sugar. A fourth conserved sequence, the "PEPCK-
specific domain", (GTWYGGEMKK in E.coli, and GTEYAGEMKK in S.aureus) is
thought to form part of the PEPCK active site (Matte et al., 1996). Despite the
highly conserved nature of these PEPCK sequences, "best fit" comparisons with the
M. tuberculosis and M. leprae ORFs revealed no significant aa sequence identity. The
presumed identity of the M. leprae protein is therefore open to question. It is
surprising, given the level of sequence identity shared between the M.tuberculosis
and M.leprae proteins, that only the latter was identified as a putative PEPCK. In
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addition, at ~38.5kDa, the M.leprae protein is considerably smaller than other
bacterial PEPCKs which have been reported in Escherichia coli K-12 (~60kDa)
(Medina et al., 1990), Rhizobium NGR234 (58.4kDa) (Osteras et al., 1991),
Staphylococcus aureus (~59kDa) (Scovill et al., 1996), Anaerobiospirillum
succiniciproducens (58.7kDa) (Laivenieks et al., 1997) and Ruminococcus
flavefaciens (66.3kDa) (Schocke and Weimer, 1997).
The possibility that p40 may function as a PEPCK raises new questions regarding its
subspecies-specificity. Within the context of "housekeeping proteins", it is difficult
to perceive how such a ubiquitous enzyme could exist in an antigenically distinct
isoform in IS901/902-positive strains of M.avium. In addition, if future research
confirms a housekeeping function for p40, a role in the observed virulence of
M.avium type A/I for BALB/c mice (Kunze et al., 1991; Pedrosa et al., 1994) will
look less likely.
6.9 Future Work
The identification of the M.tuberculosis and M.leprae cosmid sequences creates new
openings in the search for the gene encoding the M.avium type A/I p40 antigen.
Using primers designed from regions which are conserved between the
M.tuberculosis and M.leprae genes, amplification of DNA fragments from
M.tuberculosis genomic DNA hopefully will provide a probe which will lead to the
identification and isolation of the M.avium type A/I p40 gene. With this goal
achieved, it will be possible to assess the distribution of the p40 gene, not just within
the MAC, but among other species of the genus. Work towards this end, and towards
establishing a biological function for p40, is currently underway at the MRI.
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25 x Agarase Buffer
0.75M Bis-Tris/HCl pH6.0, 0.25M Na2EDTA
Buffer-A
50mM Tris/HCl pH8.0, 300mM NaCl
Buffer-B






50mM bis-Tris/HCl pH7.0, 1.5M (NH4)2S04
BTN Buffer
50mM bis-Tris/HCl pH7.0, 150mM NaCl
Calcium Chloride Transformation Buffer (CCTB)
lOmM MES/KOH pH6.2, lOOmM KC1, 50mM CaCl2
Coating Antibody Buffer (CAB)
15mM Na2C03, 35mM NaHC03 pH9.6
Coomassie Brilliant Blue Stain
0.04% (wt/v) Coomassie Brilliant Blue R, 62mM C2HC1302, 7.4% (v/v) glacial acetic
acid, 50% (v/v) methanol
Coomassie Destaining Solution
7% (v/v) glacial acetic acid, 23% (v/v) methanol
Colony Lysis Solution
2 x SSC, 5% (wt/v) SDS
Denaturing Solution
1,5M NaCl, 0.5M NaOH
cclxxiv
100 x Denhardt's Solution
2% (wt/v) bovine serum albumin, 2% (wt/v) Ficoll 400, 2% (wt/v) polyvinylpyrrolidone
DMSO and DTT Solution (DnD)
1M DTT, 90% (7V) DMSO, lOmM KC2H302 pH7.5
EcoYtl Methylase Buffer
50mM Tris/HCl pH7.5, ImM Na2EDTA, 5mM DTT, lOpM S-adenosyl-L-
methionine
ELISA Substrate
25mM C6H807, 50mM Na2HP04, 416pM tetramethylbenzidine, 1.8mM H202
Gel Loading Buffer (GLB)
50mM Na2EDTA, 0.1% (wt/v) (bromophenol blue, 25% (wt/v) sucrose or Ficoll 400
1 x Glycerol-Tolerant Sequencing Buffer (GTSB)
89mM Tris, 28.5mM taurine, 0.5mM Na2EDTA
pH correct at 9.0
4M Guanidinium Isothiocyanate Solution (4M GIT)
4M guanidinium isothiocyanate, 50mM Tris/HCl pH7.5, lOmM Na2EDTA, 2% (wt/v)
sarcosyl, 145mM 2-P-mercaptoethanol
Hanks Basic Salt solution (HBSS)
1.3mM CaCl2, 5.4mM KC1, 0.5mM KH2P04, 0.8mM MgS04, 136.9mM NaCl,
0.34mM Na2HP04, 5.6mM D-glucose, 0.03mM phenol red
High Efficiency Transformation Buffer (HETB)
lOmM MES/KOH pH6.2, lOOmM KC1, lOmM CaCl2, 45mM MnCl2.4H20, 3mM
Co(NH3)6C13
Hybridisation Solution
6 x SSC, 5 x Denhardt's solution, 0.5% (wt/v) SDS, 100pg/ml denatured salmon
sperm DNA, 10% (wt/v) dextran sulphate
4 x Laemmli Denaturing Buffer (LDB)
0.5M Tris/HCl pH6.8, 4% (wt/v) SDS, 1.2 M 2-P-mercaptoethanol, 40% (wt/v)
sucrose, 0.1% (wt/v) bromophenol blue
1 x Laemmli Electrode Buffer (LEB)
0.025M Tris, 0.192M glycine, 0.1% (wt/v) SDS
pH correct at 8.3
cclxxv
4 x Laemmli Resolving Gel Buffer (LRGB)
1.49M Tris/HCl pH8.8, 0.4% (wt/v) SDS
2 x Laemmli Stacking Gel Buffer (LSGB)
0.25M Tris/HCl pH6.8, 0.2% (wt/v) SDS
Membrane Washing Solution
5 x SSC, 0.1% (wt/v) SDS
M9-Salts
42mM Na2HP04, 45mM KH2P04, 8.5mM NaCl, 18.7mM NH4C1
pH adjusted to 7.5
Neutralising Solution
0.5M Tris/HCl pH8.0, 1.5M NaCl
NETN Buffer
20mM Tris/HCl pH8.0, lOOmM NaCl, ImM Na2EDTA, 0.5% (v/v) Nonidet-P40
1 x Phosphate Buffered Saline (PBS)
0.137M NaCl, 0.003M KC1, 0.008M Na2HP04, 0.015M KH2P04
pH adjusted to 6.9
Plate Washing Buffer (PWB)
1 x PBS, 0.05% (v/v) polyoxyethylenesorbitan monolaurate (Tween 20)
Pre-Hybridisation Solution
6 x SSC, 5 x Denhardt's solution, 0.5% (wt/v) SDS, 100pg/ml denatured salmon
sperm DNA
SDS Extraction Buffer
50mM Tris/HCl pH8.0, ImM Na2EDTA, lOOmM NaCl, 2% (wt/v) SDS
SM Buffer
50mM Tris/HCl pH7.5, lOmM MgS04, lOOmM NaCl, 0.02% (wt/v) gelatin
Sodium Borate Blot Buffer
50mM boric acid, 20% (v/v) methanol, 3mM 2-P-mercaptoethanol
pH adjusted to 8.0 with NaOH
20 x Standard Saline Citrate (SSC)
3M NaCl, 0.3M C6H5Na307.2H20
pH adjusted to 7.0 with citric acid
cclxxvi
10 x TBE
0.89M Tris, 0.89M boric acid, 0.025M Na2EDTA
pH correct at 8.3
1 x TE Buffer
lOmM Tris/HCl pH7.5, ImM Na2EDTA
1 x Thin Layer Chromatography Buffer (TLCB)
0.75M KH2P04
pH adjusted to 3.5 with phosphoric acid
1 x TNE Buffer
lOmM Tris/HCl pH7.5, lOOmM NaCl, ImM Na2EDTA
Tris Buffered Phenol
Phenol saturated with lOmM Tris/HCl pH7.5
Tris Glycine Blot Buffer (TGBB)
20mM Tris, 153mM glycine, 20% (v/v) methanol
pH correct at 8.0
10 x T4 PNK Buffer
500mM Tris/HCl pH7.6, lOOmM MgCl2, 5mM DTT), ImM ATP, ImM Na2EDTA,
ImM spermidine
Wash Ethanol
lOmM Tris/HCl pH7.5, ImM Na2EDTA in 70% (v/v) ethanol
cclxxvii
APPENDIX 3.
Bacterial Strains and Vectors
E.coli host strains
Strain Genotype Reference
AD202* F-, ompT::kan, relAl, araDX39, rbsR, Akiyama and Ito, 1990
(Dr. T. Saito) A(argF-/ac)U169, rpsL 150(strr) ,//7>B5 301,
deoCX,ptsF25
DH1 recAX, endAX, gyrA96, thi-\, relAX, Hanahan, 1983
(Invitrogen) fe<iR17(rk", mk+), supE44
HB101 thi-1, hsdS20 (rB",mB"), supE44, recA\3, Boyer and Roulland-
(Invitrogen) ara-14, leuB6, proAl, lacYl, rpsL20(stxr), Dussoix,1969
xyl-5, mtl-\
JM109 endAX, recAX, gyrA96, hsd R17(rk",mk+), Yanisch-Perron et al., 1985
(Promega) relAX, supE44, A(lac-proAB), thi,
[F', traD36,proAB, lacXQZ AMI5]
NM522 supE, thi, A(lac-proAB), Ahsd5(rk~,mk~), Gough and Murray, 1983
(Promega) [F', proAB, lacYlZAM 15 ]
Y1088 tX4\mcrA), A(argF-lac)XJ 169, supE, supF, Young and Davis, 1983b
(Stratagene) hsdR(rk~,mk+), metB, trpR, tonA2X,
jt?roC::Tn5(kanr), [pMC9,ampr,tetr, lacXcl\
Y1090 A(argF-lac)XJ X 69, A(Ion)? araDX39, Young and Davis, 1983b
(Stratagene) rpsL(strr), supF, mcrA, tr/?C22::TnlO(tetr),
[pMC9,ampr,tetr, lacll]
(*A gift from Dr. Takashi Saito, Division ofMolecular Genetics, School ofMedicine,




M. avium type A/I
M.avium type A/I
Source/Details
MRI, deer isolate, strain JD88/118, IS901/902 +ve
NCTC 8559, chicken isolate, IS901/902 +ve
M.avium type A** Strain T133 (IS901/902 -ve), human (HIV patient) isolate
M.a.paratuberculosis MRI, deer isolate, strain JD88/107, IS900 +ve













NCTC 10803, (ATCC 19981)
SMRL, City Hospital, Edinburgh, human isolate, 38320/93
SMRL, City Hospital, Edinburgh, human isolate, 35056/93
SMRL, City Hospital, Edinburgh, human isolate, 34902/93
SMRL, City Hospital, Edinburgh, human isolate, 33811/93




SMRL, City Hospital, Edinburgh, human isolate, 17205
SMRL, City Hospital, Edinburgh, human isolate, 20963
SMRL, City Hospital, Edinburgh, human isolate, 3433
(** A gift from Dr. J.J. McFadden, Molecular Biology Group, Dept. of
Microbiology, University of Surrey, Guildford, Surrey, GU2 5XH, UK.)
(*** a gift from Dr. M.J. Colston, MRC National Institute of Medical Research, The
Ridgeway, Mill Hill, London NW1 1AA.)
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Plasmid and phage vectors:-
Vector
pBluescript KS" (Stratagene)





Short et al., 1988
Smith and Johnson, 1988
Scherf et al., 1990
Yanisch-Perron et al., 1985
Young and Davis, 1983a




IUT (International Union against Tuberculosis) medium
61% whole hen's egg, 50mM KH2P04, 25mM Na2HP04.2H20, 1.6mM
MgS04.7H20, 14mM C6H807.H20, 67mM L.asparagine, 0.2% glycerol, 0.026%
malachite green, pH 7.0. Sterilise at 121 °C for 15min.
L-B agar
1% Bacto®-tryptone, 0.5% Bacto®-yeast extract, lOmM NaCl, pH7.5, 1.5% Bacto®-
agar. Sterilise at 121°C for 15min.
L-B top agarose
1% Bacto®-tryptone, 0.5% Bacto®-yeast extract, lOmM NaCl, pH7.5, 0.7% agarose.
Sterilise at 121 °C for 15min.
Lowenstein-Jensen pyruvate medium (L-JP)
64.6% whole hen's egg, 50mM KH2P04, 25mM Na2HP04.2H20, 114mM
C3H303Na, 14mM C6H807.H20, 0.026% malachite green, 0.006% trypan blue, pH
7.0. Sterilise at 121 °C for 15min.
Luria-Bertani (L-B) broth
1% Bacto®-tryptone, 0.5% Bacto®-yeast extract, lOmM NaCl, pH7.5. Sterilise at
121 °C for 15min.
Minimal agar (M-9 medium)
42mM Na2HP04, 45mM KH2P04, 8.5mM NaCl, 18.7mM NH4C1, pH7.5, 1.5%
Bacto -agar. Sterilise at 121 °C for 15min and supplement as follows using sterile
stock solutions; 2mM MgS04, O.lmM CaCl2, 0.2% glucose, ImM thiamine-HCl.
Modified 7H11+ medium
2.1% 7H11 agar (Difco), 2.3mM L.asparagine, 2.5% glycerol, 2pg/ml mycobactin J
(Allied Monitor), pH 7.0. Sterilise at 121 °C for 15min and supplement as follows
using sterile stock reagents; 10% Middlebrook OADC enrichment (Difco), 20% heat-
inactivated new born calf serum (Life Technologies), *Selectatabs, Code MS 24
(Mast Laboratories).
Normal 7H11 medium
2.1% 7H11 agar (Difco), 0.5% glycerol, pH 7.0. Sterilise at 121°C for 15min and
supplement as follows using sterile stock reagents; 10% Middlebrook OADC
enrichment (Difco), pH 7.0, *Selectatabs, Code MS 24 (Mast Laboratories).
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1 x RPMI-1640 medium
RPMI-1640 medium (Life Technologies) supplemented as follows using sterile stock
solutions; 10% heat-inactivated foetal calf serum (Life Technologies ), 30mM
HEPES (N-[2-Hydroxyethyl]piperazine-N'-[2-ethanesulphonic acid]), 2mM
glutamine, 24mM NaHC03, 0.74mM 2-mercaptoethanol, 50pg/ml gentamycin,
50iu/ml mycostatin.
SOB agar
2% Bacto®-tryptone, 0.5% Bacto®-yeast extract, lOmM NaCl, 2.5mM KC1, 5mM
MgCl2.6H20, 5mM MgSO4.7H20, 1.5% Bacto®-agar, pH7.0. Sterilise at 121 °C for
15min.
SOB broth
2% Bacto®-tryptone, 0.5% Bacto®-yeast extract, lOmM NaCl, 2.5mM KC1, 5mM
MgCl2.6H20, 5mM MgSO4.7H20, pH7.0. Sterilise at 121°C for 15min.
SOC broth
2% Bacto®-tryptone, 0.5% Bacto®-yeast extract, lOmM NaCl, 2.5mM KC1, 5mM
MgCl2.6H20, 5mM MgSO4.7H20, pH 7.0. Sterilise at 121°C for 15min and
supplement with sterile glucose to 0.36%.
Stuart's medium
0.25% casein hydrolysate, 3mM L-asparagine, 18mM Na2HP04, 7mM KH2P04,
5mM Na3C6H507.2H20, 2mM MgS04.7H20, 2.5% glycerol, 0.05% Tween 80
(polyoxyethylenesorbitan monooleate), 2pg/ml mycobactin J (Allied Monitor), pH
7.0, 1.5% Bacto -agar. Sterilise at 115°C for 15min and supplement as follows; heat-
inactivated new born calf serum (Life Technologies) to 20% (v/v), *Selectatabs, Code
MS 24 (Mast Laboratories).
Supplemented L-B media
All L-B media intended for E.coli host strains used to support the propagation of
Agtl 1 was supplemented with maltose at 0.2% (wt/v), MgS04 at lOmM and ampicillin
at 50pg/ml.
*Each Mycobacteria Selectatab, Code MS 24, contains the following antibiotics:-




One Selectatab was used per 500ml medium.
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Two Markers, \S901-\S902 and p40, Identified by PCR and by Using
Monoclonal Antibodies in Mycobacterium avium Strains
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The occurrence of two markers, a newly identified 40-kDa protein (p40) and the insertion sequence IS901-
IS902, in strains ofMycobacterium avium subspp. was evaluated. Analysis of 184 type and field strains of the
M. avium complex from human, animal, and environmental sources by PCR specific to IS901 and by a
monoclonal antibody specific to p40 demonstrated the presence of the two molecular markers in all of the M.
avium subsp. silvaticum strains examined and also in a number of M. avium subsp. avium strains (the latter
isolated mainly from pigs). The appearance of the two markers was completely concurrent in all strains.
Further, the marker-positive M. avium subsp. avium strains were mainly serotype 2, whereas M. avium complex
strains of serotypes 4, 6, 8, 9, and 10 were marker negative. The M. avium subsp. avium type strain ATCC 25291
and approximately 50% of the M. avium subsp. avium field strains isolated from animals contained the
markers, while only one strain of human origin was found to be marker positive. Therefore, IS90/ and p40
appear to have substantial potential to differentiate among isolates of the M. avium complex. This observation
raises new issues regarding classification of strains, since the presence of the markers was found to be
inconsistent with the present taxonomic grouping of M. avium subspp.
The Mycobacterium avium complex is a group of mycobac¬
teria that are widespread in animals and the environment. The
complex consists of M. avium, M. intracellular, and M. para-
tuberculosis, as well as the wood pigeon bacillus. These slowly
growing mycobacteria can infect and cause disease in lungs,
lymph nodes, intestines, skin, bones, and soft tissues of animals
and humans. M. avium infections have become the most com¬
monly disseminated bacterial infections in immune-compro¬
mised populations such as patients with AIDS (12). M. para-
tuberculosis is the causative organism of paratuberculosis
(Johne's disease), a debilitating chronic enteritis in ruminants,
and it has been associated with Crohn's disease in humans (7,
25). The wood pigeon bacillus can cause enteritis in ruminants
as well as disseminated infection in other hosts (8).
Taxonomic analysis of the Mycobacterium genus is compli¬
cated, and a number of schemes have been proposed to dis¬
criminate and classify organisms within the M. avium complex.
The use of seroagglutination has enabled discrimination ofM.
avium and M. intracellular (28, 29). Genetic analyses, partic¬
ularly those examining the 16S rRNA genes, have been useful
for discrimination of strains (23, 24) and even identification of
new species (4). However, this approach has failed to discrim¬
inate among M. avium, M. paratuberculosis, and the wood pi¬
geon bacillus (27, 32) and has led to suggestions that they were
one species. Attempts to discriminate slowly growing mycobac¬
teria with DNA probes have been reported, and considerable
advances have followed the identification of the insertion ele¬
ments IS900 and IS90/-IS902 in M. paratuberculosis (10) and
strains of M. avium, respectively (18, 22).
Each of the two insertion elements contains a unique se¬
quence at the 5' end of the gene which has formed the basis for
PCR analysis of mycobacteria in several laboratories (6, 35,
36). IS900 has been identified only in M. paratuberculosis
strains (10), whereas IS90/-IS902 has been found in wood
* Corresponding author. Phone: 45 35300100. Fax: 45 35300120.
Electronic mail address: pa@svs.dk.
pigeon bacillus or in M. avium strains isolated mainly from
animals (17, 18, 22).
Thorel et al. proposed M. avium, M. paratuberculosis, and
the wood pigeon bacillus as a single species with three subspe¬
cies: M. avium subsp. avium, M. avium subsp. paratuberculosis,
and M. avium subsp. silvaticum (31). This was based on genetic
analysis and a number of culture characteristics such as myco-
bactin dependence, ability to grow on egg medium, and growth
stimulation by pyruvate or pH 5.5.
Another grouping of strains was proposed by Kunze et al.
(17) on the basis of the insertion elements IS900 and IS90/.
These authors suggested that M. paratuberculosis was defined
by the presence of IS900. M. avium consisted of two distinct
groups, referred to as type A/I, containing IS901 and type A
not having this insertion element. The type A/I group corre¬
sponded mainly to M. avium subsp. silvaticum but also included
M. avium subsp. avium strains, while type A corresponded to
the remaining M. avium subsp. avium group. The division in
type A and A/I was further supported by differences in plasmid
possession and serotype antigens.
Recently, a 40-kDa protein (p40) was identified in a M.
avium subsp. silvaticum field strain but could not be detected in
isolates of M. avium subsp. paratuberculosis. Preliminary se¬
quence analysis of this protein revealed that the amino-termi-
nal 20 amino acids were not homologous to any known pro¬
tein. Further, polyclonal sera from sheep and deer naturally
or experimentally infected with M. avium subsp. silvaticum
reacted with the 40-kDa antigen in immunoblots (5). So¬
dium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) analysis demonstrated that p40 is one of the most
abundant antigens in strains in which it is found to be present
(12a). The function of the protein is not known. In the present
study, 184 mycobacterial strains were examined by PCR spe¬
cific to IS900 and IS90/-IS902, by a monoclonal antibody
(MAb) raised against the 40-kDa protein, and by serotyping in
order to evaluate the distribution of the two markers IS901 and
p40.
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TABLE 1. Source and origin of 184 M. avium complex strains used in this study and distribution of IS900, IS90/, and
p40 in all strains and serotypes of M. avium subsp. avium type, and reference strains"
No. of strains showing the
Strain designation Total no. Origin presence of: Serotype'' Source
IS900 IS907 p40
Reference strains
M. avium subsp. paratuberculosis
ATCC 19698 1 Bovine 1 0 0
M. avium subsp. avium
ATCC 19075 1 Human 0 1 1 2
ATCC 25291 1 Avian 0 1 1 2
ATCC 15769 1 Avian 0 0 0 1
NCTC 8551 1 Porcine 0 1 1 2
NCTC 8552 1 Bovine 0 1 1 2
NCTC 8558 1 Ovine 0 1 1 2
NCTC 8559 1 Avian 0 1 1 2
NCTC 8562 1 Avian 0 1 1 2
Field strains
M. avium subsp. paratuberculosis 25 Bovine 25 0 0 NVL
7 Cervine 7 0 0 NVL
6 Caprine 6 0 0 FS
M. avium subsp. avium 42 Human 0 1 1 SSI
62 Porcine 0 31 31 NVL
6 Cervine 0 2 2 NVL
20 Environment 0 0 0 NVL
1 Bovine 0 0 0 NVL
1 Avian 0 1 1 NVL
M. avium subsp. silvaticum 5 Wild animals 0 5 5 FS, NVL
b ATCC, American Type Culture Collection; NCTC, National Collection of Type Cultures; FS, Finn Saxegaard, National Veterinary Institute; NVL, National
Veterinary Laboratory; SSI, Statens Seruminstitut.
h The serotypes of the M. avium subsp. avium field strains are listed in Table 2.
MATERIALS AND METHODS
Mycobacterial strains and growth conditions. The mycobacterial strains used
in this study are listed in Table 1. The collection of strains consisted of a number
of type strains from the American Type Culture Collection, Rockville, Md.. and
the National Collection of Type Cultures, London. United Kingdom; a number
of human isolates (provided by Kurt Fuursted, Statens Seruminstitut, Copenha¬
gen, Denmark); and isolates from goats and wild animals (provided by Finn
Saxegaard, National Veterinary Institute, Oslo, Norway) as well as a number of
field isolates from pigs, cattle, farm deer, and environmental sources collected at
the National Veterinary Laboratory, Copenhagen, Denmark. The M. avium
subsp. paratuberculosis strains were isolated from feces, mesenteric lymph nodes,
or intestinal mucosa. Other strains from humans or animals were isolated from
various organs.
Fecal samples were decontaminated by the method described by Beerwerth
(3), while tissue samples were decontaminated with 5% sulfuric acid for 10 min.
Mycobacteria were grown on slopes of modified Lovenstein-Jensen medium
(14) or Middlebrook 7H11 medium. The identification of field strains was based
on growth rate, colonial morphology, mycobactin dependence, growth stimula¬
tion by pyruvate, resistance to isoniazid, and serotyping. Furthermore, 66 of the
M. avium subsp. avium field strains from all sources were tested by the Gen-
Probe (San Diego, Calif.) Rapid Diagnostic System according to the manufac¬
turer's recommendations for confirmation of M. avium identity.
The five wood pigeon strains have previously been identified as such by F.
Saxegaard (26a) and by J. B. Jorgensen (15).
Serotyping. Serotyping was performed as a tube agglutination test with 25
antisera as described by J. B. Jorgensen (13). In cases of cross-reactions, an
antibody absorption test was performed (28). No further examination was made
of strains that were nonagglutinable or that showed spontaneous agglutination.
Preparation of MAbs. The 40-kDa antigen was purified by high-performance
liquid chromatography from a M. avium subsp. silvaticum field strain (5). BALB/c
mice were immunized intraperitoneally with the purified antigen adsorbed to
AI(OH)3. The mice were immunized twice at intervals of 2 weeks and were
boosted with the same amount of antigen 3 days before the fusion with the
myeloma cell line P3 X63 Ag8-653 (16) by standard procedures (9). Screening of
supernatant from growing hybridomas was performed by an enzyme-linked im¬
munosorbent assay (ELISA) essentially as described below. Hybridoma super-
natants diluted 1:10 were screened against crude antigen from M. avium subsp.
avium ATCC 25291 and M. avium subsp. paratuberculosis ATCC 19698. The
corresponding hybridomas were cloned by limiting dilution.
ELISA. An ELISA was used for the examination of antigen from different
mycobacterium strains. Microtiter plates were coated with 50 p.1 of crude antigen
diluted in 50 mM sodium carbonate buffer (pH 9.6). Each antigen was tested with
the hybridoma supernatant diluted 1:10 and 1:100 in phosphate-buffered saline
(PBS) containing 0.05% Twecn 20 and 1% bovine serum albumin and was
incubated for 2 h at 20°C.
Horseradish peroxidase-conjugated rabbit anti-mouse immunoglobulin (DAKO.
Glostrup, Denmark) diluted 1:1,000 was added for 1 h. The substrate-dye solu¬
tion (0.07% 1,2-phenylenediamine, 0.04% H202 in 10 mM citrate [pH 5.0]) was
allowed to react for 20 min; the reaction was stopped by the addition of 0.5 M
H2S04. The optical density at 490 nm was measured with 650 nm as the refer¬
ence.
In addition to the specific MAb, the ELISA analysis included as a positive
control a MAb directed against an epitope present in all M. avium subsp. isolates
(16a) and as a negative control a MAb raised against Actinobacillus pleuropneu-
moniae.
Sera from immunized mice were diluted 1:1,000 and were used as mentioned
above.
Antigen preparation. Crude antigen was produced from cultured mycobacte¬
ria. The mycobacteria were harvested in 10 mM PBS (pH 7.2) containing 0.5%
phenol, washed three times in PBS, disrupted with zirconium beads in a bead
beater (Biospec Products, Bartlesville, Okla.) four times for 50 s, and clarified by
centrifugation for 30 min at 20,000 x g. Finally, the suspension was filtered
through a 0.22-p.m-pore-size filter.
SDS-PAGE and immunoblotting. Antigens from different mycobacteria strains
were separated on 12.5% polyacrylamide gels (19) and transferred onto nitro¬
cellulose membranes by standard procedures (33). The protein concentrations of
the individual samples were adjusted according to visual judgment of silver-
stained gels (21).
The nitrocellulose membranes were cut into strips and incubated overnight
with MAbs or serum and were visualized by peroxidase-conjugated rabbit anti-
mouse immunoglobulin (DAKO) diluted 1:1 .(MM) and then by staining with tet-
ramethylbcnzidine and hydrogen peroxide.
PCR. Cultured mycobacteria were disrupted by bead beating. A 2-p.l sample
was inoculated into 48 p.1 of a prepared reaction mixture containing 65 mM
Tris-HCl (pH 8.8), 2 mM MgCl2, the four deoxyribonucleotide triphosphates
(100 p.M each), 65 pmol of each of the oligonucleotide primers, and 0.5 U of Taq
polymerase (Boehringer, Mannheim, Germany, or Perkin-Elmer Cetus, Nor-
walk, Conn.), and the mixture was covered with 50 p.1 of paraffin oil. Samples
were subjected to an initial denaturation step 94°C for 3 min and then to 35
cycles of denaturation at 94°C for 1 min, annealing at 55°C for 1 min, and
extension at 72°C for 1 min in a thermal cycler.
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The primers for IS90/ PCR were GTCTGGGATTGGATGTCCTG (primer
901a) and CACCACGTGGTTAGCAATCC (primer 901c), which were derived
from positions 19 to 394 of the IS90/ sequence (18). Primers for IS900 PCR were
CGTCGTTAATAACAATGCAG (primer 11) and GGCCGTGCGTTAGGCT
TCGA (primer 36), which were derived from positions 27 to 304 of the IS900
sequence (10). Amplification products were analyzed by PAGE. Five microliters
of the reaction product was subjected to electrophoresis through a 7.5% poly-
acrylamide gel in a Tris-phosphate buffer (pH 7.5). The gel was fixed in 10%
ethanol-0.5% acetic acid and was silver stained according to standard protocols
(21). Samples were considered IS90/-1S902 positive when a single band of DNA,
375 bp in size, was evident in the gels. 1S900 was identified by the appearance of
a 279-bp band of DNA. Amplification products were digested with the restriction
enzymes Mspl and Rsal and were analyzed on a 10% polyacrylamide gel, fixed,
and silver stained as mentioned above. Agarose gel electrophoresis and Southern
blotting were performed by standard procedures. Nitrocellulose filters were
hybridized with a DNA probe labelled with 35S-dATP (Amersham International)
as described earlier (1). The hybridization probe was the 375-bp PCR amplifi¬
cation product using DNA from M. avium subsp. avium ATCC 25291 as a target.
DNA cycle sequencing (30) was performed as prescribed by the supplier (Cir-
cumVent Thermal Cycle Dideoxy DNA Sequencing Kit; New England Biolabs,
Beverly, Mass.).
RESULTS
Sera and MAbs. ELISA screening of hybridoma superna-
tants led to the identification of 10 clones producing MAbs to
p40. One of these, MAb 6.34, reacted in ELISA as well as in
immunoblotting and was chosen for this study.
The molecular specificity of MAb 6.34 and of murine serum
raised against the 40-kDa protein was demonstrated by iramu-
noblot analysis (Fig. 1). The murine serum (Fig. 1A) bound
strongly to a 40-kD protein present in the M. avium subsp.
avium serotype 2 strains ATCC 19075 and ATCC 25291 (lanes
3 and 4, respectively), whereas this protein was not identified in
the M. avium subsp. avium serotype 1 strain ATCC 15769 (lane
2) or in M. avium subsp.paratuberculosis ATCC 19698 (lane 1).
Minor reaction was seen with other antigens (especially seen in
lane 4). The reaction of MAb 6.34 is displayed in Fig. IB. This
MAb reacted only with a 40-kDa antigen present in the M.
avium subsp. avium strains ATCC 19075 (lane 3) and ATCC
25291 (lane 4) as well as the field strains 42 (M. avium subsp.
silvaticum [lane 5]) and FGR41 (M. avium subsp. avium sero¬
type 2 [lane 6]). There was no reaction with M. avium subsp.
paratuberculosis (lane 1) and M. avium subsp. avium ATCC
15769 (lane 2).
Field strains. The specificities of the MAbs were further
investigated by ELISA with MAb 6.34 and by immunoblot
analyses of field strains. Antigens from 64 strains were sub¬
jected to SDS-PAGE, blotted onto a nitrocellulose membrane,
and incubated with MAb 6.34. A single 40-kDa band was
observed for 15 strains, while 49 strains gave negative results.
The ELISA analysis demonstrated that identical results was
obtained by the two immunological methods (data not shown).
Antigens from 39 of the above-mentioned 64 strains were
also tested by ELISA with murine serum instead of MAb 6.34.
Murine serum showed results identical to those obtained with
the MAb. This suggested that the specificity of p40 is not
confined to a single epitope.
PCR. The published DNA sequences of the insertion se¬
quences IS907 (18) and IS902 (22) were compared for selec¬
tion of primers for specific amplification of a 375-bp fragment.
The specificity of the PCR was examined by amplification with
type strains of mycobacteria (Table 1). The insertion sequence
was identified in the M. avium subsp. avium strains ATCC
19075, ATCC 25291, NCTC 8551, NCTC 8552, NCTC 8558,
NCTC 8559, and NCTC 8562 by the appearance of a 375-bp
fragment, whereas no amplification was observed for strain
ATCC 15769 or for the M. avium subsp. paratuberculosis strain
ATCC 19698.
The amplification products were further examined by re-




FIG. 1. Immunoblot of antigens from strains of M. avium subspp. showing
the reactivities of murine serum to p40 (A) and MAb 6.34 (B). Lanes: 1, M.
avium subsp. paratuberculosis ATCC 19698; 2, M. avium subsp. avium ATCC
15769; 3, M. avium subsp. avium ATCC 19075; 4, M. avium subsp. avium ATCC
25291; 5,
M. avium subsp. silvaticum field strain; 6, M. avium subsp. avium field strain. The
arrows indicate the positions of a 40-kDa band.
striction fragment analysis. Amplified DNAs from ATCC
25291 and ATCC 19075 digested with Rial showed fragments
of 241 and 134 bp, while digestion with Mspl showed fragments
of 282, 73, and 21 bp, as could be predicted from the published
sequence of IS907 (not shown).
For verification of the PCR, the amplification products from
12 IS907 positive strains were examined by digestion with the
restriction enzymes Mspl and RsaI, respectively. The amplifi¬
cation products from all strains showed Rsal and Mspl frag¬
ments of identical sizes which were indistinguishable from the
expected size (Rsal, 241 and 134 bp; Mspl, 282, 73, and 21 bp
[data not shown]).
The identities of the amplification products were further
confirmed by Southern blotting with purified amplification
product from M. avium subsp. avium ATCC 25291 as probe
(not shown). Primers 11 and 36 directed the amplification of a
279-bp fragment with ATCC 19698 but not with any of the
other type or reference strains (Table 1).
Partial DNA sequence determinations (average, 166 nucle¬
otides) of the amplification products of ATCC 25291 and
ATCC 19698 and six field strains confirmed the specificity of
the amplification.
1 2 3 4 5
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TABLE 2. Serotypes of 132 M. avium subsp. avium field strains
No. of isolates of the following serotypes":
1 2 3 4 6 8 9 10 1/6 2/3 2/8 3/9 4/8 NA SA Total
Human 3 3(1) 1 8 5 2 4 9 1 4 2 42
Porcine 2(1) 30 (29) 4 8 3 8 1 1 1(1) 3 1 62
Cervine 1 1(1) 1(1) 2 1 6
Environment 1 5 4 4 3 3 20
Bovine 1 1
Avian 1(1) 1
Total 7(2) 34 (31) 2(1) 14 18 7 16 1 1 10(1) 1 7 1 8 5 132
" Numbers of IS901- and p40-positive isolates are given in parentheses. NA. not agglutinable; SA. spontaneous agglutination.
Distribution of IS900, IS901, and p40. A total of 184 type
and field strains were analyzed by PCR specific to IS9W or to
IS900 and by ELISA with MAb.
All of the 38 strains identified by culture as M. avium subsp.
paratuberculosis showed positive reactions with the IS900 PCR,
whereas all other strains were found negative. Of the 184
strains analyzed, 47 were IS901 positive and 137 were IS901
negative. All strains that were found to contain IS901 were also
shown to be positive by monoclonal ELISA, whereas IS901-
negative strains did not react with MAb 6.34. This suggests that
the two markers IS901 and the 6.34 epitope do not segregate
independently (P < 0.001 [x2 test]).
Association of IS90I and p40 with serotypes. With the ex¬
ception of the M. avium subsp. paratuberculosis strains, all of
the isolates were serotyped. Of the five M. avium subsp. silvat-
icum strains, two were untypeable, one was serotype 2, and two
strains were agglutinated with both type 2 and type 3 sera.
The serotypes as well as the presence of p40 and the inser¬
tion elements IS900 and IS90I in type and reference strains are
listed in Table 1.
The distribution of serotypes of the 132 M. avium subsp.
avium strains is shown in Table 2. Of 34 field strains identified
as serotype 2, 31 were positive for both markers, while 3 strains
did not possess any of the two markers. Furthermore, the
markers were identified in 2 of 7 serotype 1 isolates, in 1 of 2
serotype 3 isolates, and 1 of 10 serotype 2/3 isolates. All but
one of the strains that contained IS9M and p40 were isolated
from animals.
DISCUSSION
The M. avium complex consists of a group of microorgan¬
isms whose members are not readily distinguishable from one
another. They are important pathogens in animals and hu¬
mans, and the AIDS epidemic has drawn increasing attention
to this group of bacteria. The establishment of a taxonomic
relationship among isolates has proved difficult. Different and
incomparable schemes have been used for classification, and
this may evoke some confusion.
In this study, a MAb directed against a newly identified
protein p40 and a PCR test specific for the insertion sequence
IS90/-IS992 were used for the analysis of type and field strains
of the M. avium complex. The insertion sequence appeared
concurrently with the MAb 6.34 epitope in all of the analyzed
strains. The nature of this close linkage between the two mo¬
lecular markers remains to be clarified. Only M. avium subsp.
silvaticum strains, most M. avium subsp. avium serotype 2
strains, and some serotype 1 and serotype 3 strains from ani¬
mals were found to contain the two markers. The only human
marker-positive strain was the reference strain ATCC 19075.
The correct assignment of isolates within the M. avium com¬
plex is by no means simple. In recent years, the use of DNA
probes has gained widespread acceptance as the method of
choice. However, these probes do not distinguish among M.
avium subsp. avium, M. avium subsp. paratuberculosis, and M.
avium subsp. silvaticum. The insertion sequence IS901-IS902
has previously been suggested to be specific for M. avium
subsp. silvaticum (22). The data presented here demonstrate
that this insertion element was present in all strains of M.
avium subsp. silvaticum but also in a number of M. avium
subsp. avium strains. IS901 was identified not only in field
strains but also in reference strains, including the type strain of
M. avium subsp. avium (ATCC 25291). The correct assignment
of these strains can hardly be questioned. This demonstrates
that M. avium subsp. silvaticum could not be defined by IS9W.
Another study suggested that IS907 is a marker for strains
differing in host range and virulence from other isolates of the
M. avium complex (17). In the present study, the majority of
the marker-positive strains were isolated from pigs. Neverthe¬
less, about 50% of the porcine strains were found to be marker
negative. Marker-positive and marker-negative strains could
not be distinguished by cultivation characteristics such as
growth rate and colonial morphology.
In the present study, the presence of p40 was identified by
ELISA using a specific MAb. Nevertheless, all of the strains
analyzed by ELISA using polyclonal serum only confirmed the
results obtained by the MAb. Thus, it is likely that not only the
MAb 6.34 epitope but also the 40-kDa protein are specific to a
certain group of isolates.
The different appearance of IS90/ and p40 in human and
animal isolates could support the idea that livestock is not the
primary source of human infections.
The function of p40 is not known. Partial amino acid se¬
quencing of p40 has failed to demonstrate homology with any
known protein, including the putative protein from the open
reading frame of IS907 (5). Therefore, we have no leads re¬
garding the apparently different host ranges of the two mark¬
ers.
In the present study, the majority of the marker positive
strains were serotype 2. The finding of variant prevalence of
IS90/-IS902 in different hosts could simply reflect the variant
prevalence of serotype 2. Kunze and coworkers (17) examined
a number of strains for the presence of IS90/ and found the
insertion element present in serotypes 1, 2, 3, 6, and 8. In the
present study, the insertion element was found only in sero¬
types 1, 2, and 3.
A different distribution of serotypes in human and animal
isolates has been described previously. Serovars 4, 8, 1, 9, and
6 are the most prevalent among human isolates in Western
countries (2, 11, 34), while among animal isolates serotype 2 is
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more prominent. The distribution of serotypes among porcine
isolates seems to differ considerably among countries. Serotype
2 constituted 7.3% of the isolates in Norway (26), an earlier
study found a result of 86.3% in Denmark (13), and in Japan
serotype 2 was not found at all (20, 37). This highly variant
distribution ofM. avium subsp. avium serotype 2 strains could
indicate that the molecular markers p40 and IS901 appear with
variant frequencies in different countries.
Taxonomy within the M. avium complex has been confused
by the lack of uniform characters. The taxonomic scheme pro¬
posed by Thorel et al. (31) is not in full agreement with the
system based on insertion sequences used by Kunze et al. (17).
The presence of the two markers described in the present
paper could be demonstrated without laborious DNA purifi¬
cation or time-consuming biochemical tests. Although further
work is needed to elucidate the linkage between the two mark¬
ers, we believe that the system will prove helpful in the char¬
acterization of M. avium complex isolates.
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Detection of specific T cell reactivity in sheep
infected with Mycobacterium avium subspecies
silvaticum and paratuberculosis using two defined
mycobacterial antigens
C. Burrells*, N.F. Inglis, R.C. Davies, J.M. Sharp
A 30 kDa antigen (P30) from Mycobacterium avium ssp. paratuberculosis (M. a. para¬
tuberculosis) and a 40 kDa (P40) antigen from Mycobacterium avium ssp. silvaticum (M.
a. silvaticum) were employed in two different assays to measure the cell-mediated immune
reactivity of ovine peripheral blood lymphocytes.
In lymphocyte stimulation assays, proliferative responses to the P30 were observed only
with lymphocytes from sheep inoculated with live M. a. paratuberculosis or M. a. silvati¬
cum. Although this antigen was not subspecies-specific it differentiated between animals
given live organisms and those inoculated with an inactive lysate. The P40 protein from
M. a. silvaticum showed subspecies specificity by eliciting in vitro responses only with
lymphocytes derived from sheep inoculated with live M. a. silvaticum. Similar results were
obtained using an interferon-gamma release assay which proved to be a more rapid and
sensitive system.
1. Introduction
Infections with mycobacteria induce complex immune responses in the host
involving both cell-mediated and antibody responses. Several antibody assay
techniques have been employed and more recently, enzyme-linked immunosor¬
bent assays (ELISA) have been developed as more sensitive tests in the serodi-
agnosis of mycobacterial infections such as human tuberculosis (Daniel and De-
* Corresponding author.
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banne, 1987; Sada et al., 1990), leprosy (Pessolani et al., 1991) and
paratuberculosis (Johne's disease) in cattle (McNab et al., 1991; Ritacco et al.,
1991) and sheep (Brooks et al., 1988; Sugden et al., 1991). It is known, however,
that the earliest responses and immunological resistance to mycobacterial infec¬
tion depend upon cell-mediated immune (CMI) mechanisms (Thorns and Mor¬
ris, 1983; Bloom and Godal, 1989) and that a reciprocal relationship exists be¬
tween the cellular and humoral responses in respect of the subclinical (resistant)
and clinical disease status of the host (Huygen et al., 1988; Ritacco et al., 1991).
The measurement of CMI to Mycobacterium avium ssp. paratuberculosis (M.
a. paratuberculosis) infection has been undertaken using the intradermal skin
test (Kormendy, 1988) measuring delayed-type hypersensitivity (DTH), the
lymphocyte stimulation assay (LSA) (Buergelt et al., 1977, 1978) and the migra¬
tion inhibition test (MIT) (Bendixen, 1977). These assays exhibit variable sen¬
sitivity but also lack specificity because lymphocytes are stimulated with rela¬
tively crude and undefined antigen preparations such as tuberculins or their
purified protein derivatives (PPD). Consequently, cross-reactions occur as a re¬
sult of the presence of antigens shared with other Mycobacterium spp., Actino¬
myces spp., Dermatophilus spp., Nocardia spp., Streptomyces spp., Corynebacte-
rium spp., and fungi (Chiodini et al., 1984).
In a recent development, the correlation between lymphocyte blastogenesis and
the production of immune-specific interferon-gamma (IFN-y) has been ex¬
ploited by Rothel et al. (1990) and Wood et al. (1991). They showed that the
detection of IFN-y in short-term whole blood cultures by ELISA was the most
sensitive means for the diagnosis of bovine tuberculosis.
As part of a wider programme on paratuberculosis of ruminants, studies were
undertaken on the host immune response to defined antigens of the causal mi¬
croorganism, M. a. paratuberculosis. Two antigens were studied; a 30 kDa alpha
antigen which exists in many mycobacterial species and has been shown to be a
secretory protein, and a 40 kDa protein which has been demonstrated only in
mycobacteria containing the specific insertion sequence IS901/IS902 (N.F. In-
glis et al., unpublished observations, 1993; Ahrens et al., unpublished observa¬
tions, 1993). This 40 kDa protein may therefore have potential as a specific di¬
agnostic marker for Mycobacterium avium ssp. silvaticum (M. a. silvaticum)
infections.
In the present study, the specificities of the two defined proteins were com¬
pared with PPD in tests to examine CMI responses of sheep immunised with an
inactive lysate ofM. a. paratuberculosis or infected with M. a. paratuberculosis or
M. a. silvaticum.
2. Materials and methods
2.1. Culture ofM. a. paratuberculosis
In vitro propagation of a strain (JD88/107) ofM. a. paratuberculosis isolated
from a red deer (Cervus elaphus) (Nyange, 1990) was performed on solid me-
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dium as previously described (Stuart, 1965) except that crude Mycobacterium
phlei mycobactin was replaced by purified mycobactin J (Allied Monitor Inc.,
Fayette, MO) (Merkal and McCullough, 1982). Cultures were incubated at 37°C
for 6-8 weeks.
2.2. Preparation ofcrude lysate for immunisations
Mycobacterium a. paratuberculosis cells scraped from the surface of the growth
medium were washed three times and resuspended in distilled water. Mechanical
rupture was achieved using zirconium beads in a mini bead-beater as described
by Hurley et al. (1987). After separation from the beads, the lysate was centri-
fuged at 30 000X# for 30 min to remove intact bacteria. Supernates were pooled
and the protein concentration was determined using the Bio-Rad protein assay
kit (Bio-Rad Laboratories, Hemel Hempstead, UK). Lysates were adjusted to 2
mg ml-1 protein, aliquoted and stored at — 80°C.
2.3. Preparation of30 kDa antigen (P30)
Mycobacterium a. paratuberculosis organisms scraped from the surface of the
growth medium were washed three times in TE buffer (0.01 M Tris/HCl pH 7.5
containing 0.001 M EDTA, disodium salt). One gram of washed pelleted orga¬
nisms was resuspended in 3 ml TEM buffer (TE buffer adjusted to 0.005 M with
2-/?-mercaptoethanol containing 0.001 M phenylmethylsulphonyl fluoride
(PMSF)) and physically ruptured as above.
Cell lysates were clarified by centrifuging at 100 000Xg for 60 min and the
soluble supernatant proteins were precipitated sequentially using 20% and 40%
saturated ammonium sulphate ((NH4)2S04). The precipitate was centrifuged at
30 000 Xg, dissolved in 1 ml TEM buffer, dialysed to remove salts, and proteins
fractionated by high performance liquid chromatography (HPLC) gel filtration
followed by anion-exchange chromatography.
(i) Gel filtration was carried out using PBS (0.15 M NaCl, 0.01 M phosphate,
pH 6.9) containing 0.001 M /?-mercaptoethanol on a TSK-G3000-SW silica col¬
umn (8 mm x 300 mm) at room temperature at a rate of 0.5 ml min"1. Fractions
containing a band of molecular mass 30 kDa (P30), as determined by sodium
dodecyl polyacrylamide gel electrophoresis (SDS-PAGE), were pooled.
(ii) Anion exchange chromatography: a pool of P30 was dialysed overnight
against 0.05 M bis-Tris/HCl (BT) buffer at pH 7.0 to remove extraneous matter
and absorbed to a TSK-DEAE-5PW HPLC column (8 mmx75 mm) equili¬
brated with BT buffer at 0.5 ml min-1. Bound proteins were eluted by a contin¬
uous gradient of 0-0.5 M NaCl in buffer at a rate of 0.5 ml min-1 for 30 min.
The peak of material eluting at 0.15 M NaCl was homogeneous P30 protein as
confirmed by SDS-PAGE. This P30 in 0.05 M BT buffer, pH 7.0 was then con¬
centrated using a Millipore membrane with a cut-off point of 10 000.
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2.4. Preparation of40 kDa antigen (P40)
Mycobacterium a. silvaticum scraped from the surface of solid 7H11+ me¬
dium (McClatchy et al., 1976) was washed twice in PBS before being resus-
pended in PBS containing 0.001 M PMSF. Cell lysates were prepared by passing
a suspension of 100 mg organisms in 3.0 ml PBS through a 'mini-French pressure
cell' (SLM Aminco, SLM Instruments Inc., Urbana, IL) at 20 000 psi at room
temperature. Cell lysates were clarified as above and proteins were selectively
precipitated from the supernates using 20-60% saturated (NH4)2S04. Precipi¬
tates containing P40 were identified by SDS-PAGE, centrifuged at 30 000Xg and
dissolved in 1 ml PBS. Volumes (200 p\) were fractionated by HPLC gel filtra¬
tion as for P30 except that the PBS did not contain /?-mercaptoethanol. Anion
exchange chromatography was performed as for P30 and fractions containing the
P40 were identified as above. These were diluted tenfold with 2 M (NH4)2S04
in BT buffer and clarified through a 0.45 p.m Millipore membrane. The filtrate
was finally fractionated by hydrophobic interaction HPLC using a TSK-phenyl-
5PW (8 mmx75 mm) column, equilibrated with 2 M (NH4)2S04 in BT buffer
at 0.5 ml min~'. Approximately 30% of ultraviolet-absorbing material was bound
to the column and was eluted by application of a linear gradient decreasing from
2.0 to 0 M (NH4)2S04 in BT buffer over 30 min at 0.5 ml min-1. Pure P40 was
eluted in 2 ml as a sharp peak at approximately 0.3 M (NH4)2S04.
2.5. Animals
Peripheral blood lymphocytes (PBL) from 12 sheep from various sources were
examined for reactivity to M. a. paratuberculosis PPD and the two purified
proteins:
(A) five lambs (V1-V5) each ofwhich had been injected subcutaneously with
1.0 mg crude M. a. paratuberculosis lysate in 10% aluminium hydroxide (AlOH)
first at 12 weeks of age and again 9 weeks later;
(B) four lambs each of which had been inoculated orally with 108 live myco¬
bacteria first at 1 day of age then weekly for 9 further weeks: two receiving M. a.
silvaticum (strain JD88/118) (S1-S2) and two receiving M. a. paratuberculosis
(strain JD88/107) (P1-P2), (Nyange, 1990);
(C) two 12-week-old normal control lambs (C1-C2).
2.6. Lymphocyte stimulation assay
Lymphocyte stimulation assays (LSA) were performed as described previ¬
ously (Burrells and Wells, 1977; Wells et al., 1979). Volumes (200 /A) of lym¬
phocyte suspensions (106 ml-1) were added to triplicate wells of sterile 96-well
flat-bottomed microplates (NUNC-GIBCO Ltd., Paisley, UK) containing:
(a) 20p\ whole medium as an unstimulated control culture;
(b) 20 p\ concanavalin A (Con A) (ICN Biomedicals, High Wycombe, UK)
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at a final concentration of 7.5 ml -1 culture as a positive control of lymphocyte
stimulation;
(c) 20 pi M. a. paratuberculosis PPD ('Johnin', Central Veterinary Labora¬
tory, Weybridge, UK) at a previously determined optimal final concentration of
6.25 pg ml-1 culture;
(d) 20 /A M. a. paratuberculosis P30 antigen at a previously determined opti¬
mal final concentration of 2.5 pg protein ml-1 culture;
(e) 20 p\ M. a. silvaticum P40 antigen at a previously determined optimal final
concentration of 2.5 pg protein ml-1 culture.
Following culture, harvesting and liquid scintillation counting results were ex¬
pressed as stimulation indices (SI)
_Mean CPM of stimulated cultures—Mean CPM ofblanks
Mean CPM of control cultures—Mean CPM of blanks
2.7. Interferon gamma (IFN-y) assay
A whole blood culture method followed by a sandwich ELISA as described by
Rothel et al. (1990) for the detection ofbovine IFN-y and which had been shown
to detect ovine IFN-y (Rothel et al., 1990; G. Entrican and C. Burrells, unpub¬
lished data, 1992) was used. Heparinised whole blood was cultured in duplicate
200 pi volumes in a 96-well flat-bottomed microplate in the presence of 20 p\ of
medium (control), 20p\ ofM. a. paratuberculosis PPD, 20 p\ of P30 or 20 p\ of
P40 antigen as used in the LSA. Whole blood cultures were maintained for 24 h
in a moist 5% C02/95% air atmosphere after which time microplates were cen-
trifuged at 450Xg to deposit the cells. The supernatant plasmas were harvested
and the duplicates pooled and stored at — 20 °C. A sandwich ELISA to detect
ovine IFN-y in the plasma was performed as described by Rothel et al. (1990).
Briefly, volumes (100//1) of plasma samples were added to triplicate wells of
ELISA plates pre-coated with a dilution (5 pg ml-1) of a monoclonal antibody
(IFN 9) to bovine IFN-y (Wood et al., 1990). Plates were incubated for 1 h at
20°C . After washing, 100 p\ volumes of horseradish peroxidase (HRP) conju¬
gated second anti-bovine IFN-y (IFN2) monoclonal antibody (Woodetal., 1990)
were added at a pre-determined optimal dilution. After incubation at 20°C for
30 min, plates were again washed prior to the addition of 100 p\ of substrates
(tetramethylbenzidine—TMB and hydrogen peroxide). The reaction was stopped
after 30 min by the addition of 50 pi of 0.5 M H2S04 per well and results were
obtained using a titertek multiskan plate reader (Flow Laboratories, Irvine, UK)
fitted with a 450 nm filter. Results are expressed in this study as 'corrected' opti¬
cal densities (OD) (OD450 with test antigen—OD450 with medium control).
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3. Results
3.1. Lymphocyte stimulation assay
The responses of the PBL from all animals to stimulation with the T-cell mi¬
togen Con A were generally high and in the range expected for sheep (mean CPM
of unstimulated cultures 4.9 XlO3; mean CPM of Con A stimulated cultures
227.9XlO3) (Burrells and Wells, 1977).
With the exception of the two control lambs (Group C), all the animals pro¬
vided PBL which proliferated in response to stimulation with M. a. paratubercu-
losis PPD (Fig. 1). These PPD-driven responses tended to be greater with PBL
from animals which had received live organisms (Group B; SI, S2 and PI) than
those from sheep given inactive material (Group A; VI, V2, V3, V4 and V5).
Proliferative responses to the purified P30 antigen were obtained with PBL
derived from three of the four animals inoculated with live organisms (Group
B). PBL from only one of the immunised lambs (V5) responded minimally
(57= 3.0) to P30 and PBL from the two control lambs (Group C) were not
reactive.
None of the PBL from immunised animals (Group A) responded to the P40
antigen. Lymphocytes from the two animals (SI and S2) given live M. a. silvati-
cum showed marked proliferative responses with stimulation indices of 38.0 and
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Fig. I. Proliferation of peripheral blood lymphocytes from groups of sheep in response to PPD (Johnin)
(hatched) and P30 (blank) from M. a. paraluberculosis and P40 (shaded) from M. a. silvaticum:
VI-V5, immunised with inactive M. a. paratubercutosis lysate; S1-S2, infected with live M. a. silva¬
ticum; P1-P2, infected with live M. a. paratuberculosis\C\-C2, non-immunised, non-infected normal
control lambs.
C. Burrells el al. / Veterinary Immunology and Immunopathology 45 (1995) 311-320 317
GROUP
Fig. 2. Mycobacterium a. paratuberculosis PPD (hatched) and P30 (blank) and M. a. silvaticum P40
(shaded) antigen-stimulated release of interferon-y in cultures of whole blood from groups of sheep:
VI-V5, immunised with inactive M. a. paratuberculosis; S1-S2, infected with live M. a. silvaticum-,
P1-P2, infected with live M. a. paratuberculosis-, C1-C2, non-immunised, non-infected normal con¬
trol lambs.
culosis (PI and P2) were not responsive to this protein. No responses were ob¬
tained with lymphocytes from the two control animals.
3.2. Production and release ofIFN-y
Mycobacterium a. paratuberculosis PPD induced the release of IFN-y in cul¬
tures of blood from all the experimental animals whether given non-viable my¬
cobacterial antigen or live bacteria (Fig. 2). Although a small amount of the cy¬
tokine was released by PBL from one of the immunised lambs (Group A; V4)
(cut-off OD450<0.200) in response to the P30 antigen, responses were much
greater with PBL from all the infected animals (Group B). P40-induced IFN-y
release was achieved only with blood from the two lambs (SI and S2) given live
M. a. silvaticum. PBL from the two control lambs did not produce IFN-y in re¬
sponse to any of the three antigens.
4. Discussion
On the basis of the results described, the use of purified mycobacterial antigens
together with the IFN-y release assay provides a test system which is superior to
existing assays for CMI in terms of specificity, sensitivity speed, simplicity and
cost.
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With the exception of the two negative controls, lymphocyte proliferative re¬
sponses to M. a. paratuberculosis PPD were mounted by PBL from all of the an¬
imals whilst responses to the two purified antigens were mainly confined to PBL
from infected animals, only a very slight response to P30 being observed with one
immunised animal (V5). This would suggest that the two purified proteins de¬
tected a CMI directed against products secreted by live organisms.
The use of such purified antigens would therefore be advantageous over PPD
in proliferation assays due to their abilities to confer specificity and to discrimi¬
nate between animals infected with live bacteria and those given inactive material.
Evidence to support this is accumulating from several sources. Thus, killed my¬
cobacteria can stimulate the immune system but do not evoke long-term specific
CMI (Orme, 1988a,b) and major differences are apparent in the T-cell repertoire
stimulated by live and killed mycobacteria (Rook et al., 1986). Consequently, it
has been suggested that proteins secreted by actively multiplying mycobacteria
may have an important role in protection (Rook et al., 1986; Orme, 1988b).
In accord with the results presented here, Andersen et al. (1991) recently dem¬
onstrated that lymphocytes from mice given live Mycobacterium tuberculosis re¬
sponded strongly to a 32-33 kDa secreted antigen whereas mice given killed or¬
ganisms did not respond at any time. Furthermore, antibodies to the secreted
antigen were not detected during the infection. Those authors also suggest a ma¬
jor role for antigens secreted by live mycobacteria in the induction of protective
cellular immune responses.
The proliferative responses to the P40 antigen by PBL from only the two ani¬
mals given liveM. a. silvaticum enhances the evidence that this protein is specific
forM. a. silvaticum and can differentiate between animals infected with this or¬
ganism and those infected with M. a. paratuberculosis. Recently, a 40 kDa pro¬
tein antigen fromM. tuberculosis was shown to be specific forM. tuberculosis and
Mycobacterium marinum and discriminate between these and other mycobacte¬
rial species such as Mycobacterium avium, Mycobacterium africanum, Mycobac¬
terium bovis, Mycobacterium intracellular, Mycobacterium kansasii, Mycobac¬
terium fortuitum, Mycobacterium scrofulaceum and Mycobacterium szulgai
(Andersen etal., 1992).
The detection of IFN-y correlates with the demonstration of antigen-specific
lymphocyte stimulation (D'Andrea et al., 1986) and can be more sensitive
(D'Andrea et al., 1986; Hao et al., 1986). This experience was borne out by the
present results particularly with PBL from lamb P2 which showed release of IFN-
y in response to both PPD and P30 despite the slight or negative responses in
proliferation assays. In an extensive field comparison the assay for IFN-y release
by lymphocytes in 24 h cultures in response to PPD was shown to be more sensi¬
tive than the single intradermal tuberculin test for the diagnosis of bovine tuber¬
culosis (Wood et al., 1991).
While purified antigens are sought which will discriminate between other my¬
cobacterial species, we suggest that the assay system described may be a more
accurate indicator of infection, particularly at the subclinical stage or where pre¬
vious vaccination with dead mycobacteria or intradermal testing could confuse
the interpretation of the results of other assays.
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Identification of an immunogenic 40kDa protein that may be
specific for some strains of Mycobacterium avium
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Summary
Members ofthe M. avium complex are over 95% homologous and differentiation between them is
notoriously slow anddifficult. Particular difficulties are encountered in discriminating M. paralubcrcu-
losis from other mycobactin-dependent members of the group eg wood pigeon bacillus (syn. M. a.
silvaticum). li e have identified a 40kDa protein that appears to be expressed in IS9019Q2 < strains of
Mycobacterium avium but not in Mycobacterium paratuberculosis. The amino terminal twenty amino
acids of the protein share no significant homology with any proteins currently available in the OWL
database. Theprotein stimulates strong cell-mediatedandhumoral immune responses in sheep anddeer.
Such responses are observed only in animals infected with IS901-902* strains ofM. avium. The gene
encoding the 40kOaprotein has been isolatedfrom agtll expression library of51. avium and is currently
being characterized.
Introduction
TheMycobacterium avium complex (MAC) comprises a group ofclosely related organisms (12)
that show not only phenotypic similarity, but also share up to 98% sequence identity at the genomic level
(10). Although attempts have been made to distinguish between the individual members ofthe MAC using
a number of techniques the criteria and reagents for precise classification are still not available.
Recombinant DNA technology has led recently to the identification of two species-specific genetic
markers, 1S900 in M.a. paratuberculosis (7,11) and IS901/902 in mycobactin-dependent strains ofM.
avium and M.a. silvaticum (9,13). These genetic elements have been exploited to detect these organisms
directly in pathological samples (5,15,17). The search for species-specific proteins that could be employed
to detect specific immune responses in infected animals has been less successful. So far, only the carboxy
terminus of a 34kDa protein in M.a. paratuberculosis appears to contain specific epitopes that may be
useful to detect antibodies in cattle with paratuberculosis (6,16).
The present study describes the identification ofa novel 40kDa protein which co-segregates with
the genomic insertion sequence IS901/902 in M.a. silvaticum. The 40kDa antigen provides a marker
which allows both visual discrimination between M.a. silvaticum and M.a. paratuberculosis at the
polypeptide level and immunological differentiation between animals infected with these M. avium
subspecies.
Identification of a 40kDa protein in IS901/902+ strains of M. avium
Comparison of the polypeptide compositions of 19 MAC isolates by SDS-PAGE revealed the
presence ofa prominent protein, with an apparent molecular weight of40kDa (Figure 1) This protein was
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Figure 1:SDS-PAGE showing the polypeptide compositions of 19 MAC isolates. Isolates in lanes 1. 2. 6. 8. 10. 13. 15.
17 and 19 were identified as At.a. paratuberculosis by PCR for 1S900. Isolates in lanes 3. 4. 5. 7.9. 11. 12. 14.
16and 18 were identified as IS901/902 positive by PCR. A prominent 40kDa protein is visible only in 1S901/902 positive
isolates.
identified only in those isolates containing IS901/902, and was absent in isolates positive for IS900. No
isolate was shown to harbor either IS901/902 or the 40kDa antigen alone.
These preliminary observations have since been corroborated in a further and more extensive
study in which 33 of 161 MAC type-and field-strains were shown to contain both 40kDa and IS901/902
(1). All 33 of these 40kDa and IS901/902 positive isolates were shown to be serotype 2, although 10%
of serotype 2 isolates contained neither 40kDa nor IS901/902. None of the remaining 128 isolates,
comprising a number of serotypes, could be shown to harbor either 40kDa or IS901/902 alone.
The 40kDa protein was purified to homogeneity by a series of chromatographic procedures (4)
and the first 20 NH, terminal amino acids sequenced from western blots by Edman degradation. No
significant homology was demonstrated with any protein currently available in the OWL database or with
the amino acid sequence deduced from the ORF contained within IS901/902.
N. F. Inglis el aI
Immune response of
Infected sheep to the
40kDa protein
Peripheral blood lympho¬
cytes (PBL) from 12 sheep were
examined for reactivity to
M.a. paralnbercii/osis PPD and
purified 40kDa antigen by both the
lymphocyte stimulation assay
(LSA) and the5-interferon(5-IFN)-
ELISA (4). Experimental animals
were in three separate groups as
follows:
Group A. 5 lambs (VI-
V5), each of which was injected
subcutaneouslywith 1 Omgofcrude
M.a. paratuberculosis cell lysate in
10% aluminum hydroxide at 12 and
21 weeks of age.
Group B. 4 lambs, each of
which was dosed orally with 10s
cfu live mycobacteria at 1 day old
and then weekly for a further 9
weeks. Two lambs (S1,S2) received
M.a. silvaticum (strain JD88/118),
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Figure 2: CMI responses toM.n. paratuberculosisPPD and the 40kDa protein
Groups of sheep are described in the text. □. response to PPD; □ response to
40kDa protein.
CMI responses to M.a.
paratuberculosis PPD were detected by LSA and IFN-5 ELISA in all animals except the uninoculated
controls (Figure 2) Higher responses were observed with PBL from the animals receiving live organisms.
In contrast, only the two lambs (S1 and S2) given liveMa. silvaticum responded to stimulation with the
40kDa protein. These observations demonstrate that the 40kDa protein is expressed in vivo as well as in
vitro. They further highlight the diagnostic potential ofthe 40kDa protein, particularly its ability to detect
specific immune responses in animals infected with IS901/902-containing M. avium and discriminate
these from those in animals infected with M.a. paratuberculosis.
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Immunization of Mice with 40kDa Protein
Strains ofM avium that contained IS901/902 (RFLP type A/I) were noted to be more virulent
in mice than strains without the insertion sequence (RFLP type A) (9). Given the complete concordance
between IS901/902 and the 40kDa protein, it was postulated that vaccination with this protein could
protect recipient mice against subsequent challenge with liveMa. silvaticum.
Three groups of 32 newly weaned male BALB/c mice were inoculated as follows:
Group A. 2pug ofpurified 40kDa protein in Freunds incomplete adjuvant (IFA) was inoculated
intraperitoneally in a total volume of 100 pi at 3, 6 and 9 weeks of age.
Group B. 10 pul ofPBS in IFA was inoculated as described for group A.
Group C. 10 pul of PBS was inoculated as described for group A.
When mice in group A had seroconverted to the 40kDa protein, all 96 mice were inoculated
intravenously with 10s cfu liveMa. silvaticum in 100 pi ofPBS. Eight mice from each group were killed
at 6hr and 30,60 and 90 days post challenge. Spleens and livers were removed asceptically and the number
of viable organisms in each organ calculated.
The results of this experiment showed that the 40kDa protein did not confer protection in that
bacterial proliferation was not measurably impeded. There were no significant differences between the
numbers of organisms recovered from the spleens or livers of vaccinated and placebo mice (Figure 3).
However, recent work has shown that depot adjuvants like IFA and aluminum hydroxide stimulatemurine
Th, cell responses characterized by the release ofIL-4 and IL-5, leading ultimately to antibody production
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Figure 3:Viable counts of.M.a. silvaticum recovered from the spleens and livers of vaccinated and placebo mice. Groups
of mice are described in the text.
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upon a cellular immune response, it is perhaps not surprising that the immunization strategy used in the
present study was unsuccessful. Recently, methods have been described to present defined mycobacterial
proteins to the murine immune system so that CMI responses are stimulated and even protection induced
(2,14). The success ofthose experiments illustrates the important point that antigens identified as potential
vaccine components must be delivered and presented to the immune system correctly if their true
immunogenic value is to be correctly assessed, and such work needs to be repeated with the 40kDa
protein.
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SUMMARY
A gene encoding the bacterioferritin subunit (Bfr) of Mycobacterium avium (Ma) subspecies silvaticum has been cloned,
sequenced and expressed. The 477-bp open reading frame codes for 159 amino acids, which were shown to share up to
92% identity with the Bfr of five bacterial genera. The recombinant Bfr exhibits serological cross-reactivity with Ma
paratuberculosis antigen D, a protein of approx. 20 kDa in cell lysates of Ma paratuberculosis and Ma silvaticum and a
protein of 20-22 kDa in sonicates of M. leprae.
Bacterioferritins (Bfr), instrumental in the storage of
iron in at least ten diverse bacterial genera, are spherical
multimers of approx. 400 kDa, assembled from 24 sub-
units of 17-20 kDa each (Grossman et al„ 1992). Four
Xgtll re-clones were isolated from a Ma silvaticum geno¬
mic library by screening with Ab from a hyperimmune
rabbit (Young et ah, 1985). A 3.1-kb insert from one clone
(X/R692) was subcloned into pBluescript (clone pR692)
and the sequence of the first 725 nt (EMBL accession
No. X76906) revealed a 477-bp ORF (159 aa, 17.4 kDa).
The predicted ATG start codon was preceded by a poten¬
tial Shine-Dalgarno sequence from nt 66 to 71.
A FASTA search of the EMBL database revealed that
the 725-bp cloned sequence shared 80% nt sequence
identity with 500-bp of M. leprae genomic DNA (in
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cosmid mlb38; L01095), 59% with 455 bp of the gene
encoding an iron storage protein of Azotobacter vinelandii
(M83692) and 56% with the 598-bp sequence of the E.
coli bfr (M27176). DAP and SWEEP searches of the
OWL database using the deduced 159-aa sequence
revealed homology with five bacterial proteins, the Bfr of
Ma paratuberculosis (antigen D) (Brooks et al., 1991),
Azotobacter vinelandii (Andrews et al., 1991), Escherichia
coli (Andrews et al., 1989), Nitrobacter winogradskyi
(Kurokawa et al., 1989) and Synechocystis PCC 6803
(Laulhere et al., 1992). The deduced aa sequence of clone
pR692 was also 92% homologous to 162 aa of the
translated M. leprae sequence (nt 20960-21 439, reverse
strand on cosmid mlb38). There is only a single aa substi¬
tution between this translated cosmid sequence and the
first 14 N-terminal aa reported for the M. leprae 22-kDa
major membrane protein (M MP-11) (Hunter et al., 1990).
Alignment of the first 42 N-terminal aa of the known Bfr
(Fig. 1) revealed strong identity, including the Bfr consen¬
sus pattern M-X-G-X3-V-( LIV)-X,-L-X-K.
Serological confirmation that clone pR692 encoded the
mycobacterial Bfr was obtained using affinity purified
polyclonal Ab(Beall and Mitchell, 1986). Ab eiuted from
the induced pR692-(5-Gal fusion protein reacted with

















Fig. 1. Alignment of the first 42 N-tcrminal aa of known Bfr. Black boxing indicates complete identity; shaded boxing represents conserved aa.
Accession numbers for the OWL database are given below in parentheses. Symbols: r692, translation of the Ma silvatiatm genomic sequence
A./R692; mlb38cos. translation of the M. leprae genomic sequence L01095. reverse strand; bfrmaptb, Ma paratuberculosis (A44^,9?t); bfrnitwi, Nitrobacter















Fig. 2. Western blot of mycobacterial proteins reacted with affinity-
purified ovine Ab. Lanes: 1. purified kR692-(3Gal fusion protein; 2. puri¬
fied Ma paratuberculosis antigen D: 3. Ma paratuberculosis cell lysate:
4. Ma silvaticum cell lysate; 5. M. leprae cell sonicate. The additional
faint bands in lanes 3 and 4 are artefacts of the Ab elution protocol.
They appear consistently and regardless of the antigenic identity of the
re-protein used for affinity purification.
an antigen ofapprox. 20 kDa in cell lysates of Ma paratu¬
berculosis and Ma silvaticum and an antigen of approx.
20-22 kDa in a M. leprae cell sonicate (Fig. 2).
This work provides clear evidence that clone 2^/R692
encodes the subunit of Ma silcaticum Bfr and further sup¬
ports the identification of M. leprae MMP-II as a Bfr.
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